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Summary 
 
Malaria is a vector-borne disease caused by the protozoan parasite of the genus Plas-
modium and it is transmitted from human to human by female Anopheles mosquitoes 
during a blood meal. For malaria transmission to occur, the malaria parasite must un-
dergo a crucial developmental sexual phase inside the mosquito midgut. In this study, 
we sought to investigate the interplay of the malaria parasite in the mosquito midgut 
with regard to the identification of novel types of transmission blocking intervention 
strategies. These strategies are aimed at reducing the spread of malaria by blocking the 
development of the mosquito midgut-specific stages of Plasmodium. We focused on 
three aspects. 
The first aspect was to investigate the interplay between mosquito midgut bacteria and 
malaria parasites in order to determine the potential influence of malaria parasites on 
the composition of the mosquito gut microbiota and also determine midgut bacteria 
which could be exploited as vehicles for the generation of paratransgenic Anopheles 
mosquitoes. We analyzed the microbial diversity of gut bacteria of the Asian malaria 
vector Anopheles stephensi during development and under different feeding regimes, 
including feeds on malaria parasite-infected blood, using the human pathogenic P. fal-
ciparum as well as the rodent malaria model P. berghei. 16S rRNA and DGGE 
analyses demonstrated a reduction in the microbial diversity during mosquito devel-
opment from egg to adult and identified the gram-negative bacterium Elizabethkingia 
meningoseptica as the dominant species in the midgut of laboratory-reared male and 
female mosquitoes. E. meningoseptica is transmitted between generations and its pre-
dominance in the mosquito midgut was not altered by diet, when the gut microbiota 
was compared between sugar-fed and blood-fed female mosquitoes. Furthermore, 
feeds on blood infected with malaria parasites did not impact the presence of E. men-
ingoseptica in the gut. Interestingly, extracts from E. meningoseptica exhibited 
antibacterial, antifungal and antiplasmodial activities, which may account for its 
dominance in the midgut of the malaria vector. Isolates of E. meningoseptica were cul-
tivable, making the bacterium a potential candidate vehicle for the generation of 
paratransgenic Anopheles mosquitoes. 
The second aspect of this thesis was to determine transcriptome changes that occur 
during the first half hour following transmission of P. falciparum to the mosquito vec-
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tor in order to better understand gene regulation mechanisms important for the change 
of hosts and determine novel proteins which could be exploited in malaria transmis-
sion blocking interventions. We initially used suppression subtractive hybridization 
(SSH) to compare mRNA levels of P. falciparum gametocytes before and 30 min fol-
lowing activation. We identified a total of 126 genes for which transcript expression 
changed during gametogenesis. Among these, 17.5% had putative functions in signal-
ing, 14.3% were assigned to cell cycle and gene expression, 8.7% were linked to the 
cytoskeleton or motor complex, 7.9% were involved in proteostasis and 6.4% in meta-
bolism, 12.7% were genes encoding for cell surface-associated proteins, 11.9% were 
assigned to other functions, and 20.6% represented genes of unknown function. For 
40% of the identified genes there has as yet not been any protein evidence. We further 
selected a subset of 34 genes from all the above ontology groups and analyzed the 
transcript changes during gametogenesis in detail by quantitative real-time RT-PCR. 
Of these, 29 genes were expressed in gametocytes, and for 20 genes transcript expres-
sion in gametocytes was increased compared to asexual blood stage parasites. 
Transcript levels of eight genes were particularly high in activated gametocytes, point-
ing at functions downstream of gametocyte transmission to the mosquito which could 
be exploited in malaria transmission blocking strategies. 
The last aspect of this thesis was to determine the transmission blocking effect of a 
range of antimicrobial molecules as transmission blocking agents. The molecules were 
either isolated from insect hemolymph or recombinantly expressed in tobacco and de-
signed to act either directly on the mosquito midgut stages or cover receptors on 
mosquito tissues like the midgut epithelium which the parasite would need for transit. 
We were able to show an antiplasmodial and transmission blocking effect of the anti-
microbial molecule harmonine, a defense compound isolated from the hemolymph of 
the Asian ladybug Harmonia axyridis. Harmonine thus represents a potential lead 
structure for the development of novel antimalarials. 
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Zusammenfassung 
 
Die Tropenkrankheit Malaria, wird durch eine Infektion mit einzelligen Parasiten der 
Gattung Plasmodium verursacht und durch den Stich der weiblichen Anopheles-
Mücke von Mensch zu Mensch verbreitet. Dabei kann eine erfolgreiche Übertragung 
des Parasiten auf den Menschen nur dann stattfinden, wenn der Parasit seine sexuelle 
Entwicklungsphase im Mitteldarm der Mücke erfolgreich durchläuft. Ziel dieser Ar-
beit war es daher, die Wechselwirkungen des Malariaparasiten im Mitteldarm der 
Mücke in Hinblick auf die Identifizierung möglicher neuer transmissionsblockierender 
Strategien zu untersuchen. Der Zweck von transmissionsblockierende Strategien ist es, 
der Verbreitung der Malaria durch die Mücke entgegenzuwirken, indem die Entwick-
lung des Parasiten in der Mücke unterbunden und dadurch der Lebenszyklus des 
Parasiten unterbrochen wird. Der Schwerpunkt der vorliegenden Arbeit lag auf insge-
samt drei Aspekten. 
Der erste Aspekt der Arbeit befasste sich mit der Wechselwirkung zwischen dem Para-
siten und der mikrobiellen Darmflora der Mücke. Dabei sollte der mögliche Einfluss 
des Parasiten auf die Darmflora untersucht werden und weiterführend die potentielle 
Verwendung von Darmbakterien als Vehikel für die Herstellung paratransgener Mü-
cken erforscht werden. Vergleichende16S-rRNA- und DGGE-Analysen an der 
Darmflora des asiatischen Malariavektors Anopheles stephensi zeigten eine deutliche 
Reduktion der mikrobiellen Diversität während der Entwicklung vom Ei zur adulten 
Mücke. Zudem konnte das gram-negative Bakterium Elizabethkingia meningoseptica, 
das sich stadien- und generationsübergreifend verbreitet, als dominante Darmspezies 
bei im Labor aufgezogenen weiblichen und männlichen An. stephensi festgestellt wer-
den. Die Dominanz von E. meningoseptica wurde zudem nicht durch die Aufnahme 
von infiziertem Blut oder einer veränderten Nahrung beeinflusst. Für die Studien wur-
de sowohl der humanpathogene Parasit P. falciparum als auch der Nagermalariaerreger 
P. berghei verwendet. Weiterführende Versuche zeigten, dass Extrakte von E. menin-
goseptica antibakterielle, antifungale und antiplasmodiale Aktivitäten aufwiesen, die 
ein möglicher Grund für die Dominanz dieser Spezies im Mitteldarm des Vektors war-
en. Isolate von E. meningoseptica sind im Labor kultivierbar; dadurch stellt das 
Bakterium einen potentiellen Kandidaten zur Generierung von paratransgenen Ano-
pheles-Mücken dar. 
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Ein zweites Ziel dieser Arbeit war es, mögliche Unterschiede in der Genexpression 
von P. falciparum darzustellen, die in den ersten 30 Minuten nach dessen Übertragung 
auf die Mücke erfolgen. Dies hatte zum einen zum Zweck, die durch den Wirtswechsel 
hervorgerufenen Genregulationen besser zu verstehen, und bot zum anderen die Mög-
lichkeit, neue Proteine zu identifizieren, die als potentielle transmissionsblockierende 
Ziele genutzt werden können. Mittels supression substractive hybridization (SSH) 
konnten insgesamt 126 Gene identifiziert werden, deren Expression sich während der 
Gametogenese verändert. Die identifizierten Gene konnten einer Vielzahl von putati-
ven Funktionen wie zum Beispiel in der Signaltransduktion (17,5%), im Zellzyklus 
(14,3%) oder im Zytoskelett (8,7%) zugeordnet werden. Des Weiteren wurden 7,9% 
der Gene eine Funktion in der Proteastase und 6,4% in metabolischen Prozessen zu-
geordnet. 12,7% der Gene kodierten für zelloberflächenassoziierte Proteine. 11,9% der 
Gene hatten anderen Funktionen, während 20% der Gene keine putative Funktion zu-
geordnet werden konnte. Etwa 40% der identifizierten Genprodukte waren bisher nicht 
in Proteomstudien nachgewiesen worden. In weiterführenden Analysen wurden 34 
Gene aus jeder ontologischen Gruppe ausgewählt und deren Expressionsveränderung 
per quantitativer real time RT-PCR im Detail untersucht. Für 29 Gene konnte dabei 
eine Transkriptexpression in Gametozyten nachgewiesen werden. Zudem wiesen 20 
Gene eine erhöhte Expression in Gametozyten im Vergleich asexuellen Stadien auf. 
Insgesamt zeigten 8 Gene besonders hohe Transkriptlevel in aktivierten Gametozyten, 
was auf eine Funktion dieser Proteine während der Übertragung des Parasiten auf die 
Mücke hindeutet und diese somit potentielle Angriffspunkte für transmissionsblockie-
rende Strategien darstellen könnten. 
Im letzten Teil dieser Arbeit stand die Untersuchung verschiedener antimikrobieller 
Substanzen in Bezug auf ihre transmissionsblockierenden Eigenschaften im Vorder-
grund. Die Substanzen waren entweder direkt aus der Hämolymphe verschiedener 
Insekten isoliert oder rekombinant in transgenem Tabak exprimiert worden. Dabei 
wurden die rekombinanten Peptide so ausgewählt, dass sie entweder gegen die Mittel-
darmstadien des Parasiten wirken oder mückenspezifische Rezeptoren blockieren, die 
der Parasit für seine weitere Entwicklung benötigt. Dabei konnte gezeigt werden, dass 
das antimikrobielle Molekül Harmonin, ein Abwehrmolekül aus der Hämolymphe des 
asiatischen Marienkäfers Harmonia axyridis, antiplasmodiale als auch transmissions-
blockierende Eigenschaften besitzt. Harmonin stellt daher eine potentielle Leitstruktur 
für die Entwicklung neuer Malariawirkstoffe dar.  
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1. Introduction 
1.1 Malaria 
Malaria is a vector-borne devastating disease caused by protozoan parasites of the ge-
nus Plasmodium and transmitted by female Anopheles mosquitoes. The disease in 
humans is caused by four main species; Plasmodium falciparum, P. vivax, P. ovale and 
P. malariae with P. falciparum being the agent responsible for malaria tropica which is 
considered as the most deadly form of the disease (reviewed in Greenwood et al, 
2008). Human infections with P. knowlesi, a malaria parasite that normally infects 
monkeys, have also been described in virtually all southeast Asian countries and the 
species is now considered as the fifth human pathogen (White, 2008; Cox-Singh and 
Singh 2008; reviewed in Singh and Daneshvar, 2013). In endemic regions, co-
infection of humans with more than one Plasmodium species is possible (Mehlotra et 
al., 2000).  
According to the WHO World Malaria Report, malaria is responsible for approximate-
ly 216 million clinical cases and 665,000 deaths annually affecting mainly children 
below the age of five  and pregnant woman principally in Sub-Saharan Africa (WHO 
Malaria Report, 2011). Estimates also show that about 3.3 billion people are at risk of 
malaria in 99 countries with ongoing malaria transmission (Figure 1). Specific popula-
tion risk groups include young children in stable transmission areas who have not yet 
developed protective immunity against the most severe forms of the disease, pregnant 
women since the disease leads to low birth weight and high rates of miscarriages 
which can result to maternal death, people with HIV/AIDS and international travelers 
who lack immunity and are visiting malaria endemic areas. 
The onset of malaria symptoms takes place 10-15 days after being bitten by an in-
fected mosquito, resulting in fever, chills, headaches, and vomiting (Ashley et al., 
2003; Sherman 2005; Acharya et al., 2007). If these symptoms are not addressed with 
chemotherapeutic treatment, the disease may progress to severe malaria (Ashley et al., 
2003; Ndam et al., 2007), which consists of severe anaemia, acute respiratory failure, 
hypoglycemia, renal failure, pulmonary edema, seizures, and unarousable coma 
(Ndam et al., 2007).  
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Malaria cases continue to rise in affected areas due to weak health systems, wide-
spread poverty (Hargreaves et al., 2000) and climate change which favors the 
abundance and distribution of the malaria vectors (Khasnis and Nettleman 2005). 
Also, efforts to completely eradicate the disease have been hampered by the lack of an 
effective vaccine and the rapid emergence of drug resistant parasites and insecticide- 
resistant mosquitoes. The WHO recommends the use of artemisinin-based combina-
tion therapies (ACTs) as the first‐line treatment for falciparum malaria in all endemic 
regions. However, there have been reports of the emergence of resistance to artemisi-
nins (Dondorp et al., 2009; Phyo et al., 2012) thereby threatening the use of the drug. 
Hopes of a highly efficient malaria vaccine are also being lost as the RTS, S/AS01 
vaccine which was shown in a phase III clinical trial to reduced malaria by half in 
children 5 to 17 months of age during a 12 months period after vaccination (Agnandji 
et al., 2011) now shows just an efficacy of 16% over a 4 years period (Olotu et al., 
2013). There is therefore the need to develop new strategies aimed at eradicating the 
disease. The malaria transmission blocking strategies which are aimed at disrupting 
the transmission of the disease from human to human by the mosquito seems to be the 
best alternative since the mosquito midgut malaria parasite stages undergo severe 
losses in parasite number. 
 
 
 
Figure 1: Countries or areas at risk of malaria transmission (Adapted from 
http://www.iamat.org/pdf/world_malaria_risk_chart.pdf) 
 Introduction 
3 
1.2 The P. falciparum life cycle 
P. falciparum exhibits a complex life cycle which alternates between the human host 
and the Anopheles mosquito (Figure 2). Infection is initiated through the bite of an in-
fected female Anopheles mosquito and the release of sporoziotes from the salivary 
gland into the blood stream during feeding (Matuschewski 2006). The sporozoites are 
carried in the blood stream to the liver within half an hour where they invade hepato-
cytes. In the hepatocytes, the sporozoites begin to multiply asexually and within 6-15 
days produce uninucleated merozoites contained inside host cell vesicles called mero-
somes. The merozoites are eventually released into the blood stream through budding 
of the merosome where they invade red blood cells. Within 48 h, the parasites begin 
replicating mitotically, progressing through a set of stages i.e. ring, trophozoite and 
schizont (Figure 3A). The mature schizonts then burst releasing merozoites, which 
immediately invade new uninfected red blood cells and the cycle continues leading to 
the clinical manifestations of the disease. Some of the schizonts are stimulated to re-
lease merozoites which develop into male and female gametocytes that mature from 
stage I to stage V in the blood (Figure 3B). Maturation of P. falciparum from stage I to 
stage V takes approximately 10 days. The mature gametocytes circulate in the human's 
blood stream, but remain dormant until they are taken up by a blood-feeding mosquito. 
In the midgut of the mosquito, the gametocytes become activated by the drop in tem-
perature and the mosquito derived molecule xanthurenic acid (Billker et al., 1998; 
Garcia et al., 1998; reviewed in Kuehn and Pradel, 2010). Male and female gametes 
emerge from gametocytes and fertilization occurs to form a zygote. The zygote further 
develops into a motile ookinete which traverses the midgut epithelium. At the basal 
lamina the ookinete transforms to a sessile oocyst which matures and produce thou-
sands of sporozoites that become released and invade the mosquito salivary gland. The 
life cycle is complete when the mosquito infects another human following a blood 
meal. 
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Figure 2: The malaria life cycle (Su et al., 2007). 
 
 
 
 
Figure 3: Blood stages of P. falciparum. (A) Shows the time course of development from 
ring stages to schizonts in vitro (Adapted from Radfar et al., 2009). The ring stage is observed 
between 6 and 22 h, the trophozoites between 22 and 38 h and the schizont stage is observed 
between 38 and 48 h and merozoites at 48 h just before invasion. (B) Shows the different ga-
metocytes stages during development from stage I to V (modified from Sutherland 2009). 
A 
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1.3 The malaria vector-Anopheles  
Female mosquitoes of the genus Anopheles are vectors of the Plasmodium parasites 
that cause malaria. There are approximately 465 Anopheles species and about 70 of 
these can spread malaria parasites between humans (Sinka et al., 2012). Different 
Anopheles species transmit the disease depending on the region and the environment.  
Anopheles gambiae and Anopheles funestus mosquitoes are the main vectors in Africa, 
where 90% of malaria-related deaths occur (Lindh et al., 2005) and Anopheles ste-
phensi, the main vector in Asia is responsible for the transmission of the malaria 
parasite P. vivax (Rani et al., 2009). 
The Anopheles mosquito undergoes four main stages during its life cycle i.e. egg, 
larva, pupa, and adult (Figure 4). The first three stages (egg, larva and pupa) are 
aquatic and take about 5-14 days, depending on the species and the ambient tempera-
ture. Eggs are laid on water by females and develop into larvae within 2-3 days 
depending on the temperature. Anopheles larvae go through four stages, or instars, af-
ter which they metamorphose into pupae. At the end of each instar, the larvae molt, 
shedding their exoskeleton, to allow for further growth. The larvae feed on algae, bac-
teria, and other microorganisms in the surface microlayer (Wotton et al., 1997). The 
pupae then develop into adults within 2-3 days. Male Anopheles mosquitoes feed ex-
clusively on sugar sources and therefore do not transmit the disease. Female 
mosquitoes also feed on sugar from different sources but need blood for the develop-
ment of their eggs. 
 
Figure 4: Life cycle of Anopheles species. (Modified from 
www.wumcd.org/mosquito/lifecycle.html) 
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1.4 The malaria life cycle in the mosquito midgut 
For malaria transmission to occur, the malaria parasite must undergo a crucial devel-
opmental sexual phase inside the mosquito vector (Figure 5) which involves multiple 
developmental steps i.e. gametogenesis, fertilization, followed by zygote, ookinete and 
oocyst formation (reviewed in Kuehn and Pradel, 2010). This sexual phase starts when 
Plasmodium gametocytes (male and female gametocytes) are ingested by Anopheles 
mosquitoes during a blood meal. In the midgut of the mosquito, the gametocytes be-
come activated by the drop in temperature and the mosquito derived molecule 
xanthurenic acid (Billker et al., 1998; Garcia et al., 1998; reviewed in Kuehn and Pra-
del, 2010). Gametocyte activation leads to rounding up of the cell within 5 mins, 
followed by parasite egress from the enveloping erythrocyte. The egress process in-
volves the rupture of two membranes, the parasitophorous vacuole membrane (PVM) 
and the erythrocyte membrane (Sologub et al., 2011; reviewed in Wirth and Pradel, 
2012). During gametogenesis the microgametocyte replicates its genome three times 
in order to produce eight motile microgametes. Following the fusion of micro- and 
macrogametes a zygote forms within 30 mins post blood meal and develops into an 
infective ookinete within the following 24 hours. The motile ookinete possesses an 
apical complex which enables it to traverse the midgut epithelium before settling down 
and forming an oocyst between epithelium and basal lamina (reviewed in Pradel, 
2007). 
Noteworthy, the midgut stages have to persevere outside a host cell for more than one 
day. During this time period, the cells are highly vulnerable to the aggressive factors of 
the gut, which among others include bacteria as well as human immune cells, antibo-
dies and complement proteins present in the blood meal, and this exposure results in 
an approximate 1000-fold loss of parasite abundance (Vaughan et al., 1994; (reviewed 
in Pradel 2007; Kuehn and Pradel, 2010)). Because of these reasons, the malaria para-
site midgut stages are considered bottle necks of the parasite life cycle (Figure 6) and 
represent prime targets for transmission blocking strategies (Abraham et al., 2004; 
Drexler et al., 2008). 
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Figure 5: P. falciparum development in the mosquito midgut (modified from Kuehn and 
Pradel, 2007). Following maturation of intraerythrocytic gametocytes in the human host, they 
are taken up by the blood feeding female mosquito. Once they enter the midgut, they become 
activated and round up and emerge from the host erythrocyte. During gametogenesis, the fe-
male macrogametes transform into a macrogamete, while the activated male microgamete 
form eight motile microgametes within 15 min post blood meal. Within approximately 20 min 
post activation, the motile microgamete fertilizes the macrogamete resulting in the formation 
of a zygote which transforms into an infective ookinete within 24 h. 
 
 
 
 
Figure 6: Bottleneck in malaria parasite life cycle (modified from 
http://www.malariavaccine.org/files/11122009_VectorbiologyandTBVs_ASTMH-
DC_SINDEN.pdf ). From the hundreds of thousands of parasites in the human blood, the 
number of parasites drops below five ookinetes in the mosquito midgut  
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1.5 Anopheles mosquito midgut bacteria  
The midgut of Anopheles mosquitoes is inhabited by bacteria and several studies have 
investigated these midgut bacteria either from lab-reared and field collected malaria 
vectors (Table 1). In a recent study on An. gambiae in Cameroon, Boissière and col-
leagues reported that 90% of gut bacteria from mosquitoes collected in natural 
breeding sites belong to the Proteobacteria, while in lab-reared mosquitoes more than 
95% of the bacteria belong to the Elizabethkingia sp. (Boissière et al., 2012). In a 
broad study whereby 454 pyrosequencing was used to investigate the bacterial diversi-
ty in the guts of eight species of mosquitoes collected from the coastal region of 
Kenya, four main classes of  bacteria  of  the  Gammaproteobacteria, Alphaproteobac-
teria, Flavobacteria and Gram-positive Bacilli classes were found to be dominant 
(Osei-Poku et al., 2012).  Also, broader variety of midgut bacteria were identified in 
field-caught An. stephensi from Southern Iran, in which 5 genera were identified in the 
adult midgut, including Pseudomonas, Alcaligenes, Bordetella, Myroides and Aeromo-
nas (Chavshin et al., 2011). Similarly, An. stephensi caught in the Eastern 
Mediterranean Region exhibited a broad variety of midgut bacteria, most of which be-
longed to the γ-Proteobacteria class (Dinparast et al., 2011). Rani and colleagues (Rani 
et al., 2009) reported the dominance of uncultured Paenibacillaceae in male An. ste-
phensi caught in Haryana, India, while in field-caught females and in larvae Serratia 
marcescens dominated (Rani et al., 2009). In lab-reared mosquitoes, on the other hand, 
the authors identified Serratia marcescens and Elizabethkingia meningoseptica as the 
dominant species. Lindh and coworkers (Lindh et al., 2005) identified 16 bacterial 
species in the midgut of field-caught An. gambiae and An. funestus in Western Kenya, 
but again only two dominant bacteria species were found in lab-reared An. gambiae, 
i.e. Pantoea stewartii and E. meningoseptica (Lindh et al., 2008). The combined data 
show a high bacteria diversity in the gut of field-caught mosquitoes as compared to lab 
reared mosquitoes and the bacteria species differs independent of mosquito species 
and habitat indicating that microbial content of mosquito midguts is a result of the na-
tive aquatic source of the breeding grounds. 
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Mosquito species Bacterial species Field/lab Reference 
Anopheles  gambiae Asaia spp., Burkholderia spp., Acinetobacter spp., Ralstonia spp., Methylobacterium spp., 
Sphingomonas spp., Pseudomonas spp., Stenotrophomonas spp, Stenotrophomonas spp, 
Streptococcus, Comamonas, Sediminibacterium spp., Escherichia-Shigella spp., Bradyrhi-
zobium spp., Staphylococcus spp., Fusobacterium spp., Elizabethkingia spp., 
Gluconacetobacter spp., Neisseria spp., Schlegelella spps., Prevotella spp., Cedecea spp., 
Serratia spp. 
field Boissière et al., 2012 
Acinetobacter sp., Bacillus pumilus, Bacillus sp., Enterobacter sp., Pseudomonas putida, 
B. cereus, Exiguobacterium mexicanum, Kocuria turfanensis, Pantoea sp., Pseudomonas 
rhodesiae, Staphylococcus sp.,Athrobacter sp., Comamonas sp., Knoellia sp. 
field Cirimotich et al., 2011 
Asaia sp. Burkholderia sp., Elizabethkingia sp., Bacillus spp lab Chouaia et al., 2010 
Enterobacter asburiae, Microbacterium sp., Sphingomonas sp., Serratia 
sp.,Chryseobacterium meningosepticum, Asaia bogorensis, Bacillus subtilis, Enterobacter 
aerogenes, Escherichia coli, Herbaspirillum sp., Pantoea agglomerans, Pseudomonas 
fluorescens, Pseudomonas straminea, Phytobacter diazotrophicus, Serratia marcescens 
lab Dong et al., 2009 
Sphingomonas spp., Phenilobacterium spp., Asaia spp., Burkolderia spp., Aquabacterium 
sp., Acinetobacter spp., Pseudomonas spp. 
field Favia et al., 2007 
Acidovorax sp., Anaplasma ovis, Anaplasma sp., Bacillus sp., Bacillales sp., Mycoplasma 
sp.,Paenibacillus sp., Rhodococcus cornybacteriodes,Thorsellia anopheles, Pseudomonas 
sp., St. maltophilia,Vibro matshnikovii, Aeromonas sp., Enterobacteriaceae sp. 
field Lindh et al., 2005 
Achromobacter  xylosoiydans, Bacillus cereus, Bacillus coagulans, Bacillus mucoides, 
Bacillus thuringensis, Hydrogenophaga pseudoflava, Pseudomonas putida, Ps. stutzeri, 
Cedecea davisae, Escherichia coli,Klepsiella pneumonia, Morganella morgani, P. ag-
glomerans, Pantoea ananas, Salmonella choleraesuis, Salmonella enteritidis. 
field Straif et al., 1998 
Flavobacterium spp., Ps. Cepacia, Ps. gladioli, Aeromonas hydrophila, Cedecea lapagei, 
Klyvera cryocrescens, P. agglomerans, Serratia spp. 
 
lab Pumpuni et al., 1996 
An. stephensi Pseudomonas spp., Shewanella spp., Exiguobacterium spp., Klebsiella spp., Enterococcus 
spp., Microbacterium spp., Chryseobacterium spp., Rhodococcus spp., Kocuria  spp., 
Aeromonas spp., Alcaligenes spp., Bordetella spp., Myroides spp., Enterobacter spp. 
field Chavshin et al., 2012 
Pantoea agglomerans, Pantoea stewartii, Bacillus pumilus, Sphingomonas paucimobilis., lab Dinparast et al., 2011 
Brevundimonas aurantiaca, Lysinibacillus sphaericus, Rahnella aquatilis field Dinparast et al., 2011 
Table 1: Overview of bacteria diversity in field and lab-reared Anopheles mosquitoes 
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Micrococcus sp., Staphylococcus hominis, S. saprophyticus, Acinetobacter, iwofii,A. ra-
dioresistens, A. johnsonii,Flexibacteriaceae, Bacillus sp., Paenibacillus alginolyticus, P. 
chondroitinus, Paenibacillaceae, Herbaspirillum sp., Photorhabdus luminescens, Chry-
seobacterium indologenes, A. hemolyticus, Citrobacter freundi, Leuconostoc citreum, 
Achromobacter xylosoxidans, Acinetobacter sp., Pseudomonas putida, Bacillus cereus, B. 
firmus, Exiguobacterium, Acinetobacter venetianus, Aeromonas sobria, Acinetobacter 
popoffii, Pseudomonas anquilliseptica, Calothrix sp., Brevibacterium paucivorans, 
Dysqonomonas sp.Staphylococcus  cohnii, S. suis, Bacillus thermoamylovorans, Lactoba-
cillus, Azoarcus sp., Leptothrix sp., Hydroxenophaga, Enterobacter aerogenes, 
Ignatzschineria larvae sp, Enterobacter sp., Serratia sp. 
field Rani et al., 2009 
Chryseobacterium meninqosepticum, Agrobacter sp., Pseudomonas mendocina, Serratia 
marcescens, Elizabethkingia meningoseptica, A. tumefaciens, Pseudomonas tolaasii, Kleb-
siella sp, Comamonas sp., uncultured bacteria clone 
lab Rani et al., 2009 
Asaia spp., Gluconobacter asaii, Acetobacter aceti, Sphingomonas rhizogenes lab Favia et al., 2007 
Flavobacterium spp., Ps. cepacia, A. hydophila, C.lapagei, P. agglomerans lab Pumpuni et al., 1996 
Staphylococcus spp., Ewingella americana, serratia marcescens, lab Pumpuni et al., 1993 
An. arabiensis Acinetobacter sp., Bacillus. Pumilus, Bacillus spp., Enterobacter sp., Pseudomonas spp., 
B. cereus, Exiguobacterium mexicanum, Kocuria turfanensis, Pantoea sp., Staphylococcus 
sp., Arthrobacter sp., Comamonas sp., Enterobacter sp., Knoellia sp. 
field Cirimotich et al., 2011 
An. albimanus Flavobacterium spp., Acinetobacte spp., Ps. Capacia, Pantoea agglomerans, Serratia spp. lab Pumpuni et al., 1996 
Enterobacter amnigenus, .E. cloacae, Enterobacter sp., S. marcescens, Serratia sp. field  Gonzalez- Ceron et al., 
2003 
An. funestus Bacillus megaterium, Brevunzdiumonas diminuta, Comamonas testeroni, Flavobacterium 
resinovorum, Gluconobacter cerinus, Pseudomonas mendocina, Ps. stutzeri, St. malto-
philia, C. davisa, E. coli, Erwinia chrysanthemum, K. pneumonia, Klyvera cryosceens, P. 
agglomerans P. ananas, S. choleraesuis. 
field Straif et al., 1998 
Janibacter anopheles, Spiroplasma ap. field Lindh at al., 2005 
An. sinensis Elizabethkingia meningoseptica, Brevibacillus  centrosporus, Comomonas testosterone, 
Aeromonas punctata, Aeromonas hydrophila, Serratia ficaria, Pseudomonas fluorescence, 
Pectobacterium carotovorum, Rahnella aquatilis. 
lab Li  and Tang  2010 
An. maculipennis Serratia spp., Asaia spp., Staphylococcus spp. field and  lab Favia et al., 2007 
Aeromonas bivalvium, Pseudomonas mendocina, Lysinibacillus sphaericus, Aeromonas 
punctata. 
field  Dinparast et al., 2011 
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1.6 Effect of midgut bacteria on malaria infection in the mosquito 
The midgut bacteria of insecst have been shown to play a vital role in preventing the 
development of pathogens. Several studies have reported a protective role of Ano-
pheles midgut bacteria against malaria infection in the mosquito. The treatment of the 
mosquito midgut bacteria with antibiotics results in enhanced Plasmodium infection 
(Beier et al., 1994; Dong et al., 2009) with gram-negative bacteria highly implicated in 
reducing the mosquito infection with the malaria parasite (Pumpuni et al. 1993; Pum-
puni et al. 1996; Gonzalez-Ceron et al. 2003; Azambuja et al., 2005). Noden et al., 
also showed an improved conversion of ookinetes to oocyts in P. falciparum using an-
ti-bacterial antibodies generated against total midgut lysates (Noden et al., 2011). 
Also, the co-infection of bacteria with Plasmodium has been shown to reduce the 
number of developing oocyts in the mosquito midgut both in field and laboratory con-
ditions (Dong et al., 2009; Gonzalez-Ceron et al. 2003; Cirimotich et al., 2011). The 
mechanism by which midgut bacteria inhibit Plasmodium infection has been  studied 
only to a limited extend and it has been suspected that midgut bacteria play a role ei-
ther directly by the production of various enzymes and toxins or physical barriers 
which hinder the interaction between Plasmodium ookinetes and midgut epithelium 
(Pumpuni et al. 1993; Azambuja et al., 2005) or indirectly by stimulating the mosqui-
to’s innate immune system to produce antimicrobial molecules which then also act 
against the Plasmodium parasite ( Dong et al., 2009). Cirimotich and colleagues re-
ported the isolation of an Entobacter bacterium from wild mosquitoes in Zambia and 
showed that the inhibition of Plasmodium development by the bacterium is through 
the production of reactive oxygen species which target Plasmodium parasites in the 
mosquito midgut (Cirimotich et al., 2011). Other studies have implicated the activation 
of the mosquito’s innate immune response by bacteria. Meister and others were able to 
show  that mosquito gut bacteria drastically proliferate after a blood meal and the up-
take of Plasmodium-infected blood triggers immune defense mechanisms in the 
mosquito that are directed against both the proliferated bacteria and the malaria para-
sites (Meister et al., 2009). Global transcription profiling of septic and aseptic 
mosquitoes identified a significant subset of immune genes that were mostly up-
regulated by the mosquito’s microbiota, and which also include several anti-
Plasmodium factors (Dong et al., 2009). Antimicrobial factors up-regulated by bacte-
rial infections, which have implications on malaria parasites, include members of the 
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fibrinogen-related protein FREP family (Dong et al., 2009) and the gram-negative bac-
teria-binding protein (GNBP) family (Warr et al., 2008). 
 
1.7 Gene expression and regulation in Plasmodium gametocytes  
The identification of genes specifically expressed in Plasmodium gametocytes have 
been facilitated by the availability of genome sequence data and the application of ap-
proaches such as proteomics, microarrays and gene knockout studies (reviewed in 
Moreira et al., 2004). P. falciparum transcriptome analyses have detected 250 to 300 
genes that are specifically upregulated at the mRNA level during gametocyte devel-
opment (Young et al., 2005; Sivestrini et al., 2005). The P. falciparum proteome on the 
other hand revealed more than 900 proteins in gametocytes, 315 of which are found 
exclusively in gametocytes (Lasonder et al., 2002). Key proteins specifically ex-
pressed in Plasmodium gametocytes include Pfs16, Pfg27, Pfpeg3, Pfpeg4, Pfg377, 
Pfs230, pfs48/45 and PfCCps (reviewed in Pradel et al., 2007).  
Pfs16 a transmembrane protein expressed on the parasite parasitophorous vacuolar 
membrane (PVM) at the onset of gametocyte maturation has been described (Baker et 
al., 1994; Bruce et al., 1994; Silvestrini et al., 2005; Eksi and Williamson, 2011). Gene 
disruption studies of Pfs16 have shown a reduction in gametocyte production and an 
impaired ability of male gametocytes to exflagellate (Kongkasuriyachai et al, 2004). 
Pfg27 is transcribed at approximately 30 h post invasion (Carter el al., 1989; Sharma 
et al., 2003) and it is hypothesized to play a role in the extended period of gametocyte 
development in P. falciparum (reviewed in Baker et al., 2010). Pfg27 is also suspected 
to enable the formation of a multi-protein complex that mediates transduction of ex-
ternal signals and leads to its interaction with specific RNAs (Sharma et al., 2003).  
The male development gene 1 (PfMdv-1) also known as PfPeg3 is expressed in intra-
cellular vesicles in both male and female gametocytes but is later localized to the 
surface of developing ookinetes (Furuya et al., 2005; Lal et al., 2009). The disruption 
of the P. falciparum gene Pfpeg3 is linked to early arrest in male gametocytogenesis 
(Furuya et al., 2005).  
Pfge4 renamed as P. falciparum gametocyte development 1 gene (Pfgdv1) has been 
shown by Eksi and colleagues using gametocyte-defective parasite lines and genetic 
complementation that the gene encoding a peri-nuclear protein, is critical for early 
sexual differentiation (Eksi et al., 2012). Transcriptional analysis of Pfgdv1 negative 
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and positive parasite lines identified a set of gametocytogenesis early genes (Pfge) that 
were significantly down-regulated in the absence of Pfgdv1 and expression was re-
stored after Pfgdv1 complementation (Eksi et al., 2012).  
The Pfg377 protein is localized in the osmiophilic bodies of female gametocytes 
(Alano et al., 1995; Severini et al., 1999) and gene-disruption of pfg377 results in the 
lack of osmiophilic bodies in female gametocytes and inability of the parasite to egress 
from host erythrocytes pointing at an important role in gametocyte emergence (de 
Koning-Ward et al., 2008).  
Pfs230 and Pfs48/45 belong to the 6-cysteine repeat protein family (reviewed in Aly et 
al., 2009). Pfs230 is expressed in gametocytes and gametes plasma membrane where it 
forms a membrane bound complex with the GPI anchored Pfs48/45 (Kumar, 1987; 
Kumar and Wizel, 1992). Knockout studies of Pfs230 revealed an important unidenti-
fied function during gamete fertilization in the mosquito midgut (Eksi el al., 2006). 
Pfs48/45 is expressed in gametocytes and male gametes and gene deletion mutants in 
P. berghei showed an essential function during fertilization (van Dijk et al., 2001).  
A highly conserved family of six secreted proteins has also been shown to be ex-
pressed in the P. falciparum gametocyte parasitophorous vacuolar membrane (Pradel 
et al., 2004). They comprise multiple adhesive domains (Lasonder et al., 2002; Pradel 
et al., 2004). Five of these proteins possess common Limulus coagulation factor C 
(LCCL) domains and are termed PfCCp1 up to PfCCp5, whereas a sixth protein, 
PfFNPA, lacks this domain but shares architectural features similar to the other PfCCp 
proteins. Gene disruption of pfCCp2 or pfCCp3 result in a complete blockage of spo-
rozoite transition from the mosquitoes midgut to the salivary glands indicating that 
these proteins are essential for the parasite development in the vector (Pradel et al., 
2004) while gene disruption of pfCCp4, on the other hand revealed no essential func-
tion for sporozoite transition from the midgut to the salivary glands (Scholz et al., 
2008). 
An important post-transcriptional mechanism to regulate gene expression in Plasmo-
dium gametocytes known as translational repression has been reported (Paton et al., 
1993; Vervenne et a., 1994; Abraham et al., 2004; Hall et al., 2005). In this mechan-
ism, mRNA encoding for proteins that are required after gametocyte activation in the 
mosquito such as P25 and P28 are synthesized in gametocytes but translatinally re-
pressed (Mair et al., 2006). In a study conducted by Hall and colleagues, where the P. 
berghei gametocyte transcriptome was compared with the proteomes of gametocytes 
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and ookinetes, 9 genes were identified for which transcripts accumulated in gameto-
cytes but were not translated until the ookinete stage (Hall et al., 2005). In a recent 
study conducted by Saeed and coworkers, it was shown that in P. berghei, the mRNA 
transcript of some members of the Plasmodium LCCL protein family (PbLAP4, 
PbLAP5 and PbLAP5) accumulates in gametocytes but their proteins are not ex-
pressed indicating that they are translationally repressed (Saeed et al., 2013).  
The mechanism of translational repression in Plasmodium had been proposed (Figure 
7) (Mair et al., 2006). Using the rodent malaria parasite P. berghei, Khan and col-
leagues identified in the gametocyte specific proteome (Khan et al., 2005) an RNA 
helicase DOZI (development of zygote inhibited), a member of the DEAD-Box RNA 
helicase as part of a ribonucleoprotein complex involved in translational repression of 
female gametocytes (Mair et al., 2006). DOZI is highly expressed in the cytoplasmic 
bodies of female gametocytes where it interacts with some Plasmodium mRNAs. Mair 
and others were able to show that gene targeted disruption of DOZI resulted in a down 
regulation of approximately 370 transcripts targeted for degradation rather than trans-
lation and also preventing zygote development (Mair et al., 2006). In 2010, Mair and 
others identified an interaction partner of DOZI called CITH (homolog of worm CAR-
I and fly trailer hitch) as a component of messenger ribonucleoprotein complex 
(mRNP) involved in the maternal mRNA translational repression machinery (Mair et 
al., 2010). CITH mutants revealed that the expression of 232 transcripts were signifi-
cantly changed with 183 mRNAs more than 2 fold down regulated and 127 mRNAs 
were found to be destabilized  in both data sets (Mair et al., 2010). Also gene deletion 
mutant parasites of the two core mRNP proteins (DOZI and CITH) result in fertiliza-
tion but the zygotes fail to develop into ookinetes in a female gametocyte mutant 
fashion. 
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Figure 7: Proposed mechanism of translational repression (Modified from Mair et al., 
2006). In the presence of the RNA helicase DOZI and its interaction partner CITH specific 
transcripts are assembled into translationally quiescent mRNPs in the female gametocytes that 
are the precursors of the female gametes. These mRNAs are stored for later translation after 
gamete formation and fertilisation, which occurs in the mosquito. In the absence of DOZI and 
CITH the transcripts are neither stored in silent mRNPs nor transported to translating poly-
somes but instead are specifically degraded  
 
1.8 Transmission blocking strategies in the mosquito 
Malaria transmission blocking strategies are aimed at reducing the prevalence of ma-
laria infection in endemic communities by targeting Plasmodium within the insect 
host. These strategies thereby reduce exposure of the human population to infectious 
mosquito. This section gives a brief overview of the current malaria transmission 
blocking strategies in the mosquito. 
1.8.1 Malaria transmission blocking vaccines (TBVs) 
Malaria transmission blocking vaccines (TBVs) are designed to prevent the transmis-
sion of malaria from an infected to an uninfected individual by the Anopheles vector. 
Such vaccines do not protect an individual from infection but rather reduce the trans-
mission of the disease. TBVs target sexual phase surface antigens of the malaria 
parasite by relying on human antibodies to inhibit the parasites from developing in the 
mosquito host together with the involvement of complement or cell-mediated destruc-
 Introduction 
16 
tion of parasites (Figure 8A). Studies have also shown that it is also possible to raise 
antibodies by inoculating the host with recombinant DNA plasmids containing the 
gene encoding for the surface antigens which can produce antibodies with transmis-
sion blocking activities (Lobo et al., 1999; Coban et al., 2004; LeBlanc et al., 2008).  
The leading malaria TBV candidates include Pfs25, Pfs28, Pfs48/45 and Pfs230 and 
their orthologs in P. vivax (reviewed in (Pradel 2007; Coutinho-Abreu and Ramalho-
Ortigao, 2010; Arévalo-Herrera et al., 2011)). The TBV potential of Pfs25 has been 
demonstrated using different expression system. Goodman and others  were able to 
express the antigen in recombinant chimpanzee adenovirus 63 (ChAd63), human ade-
novirus serotype 5 (AdHu5) and modified vaccinia virus Ankara (MVA) viral vectored 
vaccines and demonstrated that sera from Ad-MVA Pfs25 immunized mice inhibited 
the transmission of P. falciparum to the mosquito both ex vivo and in vivo (Goodman 
et al., 2011). Also, multiple versions of the Pfs25 antigens in a plant virus-based tran-
sient expression system have also been generated and sera from immunized mice 
showed strong transmission blocking activity in standard membrane feeding assay 
(Farrance et al., 2011). Antibodies against algae-produced Pfs25 have also been 
showed to exhibit transmission blocking activity (Gregory et al., 2012). In others stud-
ies, the TBA  potential of Pfs25 was demonstrated using the vaccinia virus as delivery 
system of this antigen to the mammalian hosts (Kaslow et al., 1991), or using recom-
binant Pfs25 expressed in yeast ( Barr et al., 1991; Kaslow et al., 1991). However, in 
phase 1 trial aimed at assessing the safety and immunogenicity of recombinant Pfs25 
formulated with Montanide ISA 51, a water-in-oil emulsion, it was reported that the 
candidate vaccine induce transmission blocking immunity in humans but reported un-
expected side effects (Wu et al., 2008). 
Pfs28 is a 28 KDa protein encoded by a paralogue of the gene encoding Pfs25 and it is 
adjacent to Pfs25 in the genome (Duffy and Kaslow, 1997). The antigen has also been 
tested in TBA and it has been shown that antibodies produced by the injection of yeast 
Pfs28 in the presence of alum, significantly reduced the infection of An. freeborni 
mosquitoes with P. falciparum (Duffy and Kaslow, 1997). The authors further showed 
a lower infectivity when vaccination was carried out with yeast Pfs28 and Pfs25 anti-
gens injected at the same time. Gozar and colleagues also showed that Pfs25/Pfs28 
fusion proteins were significantly more potent than either Pfs25 or Pfs28 alone in eli-
citing antibodies in mice that blocked oocyst development in Anopheles freeborni 
mosquitoes (Gozar et al., 1998). Therefore there may be an advantage in combining 
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Pfs25 and Pfs28 in the same vaccine since immunization with both may be synergistic 
in inducing transmission blocking antibodies. 
Other TBV candidates to prevent the spread of P. falciparum include Pfs230 and 
Pfs48/48 (reviewed in Pradel 2007). Pfs230 and Pfs48/45 contain 14 and 3 copies, re-
spectively; of a motif that has a characteristic pattern of conserved cysteines 
(Williamson et al. 1993; Carter et al. 1995; Templeton and Kaslow, 1999; Gerloff et al. 
2005) and are classified to belong to the 6-cysteine repeat protein family (reviewed in 
Aly et al., 2009). These proteins are expressed on the surface of gametocytes and ga-
metes (reviewed in Williamson, 2003). A disruption of the gene encoding for Pfs230 
leads to reduced fertilization and oocyst formation (Eksi et al., 2006). Also, because 
Pfs230 is a very large molecule, it has been difficult to determine which regions would 
be effective in a vaccine. However, fragments have been expressed as E.coli MBP- 
fusion proteins and shown to induce some transmission blocking activity (Williamson 
et al., 1995). Although antibodies against Pf230 have been shown to block the trans-
mission of P. falciparum in the mosquito, the transmission blocking activity of Pfs230 
monoclonal antibodies was completely lost when complement was inactivated (Qua-
kyi et al., 1987) indicating that the activity is mainly mediated by complements. In this 
regard, other studies have confirmed a complement mediated transmission blocking 
effect of antibodies against Pfs230 (Healer et al., 1997; Tachibana et al., 2011). Far-
rance et al. produced a region of the Pfs230 antigen in a plant-based transient-
expression system and showed that the antigen induces a strong immune response in 
rabbits that is able to reduce oocyst count in the presence of complements by greater 
than 99% as determined by standard membrane feeding assays. (Farrance et al., 2011) 
Pfs48/45 is mainly expressed in P. falciparum gametocytes and gametes and has been 
shown to play a central role in male gamete fertility (van Dijk et al., 2001). Immuniza-
tion of mice with this recombinant protein led to production of antibody titers that 
were capable of significantly reducing P. falciparum intensity in An. stephensi (Out-
chkourov et al., 2008). In another study, a harmonized codons approach was used to 
successfully express recombinant full length Pfs48/45 in E. coli and antibodies gener-
ated showed greater than 93% transmission blocking activity in membrane feeding 
assays (Chowdhury et al., 2009). 
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1.8.2 Transgenesis 
Transgenesis in Anopheles mosquitoes is the genetic modification of the vectors to ex-
press midgut effector genes whose products can inhibit the transmission of malaria 
(Figure 8B). Several studies have shown that transgenesis targeting Plasmodium de-
velopment is feasible (reviewed in (Coutinho-Abreu et al., 2010; Wang and Jacobs- 
Lorena, 2013)). Genetically engineered An. stephensi mosquitoes expressing a 12 
amino acid salivary gland and midgut peptide 1 (SM1) substantially impaired in their 
ability to transmit malaria (Ito et al., 2002). In another study, the genetic manipulation 
of An. stephensi to express phospholipase-2 (PLA2) led to an 87% reduction in P. 
berghei oocyst intensity as compared to non-PLA2 expressing controls (Moreira et al., 
2002). C-type lectin (CELIII) was also expressed in An. stephensi mosquitoes under 
the control of a midgut-specific An. gambiae derived carboxypeptidase promoter and 
shown to be cytotoxic to P. berghei ookinetes (Yoshida et al., 2007). Kim and col-
leagues also transformed An. gambiae mosquitoes with cecropin A driven by a 
carboxylpeptidase promoter from Aedes aegypti and were able to show that the trans-
formed mosquitoes were able to inhibit P. berghei by 61% on average as compared to 
controls (Kim et al., 2004). Anopheles mosquitoes have also been transformed to pro-
duce antimicrobial peptides (Kim et al., 2004) and single chain antibodies targeting 
Plasmodium proteins (Isaacs et al., 2011).  
Despite the advances in the development of transgenic mosquitoes to limit malaria 
transmission, many challenges exist to the application of transgenetic mosquitoes in 
the field, for example, there is the lack of an effective drive mechanism to introduce 
the transgene into a population. An important additional challenge faced by genetic 
drive approaches, in general, is that anopheline vectors frequently occur in the field as 
reproductively isolated populations, thus posing a barrier for gene flow from one pop-
ulation to another (Wang et al., 2012). Also, a serious problem is the fitness of 
transgenic mosquitoes in natural habitats. 
1.8.3 Paratransgenesis 
Paratransgenesis is an alternative approach to interfere with malaria transmission 
based on the elimination of mosquito-specific parasite stages using genetically modi-
fied symbionts (Figure 8C). Bacteria mainly isolated from mosquito midgut have been 
exploited in this approach (see section 1.5) but, viruses capable of infecting mosqui-
toes like the densonucleosis viruses (DNVs) have also been tested (Ren et al., 2008). 
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For a bacterium to be used as a paratransgenic weapon, it must possess some basic re-
quirements which include; stability and ability to compete with other bacteria in the 
mosquito midgut, in vitro culturability and possibility for easy genetical alteration, 
possession of an efficient means of introduction into the mosquito (vertical or trans-
stadial transmission), effector gene product should not impair symbiont and vector fit-
ness, effector gene product should be secreted to assure interaction with the malaria 
parasite (reviewed in Wang and Jacobs-Lorena 2013). Additional advantages would be 
that the bacterium is not eliminated by the diet of the mosquito (sugar, blood or plas-
modia) or the bacterium is able to inhibit the malaria parasite on its own by producing 
inhibitory substances or activating mosquito immune response.  
The paratransgenic approach was first demonstrated by Durvasula and his colleagues 
whereby they genetically modified a bacterium, Rhodococcus rhodnii, within the mid-
gut of the kissing bug Rhodnius prolixus to express cecropin A and showed that it 
could break the transmission of trypanosomiasis (Durvasula et al., 1997). Several stud-
ies have also shown that paratransgenesis is feasible in malaria-transmitting Anopheles 
mosquitoes. E. coli was transformed with a plasmid expressing cecropin A fusion pro-
tein and fed to lab-reared An. stephensi, and was shown to inhibited the development 
of P. berghei (Yoshida et al., 2001). Furthermore, Riehle and others genetically engi-
neered E. coli to display two anti-Plasmodium effector molecules, SM1 and 
phospholipase A2, on their outer membrane surfaces and showed that the bacteria sig-
nificantly inhibited P. berghei development in An. stephensi mosquitoes (Riehle at al., 
2007). However, their studies showed that the transgenic E. coli survived poorly in the 
mosquito midgut, excluding this bacterial species as a paratransgenic tool. Therefore 
there is the need to search for new bacteria to be exploited in this strategy. 
The paratransgenic approach is advantageous over transgenesis in that; genetically 
modified bacteria can be easily produced in large quanties for testing since they can be 
easily grown in culture as compared to mass production of transgenic mosquitoes, 
bacteria can be easily freeze dried for both storage and transportation making 
introduction in remote areas possible as compared to mosquitoes. Lastly, the fitness of 
mosquitoes transformed with genetically modified bacteria in natural habitat is not 
affected as compared to the case with transgenic mosquitoes (reviewed in Cirimotich 
et al., 2011). The disadvantage of this approach is that proper characterisation of the 
bacterium is needed to avoid the release of a genetically harmful bacterium into the 
environment.
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Figure 8: Schematic depiction of transmission blocking strategies (Modified from Coutinho-Abreu & Ramalho-Ortigao 2010). (A), strategy for transmis-
sion blocking vaccines (TBVs). (B), strategy for generation of transgenesis mosquitoes. (C), strategy for paratransgenesis using bacteria and viruses
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1.8.4 Transmission blocking drugs (TBDs) 
TBDs are drugs which can be used to kill or inhibit the sexual stages of Plasmodium 
thereby reducing the transmission of malaria from human to human by the mosquito 
(reviewed in (Pradel, 2007, Kiszewski, 2011)). Like TBVs, a TBD would only kill 
gametocytes or other mosquito stages of the malaria parasite and will confer no direct 
benefit to an infected person with malaria. However, the drug will simply reduce the 
chance of that infected person to pass on infections to mosquitoes and thus, to other 
people thereby reducing the transmission of the disease. This could in turn benefit in-
dividuals by reducing the chances of re-infection. These drugs are intended to be used 
in combination with current anti-malarial drugs so as to treat infected individuals and 
at the same time preventing these individuals from transmitting the disease to mosqui-
toes. Till date, none of the clinically used anti-malarial drugs has been shown to 
completely eliminate matured gametocytes. Primaquine is the only drug that has been 
shown to be highly effective against matured gametocytes (Grewal, 1981; Vale et al., 
2009; White 2013) and a single dose has been used alongside first line therapies and 
shown to be effective in reducing P. falciparum gametocytes in blood and therefore 
reducing transmission of malaria (Burgess and Bray, 1961; Gunder, 1961; Shah et al., 
2013; Sutano et al., 2013,). Although primaquine has been shown to be highly effec-
tive as a TBD, it is being avoided due to its adverse effect on glucose-6-phosphate 
dehydrogenase (G6PD) deficient individuals. Thus the drug cannot be used in areas 
where glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent thereby 
requiring that individuals be tested before being administered the drug. Screening of 
individuals before drug administration will be very expensive especially as many in-
fected people are from very poor countries.   
Artemisinin combination therapies (ACTs) which is the current drug of choice for 
treating malaria in endemic regions contains artemisinin derivatives that have been 
shown to reduce gametocytes in P. falciparum infections (Chen et al., 1994; Price et 
al., 1996).  However, ACTs do not result in complete clearance of gametocytes in the 
blood and treated individuals are still able to infect mosquitoes (Targett et al., 2001) 
thereby limiting their transmission blocking potentials. Other compounds which have 
been shown to exhibit transmission blocking activity include Tafenoquine, an 8 ami-
noquinoline relative of primaquine shown to inhibit sporogony of P. vivax (Coleman et 
al., 2001; Ponsa et al., 2003). Epoxomicin, a naturally derived compound from Acti-
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nomycetes bacteria which acts as a protease inhibitor has also been shown to reduce P. 
falciparum gametocytes in vitro (Aminake et al., 2011) and a dose of 10 nM complete-
ly kills gametocytes after 72 h (Czesny et al., 2009). Methylene blue, the first synthetic 
drug ever used against malaria has also been shown to exhibit strong gametocytocidal 
activity against P. falciparum in vivo when it was administered in combination with 
amodiaquine and artesunate as compared to standard artesunate-amodiaquine controls 
(Coulibaly et al., 2009). Neem, a product derived from Azadirachta indica, a tree from 
India, exhibits significant activity against the sexual stages of P. falciparum in vitro 
(Udeinya et al., 2006; Udeinya et al., 2008). 
Proteases of Plasmodium have also been considered as potential candidates for trans-
mission blocking drug targets against malaria. Using P. berghei, it was shown that 
exflagellation of gametocytes can be blocked by the cysteine/serine inhibitors TPCK 
and TLCK as well as the metalloprotease inhibitor 1, 10-phenanthroline (Torres et al., 
2005). This study was confirmed by Rupp and colleagues (Rupp et al., 2008) using P. 
falciparum therefore linking a major involvement of serine proteases and metallopro-
teases in the ability of microgametes to exflagellate. Also, the membrane permeable 
cysteine protease inhibitor E64d has been shown to block oocysts formation by 80 to 
100% (Eksi et al., 2007).  
Most TBDs are designed to kill gametocytes within the human blood since it is diffi-
cultto have the drugs at reasonable concentrations in human sera so as to have a 
transmission blocking effect in the mosquito once taken up. A novel strategy will be to 
modify plants in malaria endemic areas to express these TBDs (peptides) in stable 
form in their nectar. Since Anopheles female mosquitoes also take sugar meals be-
tween blood meals, they can take up the transmission blocking agent through the 
nectar of the transmission blocking plants. The nectar containing the transmission 
blocking agent stays in the mosquito midgut and is able to reduce the infection of the 
mosquito when it takes up blood infected with Plasmodium. 
 
1.9 Overview of antimicrobial molecules tested in study 
Harmonine ((17R,9Z)-1,17-diaminooctadec-9-ene) is an antimicrobial molecules  iso-
lated from the hemolymph of the Asian harlequine ladybird Harmonia axyridis 
(Röhrich et al., 2012). Harmonia axyridis also known as the Asian lady beetle (the 
harlequin ladybird) originated from Asia and the species was introduced as a biologi-
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cal control agent against aphid and/or coccid pests into North America, Europe and the 
Soviet Union. Since its introduction, the species has become an invasive species espe-
cially in Europe outpowering and dominating the most abundant native European 
ladybirds, Coccinella septempunctata and Adalia bipunctata (Roy et al., 2008). Its in-
vasive success has been attributed to its enduring resistance against diverse pathogens 
and its ability to exude droplets of haemolymph containing deterrent alkaloids with 
harmonine as principal antimicrobial compound through its leg joints when threatened 
or attacked. 
SM1 is a small synthetic dodecapeptide that is thought to inhibit the development of 
Plasmodium parasites in the mosquito midgut by binding to proteins on the lumen of 
the mosquito midgut required for parasite invasion (Ghosh et al., 2001). Different re-
combinant variants of the pure peptide expressed in tobacco were produced.The small 
SM1 peptide was transferred to a stabilising scafford, a so called cystine-knot mini 
protein (McoTi) or an agouti related protein (AGRP) which is expected to provide an 
ideal framework for anti-plasmodial peptides to be delivered to insect guts as the pep-
tides gain stability for an extended period of time in the mosquito midgut.   
Psalmopoeus cambrigei falciparium killers (PcFk1 and PcFK2) are peptides of 33 and 
28 amino acid residues respectively which were isolated from the venom of Trinidad 
chevron tarantula Psalmopoeus cambridgei and reported to have antiplasmodial activ-
ity against the intra-erythrocytic stage of Plasmodium falciparum in vitro (Choi et al., 
2004).  
Harmonine was provided by Prof. Dr. Andreas Vilcinskas of the Fraunhofer Institute 
for Molecular Biology and Applied Ecology IME, Gießen, Germanywhile the recom-
binant peptiede were produced by Prof. Dr. Heribert Warzecha of University of 
Darmstadt, Germany.  
 
                    
Harmonine ((17R,9Z)-1,17-diaminooctadec-9-ene)                           SM1  
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Three-dimensional (3D) structure of PcFK1                        3D-structure of PcFK2 
Figure 9: Structures of antimicrobial molecules tested in study. Structure of harmonine 
was obtained from Röhrich et al., 2012, SM1 (Ghosh et al., 2009) and PcFK1& PcFK2 (Choi 
et al., 2004). 
 
1.10 Objective of this study 
Efforts to completely eradicate malaria have been hampered by the lack of an effective 
vaccine and the rapid emergence of drug-resistant parasites and insecticide-resistant 
mosquitoes. Therefore alternative strategies of combating the disease are urgently 
needed. For malaria transmission to occur the malaria parasite must undergo a crucial 
developmental sexual phase inside the mosquito midgut and because these sexual 
stages are highly vulnerable resulting in an approximate 1000-fold loss in parasite ab-
undance in the moquito midgut, they represent prime targets for transmission blocking 
strategies. It was the main aim of this PhD thesis to investigate the interplay of malaria 
parasites with the content of the mosquito midgut with regard to the identification of 
novel types of transmission blocking interventions. Such interventions are aimed at 
reducing the spread of malaria by blocking the development of the mosquito midgut-
specific stages of Plasmodium. The thesis focused on three specific objectives 
 
Specific objective 1 
The first objective of this study was to investigate the interplay between mosquito 
midgut bacteria and malaria parasites. Here, we aimed at investigating the bacterial 
diversity in the gut of lab-reared An. stephensi mosquitoes during development from 
egg to adult via 16S rRNA analysis and to determine potential changes in the gut mi-
crobiota of the female mosquito under different feeding regimes. We were particularly 
interested in investigating the tripartite interactions between gut bacteria, Plasmodium 
parasites and the mosquito host following a blood meal in order to determine the po-
tential influence of malaria parasites on the composition of the mosquito gut 
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microbiota and also determine gut bacteria which could be exploited as vehicles for 
the generation of paratransgenic Anopheles mosquitoes. 
 
Specific objective 2 
To identify transcriptome changes in the malaria parasite during the initial stage of pa-
rasite transmission from human to mosquito. To this end, we wanted to determine the 
changes in the P. falciparum gametocyte transcriptome following activation in order to 
gain in-depth knowledge on the molecular switch-over that takes place in the parasite 
during transmission from human to mosquito. By analysing the upregulation of tran-
script following parasite transmission to the mosquito we hoped to identify new 
plasmodial proteins which could be exploited as targets for malaria transmission 
blocking interventions, particularly for transmission blocking vaccines or transmission 
blocking drugs. 
 
Specific objective 3 
The last objective was to evaluate the effect of antimicrobial molecules as transmis-
sion blocking agents preventing the spread of malaria. Here, we tested the effect of a 
range of antimicrobial molecules as transmission blocking agents. The molecules were 
either isolated from insect hemolymph or recombinantly expressed in tobacco and de-
signed to act directly on the midgut stages of the malaria parasite or cover receptors on 
mosquito tissues like the midgut epithelium which the parasite would need for transit. 
The general idea for the production and testing of the transmission blocking activities 
of these recombinant peptides was to be able to develop a modified plant which is pre-
sent in malaria endemic areas that expresses a transmission blocking agent on its 
nectar in a stable form. Since Anopheles female mosquitoes also take sugar meals be-
tween blood meals, they can take up the transmission blocking agent through the 
nectar of the transmission blocking plants. The nectar containing the transmission 
blocking agent stays in the mosquito midgut and is able to reduce the infection of the 
mosquito when it takes up blood infected with Plasmodium. 
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2. Materials and Methods  
2.1 Material  
2.1.1 Labwares 
Table 2: List of labwares used in this study and their suppliers 
Labwares Suppliers  
96 well plates Nunc Hartenstein, Germany 
Amicon ultra 10K 15 ml Millipore, Germany 
Cell culture flasks, 25 cm3, 75 cm3 Schubert&Weiss 
Coverslips Hartenstein, Germany 
Cryotubes 2 ml Greiner, Flacht  
Eppendolf tubes 1.5 ml, 2.0 ml Sarstedt, Nürnbrecht  
Falcon tubes 15, 50 ml Sarstedt, Nürnbrecht  
Filters 250 ml ,500 ml, 0,2 µm Biochrom, Germany 
Gloves Laborhaus Scheller, Roth, Germany 
Hybond-ECL, 20 cm x 3 m GE Healthcare/Amersham Biosci-
ence, München  
Membrane feeder Lenz Laborglas, Germany 
Microscope slides Hartenstein, Germany 
Pap Pen for Immuno staining Sigma, Germany 
Pasteur pipettes glass, 230 mm Hartenstein, Germany 
Pasteur pipettes glass, 230mm, with filter Hartenstein, Germany 
PCR tubes Sarstedt, Nürnbrecht 
Petridishes Laborhaus Scheller, Germany 
Pipette tips 20 µl,  200, 1000µl Sarstedt, Nürnbrecht 
SafeSeal Tips Professional 300µL Biozym, Germany 
Serological Pipettes, 2 ml, 5 ml, 10 ml, 25ml Sarstedt, Nürnbrecht 
Sterile filters (0.2 μm pore size) Laborhaus Scheller, Germany 
Measuring cylinders Roth, Germany 
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2.1.2 Instruments  
Table 3: List of instruments used in this study and their suppliers 
 Instruments Manufacturer 
AccuJet® pro Brand, Germany 
Bunsen burner Schütt, Germany 
Centrifuge Heraeus, Germany 
Centrifuge , Biofuge fresco Heraeus, Germany 
Centrifuge Beckmann J2-HC  Beckmann, München  
CFX 96 Real-Time Detection System Bio-Rad, Germany 
Dry block heating thermostat Lab-4you, Berlin 
Electrophoresis chamber  Bio-Rad, Germany 
Electrophoresis chamber MIDI 1, MAXI  Roth, Germany 
Electrophoresis power supply  Bio-Rad, Germany 
Gel documentation system,  Gel Doc 2000 Bio-Rad, Germany 
Light microscope laborlux 11 Leitz, Wetzlar 
Light microscope Leica DMLS Leica, Solms 
LSM  Zeiss confocal laser scanning microscope Zeiss, Germany 
Rotar-mixer- picofuge Stratagene, Germany 
Mosquito incubator model 2015 VWR, West Chester, USA 
pH-Meter InoLab  WTW, Weilheim  
Micropipettes  Eppendorf, Hamburg  
Shaker SM 30 control  Edmund Bühler GmbH, Tübingen  
Spectrophotometer NanoDrop ND-1000  Peq-Lab, Erlangen 
Sterile bench HERA Safe Heraeus, Germany 
TCS SP5 confocal laser scanning microscope Leica, Germany 
Vacuum Pump Laboport  KNF, Freiburg  
Vortex Genie 2 Scientific industries 
Water bath Memmert, Germany 
Weighing balance Kern, Germany 
Western blot apparatus Mini-Trans-Blot  Bio-Rad, München  
Spectrophotometer multiskan Ascent Thermo Elect Thermo Electron Corporation, Finland 
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Sonication device Sonoplus HD70 Bandelin, Germany 
Transmission Electron microscope  Zeiss EM10 Zeiss,Germany 
Power supply  Bio-Rad, Germany 
PCR thermocycler primus 25 advanced  Peq-Lab, Germany 
Chromatography column PolyPrep®  
 
Bio-Rad, München  
 
 
2.1.3  Chemicals 
Chemicals used in this study were purchased from AppliChem (Darmstadt), ATCC (Manas-
sas, USA), Dianova (Hamburg), GE Healthcare (Uppsala, Sweden), Amersham Bioscience 
(München), Invitrogen/Gibco/Molecular Probes (Karlsruhe), Merck/Novagen/Calbiochem 
(Darmstadt), Roth (Karlsruhe), Sigma/Fluka (Taufkirchen), WAK Chemie (Steinbach) and 
Santa Cruz Biotechnology (Heidelberg). 
 
2.1.4 Antimicrobial molecules tested in this study 
Antimicrobial molecules tested in this study i.e. harmonine and recombinantly produced pep-
tides in tobacco (Salivary gland and midgut peptide 1 (SM1) and Psalmopoeus cambrigei 
falciparium killers) were provided by Prof. Dr. Andreas Vilcinskas of the Fraunhofer Institute 
for Molecular Biology and Applied Ecology IME, Gießen, Germany and Prof. Dr. Heribert 
Warzecha of University of Darmstadt, Germany respectively.  
 
2.1.5 Commercially available systems and enzymes 
Table 4: List of commercial kits and enzymes used in this study 
Kits and enzymes Suppliers  
Fast Plasmid Mini kit  
 
Eppendorf, Hamburg, Germany 
MasterPure DNA purification kit Epicentre Biotechnologies, Germany 
Maxima SYBR green qPCR master mix Thermo Scientific, Bonn, Germany 
NucleoSpin Plasmid QuickPure Macherey-Nagel, Düren 
NucleoSpin® Extract II Macherey-Nagel, Düren 
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Oligotex mRNA Mini Kit 
 
Qiagen, Hilden 
PCR-Select cDNA Subtraction Kit  Clontech, Mountain View, CA, USA 
pGEM®-T Easy vector  Promega,Mannheim, Germany 
QIAamp Blood Mini kit Qiagen, Hilden 
RNAse-free DNAse I  Qiagen, Hilden 
SuperScript III First-Strand Synthesis Invitrogen, Karlsruhe 
Restriction endonucleases and buffers  New England Biolabs Frankfurt, Germany 
PHUSION polymerase and buffer  New England Biolabs Frankfurt, Germany 
GOTaq polymerase and buffer  New England Biolabs Frankfurt, Germany 
T4‐DNA‐ligase and buffer  New England Biolabs Frankfurt, Germany 
 
2.1.6  Antibodies and antisera 
Table 5: List of antibodies and antisera used in this study 
Antibodies and antisera Antibody 
type 
 Dilution 
WB or IFA 
Provider 
Goat anti-mouse IgG  Alexa 594 Secondary  1:1000 (IFA) Molecular Probes 
Goat anti-mouse IgG, Alexa 488 Secondary  1:1000 (IFA) Molecular Probes 
Goat anti-rabbit IgG Alexa 594 Secondary  1:1000 (IFA) Molecular Probes 
Goat anti-rabbit IgG, Alexa 488 Secondary  1:1000 (IFA) Molecular Probes 
Mouse anti Pfactin 1 Primary  1:50 (IFA) AG Pradel 
Mouse anti Pfactin 2 Primary  1:200 (IFA) AG Pradel 
Mouse anti- PfPK2 Primary  1:20 (IFA) Brügl-AG Pradel 
Mouse anti- PfPPLP6 Primary  1:50 (IFA) Wirth-AG Pradel 
Mouse anti- Pfs230 Primary  1:500 (IFA) Kim Williamson, 
Chicago 
Mouse anti-PfCLK4 Primary  1:75 (IFA) Kern-AG Pradel 
Mouse anti-Pfs16 Primary  1:500 (IFA) Kim Williamson, 
Chicago 
Mouse anti-Pf 14-3-3 Primary 1:100 
(IFA&WB) 
Produced in this 
study 
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Mouse anti‐α5‐SU Primary  1:20 (IFA) Aminake- AG Pradel 
Neutral goat serum Blocking 1% (IFA) AG Pradel 
Neutral mouse serum Control Same as  Ab 
tested  
AG Pradel 
Rabbit  anti-PfGAP50 Primary  1:50 (IFA) Julian Rayner, Eng-
land 
Rabbit  anti-Pfs25 Primary  1:1000 (IFA) ATCC 
Rabbit anti-MSP-1 Primary  1:1000 (IFA) ATCC 
 
2.1.7  Microorganisms and parasites 
• E.coli BL21 (DE3) RIL: E. coli protein expression cell line. 
• E.Coli Nova Blue and E.Coli Top 10: E.coli cell lines for cloning. 
• E.coli 536: Cell lines for bioactivity testing. 
• Staphyloccocus aureus 8325:  Cell lines for bioactivity testing. 
• Candida albicans S314: Cell lines for bioactivity testing. 
• HeLa cells: Immortal cell line used in scientific research, it is derived from cervical 
cancer cells taken from Henrietta Lacks, who died from her disease in 1951. HeLa 
cell lines were used for cytotoxicity assays. 
• P. falciparum 3D7 (MRA 102): Originally cloned from NF54 isolate (MRA‐1000) 
by limiting dilution. Applications: Genome sequencing strain, CQ sensitive 
(www.mr4.org). Cell line was used for malstat assay. 
• P. falciparum Dd2 (MRA 150): Derived from W2‐Mef, which was selected from 
clone W2 for resistance to mefloquine. Applications: CQ‐resistant (intermediate), py-
rimethamine‐resistant, mefloquineresistant. (www.mr4.org). This cell line was used 
for the malstat assay. 
• P. falciparum WT NF54 strain: A gametocyte-producing strain isolated in 1982 
from West Africa (Ponnudurai et al., 1982). This cell line was used for the production 
of gametocytes. 
• P. falciparum F12 strain: Parasite subclones derived from gametocyte producing 
clone 3D7, which completely lost ability to produce gametocytes (Alano et al., 1995). 
• P. berghei ANKA Strain: Two strains were used, a wild type strain and a strain con-
stitutively expressing GFP through out the parasite life cycle under the control of the 
eef1a promoter (http://www.mr4.org/MR4ReagentsSearch/parasites/MRA-865.aspx).  
  Materials and Methods 
31 
2.1.8 Buffers, solutions and media 
Table 6: List of buffers, solutions and media 
Buffers, Solutions and  Media Components 
10 % Triton‐X100  10 ml of 100% Triton X‐100, dissolve in 100 
ml dH2O, store at 4°C 
10 x Giemsa buffer 
 
0.7 g KH2PO4 
1.0 g Na2HPO4 
dissolve in 800 ml dH2O, adjust pH to 7.2 and 
make up volume to 1l. 
10 x Incomplete medium  
 
10.43 g RPMI 1640 powder 
5.94 g HEPES 
0.05 g Hypoxanthine 
dissolve in 100 ml ddH2O 
sterile filter using a 0.22 μm bottle top filter 
(Millipore) 
10 x Phosphate‐buffered‐saline (PBS) 
 
80 g NaCl 
2 g KCl 
14.4 g of Na2HPO4 
2.4 g of KH2PO4 
dissolve in 800 ml dH2O, adjust pH to 7.4, 
make up volume to 1l and autoclave. 
10 x SDS‐PAGE running buffer 29 g Tris 
144 g Glycerol 
10 g SDS 
dissolve in 1l dH2O 
10 x TBS 12.1 g Tris 
87.3 g NaCl 
dissolve in 800 ml dH2O, adjust pH to 7.5 and 
make up volume to 1l. 
10 x PAGE running buffer 29 g Tris 
144 g Glycerin 
10 g SDS  
Add ddH2O to 1000 ml. 
10% AlbuMax II™ stock 10 g AlbuMax II™, dissolve in 100 ml ddH2O 
Sterile filter using a 0.22μm syringe filter. 
10% Ammonium per sulfate (APS) 
 
0.1g APS in 1ml dH2O, aliquot in tubes, store -
20°C  
1000 x Hypoxanthin stock (0.4M)  
 
0.5 g hypoxanthin, dissolve in 100 ml ddH2O 
Sterile filter using a 0.22μm syringe filter 
1mM Xanthurenic acid 0.05 g Xanthurenic acid 
1 ml 0.5 M NH4OH 
243 ml of ddH2O. 
2 x Sample bufferis 2.5 ml 500 mM Tris-HCL. pH 6.8 
2.0 ml Glycerin 
4.0 ml 10 % SDS 
0.5 ml 0.1 % Bromophenol blue 
Add ddH2O to 10 ml. 
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40% Acrylamide :Bisacrylamide ( 37.5:1) 38.93g  Acrylamide 
1.07g Bis acrylamide 
100 ml TAE 
Sterile filter (0.45µm) and store at 4°C till use 
50 x TAE buffer 242 g Trizma Base (2M) 
57.1 ml Acetic Acid (1M) 
100 ml 0.5M EDTA (pH8.0)  
Dissolve in 800 ml dH2O, adjust pH to 7.5 and 
make up volume to 1l. 
A+Medium 500 ml 1x RPMI 1640 
50 ml humanes Serum A+ 
550 μl 1000x Hypoxanthin 
550 μl 1000x Gentamicin 
Detergent buffer for inclusion bodies 20 mM Tris/HCl pH 7.5 
2 mM EDTA pH 8.0 
200 mM NaCl 
1 % Deoxycholate 
1 % NP-40 in ddH2O 
DGGE denaturing solution 0% (10% AA) 
 
 
25 ml of 40% acrylamis/bisacrylamide 
2 ml of 50x TAE  
73 ml of distilled H2O 
DGGE denaturing solution 100% (10% 
AA) 
 
 
25 ml of 40% acrylamis/bisacrylamide 
2 ml of 50x TAE  
33 ml of distilled H2O 
40 ml of Formamide 
42 g Urea 
Heat at 50°C to dissolve urea 
Elution buffer for GST purification 50 mM  Tris pH 8.0 
10 mM reduced glutathione in ddH2O 
Equilibration buffer 12.1 g Tris 
5.8 g Nacl 
10.2 g MgCl2 
Add ddH2O to 800 ml, adjust pH to 9.5 and 
make volume to 1000 ml 
Gel green staining solution 1.17g of NaCL 
60µl of gel green 
add 200ml of dH2O. 
GlcNac-Medium 550 ml A+-Medium 
6,08 g N-Acetyl-Glucosamine 
Sterile filter  
Glycerolytes 57 26.66 g Sodium lactate 
570 g Glycerol 
300 mg KCl 
517 mg Na2PO4,H2O (Monobasic sodium 
phosphate) 
1242 mg (dibasic Sodium Phosphate) 
add ddH2O to nearly 800 ml, adjust pH to 6.8 
with HPO4 make up volume to 1 l. Store at 
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4°C 
Ketamin/Xylazin (Anesthetizing solution)  Add 150 μl of 2% Xylazin (dissolved in 
methanol) to 1 ml 10% Ketamin (dissolved in 
H2O).  
 
LB (Luria-Bertani)  medium 
 
10 g Tryptone 
5 g Yeast extract 
5 g NaCl 
dissolve in 1l dH2O and autoclave 
LB (Luria-Bertani) agar  
 
10 g Tryptone 
5 g Yeast extract 
5 g NaCl 
12 g Agar 
dissolve in 1l dH2O and autoclave 
Lysis buffer for GST purification 50 mM Tris pH 8 
350 mM NaCl 
10 % Glycerin 
1 m ß- Mercaptoethanol 
10 mM Imidazol 
Lysis buffer for inclusion bodies 50 mM Tris ph 8.0 
0.25 % Sucrose (w/v). 
1 mM EDTA in ddH2O 
Lysis buffer Western-Blot (NETT) 150 μl of 5M NaCl 
50 μl of Triton-X 100 
250 μl of 1M Tris pH 8 
50 μlof 0,5M EDTA 
add 5 ml dH2O 
Malstat reagent 1 ml 10% Triton X‐100 
1 g L (+) Lactate 
0.33 g Tris 
0.033 g 3‐Acetylpyrimidin‐adenine dinucleo-
tide (3‐APAD) 
dissolve in 100 ml dH2O and adjust pH to 9 
SAX ( gametogenesis activation solution) 100 µM Xanthurenic acid 
1.67 mg/ml Glucose 
8 mg/ ml NaCl 
1 mg/ml Tris pH 8.2 in ddH2O 
SDS (sodium dodecyl sulfate) solution 
(10% w/v) 
10g SDS  
dissolve in 100 ml dH2O  
SOC medium 20 g Tryptone 
5 g Yeast Extract 
2 ml of 5 M NaCl. 
2.5 ml of 1M KCl. 
10 ml of 1M MgCl2 
10 ml of 1M MgSO4 
Dissolve in 980 ml dH2O and autoclave then 
add 20 ml of 1M sterile filtered glucose. 
Stop buffer 1.2 g Tris 
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0.4 g EDTA 
Add ddH2O to 800 ml, adjust pH to 8.0 and 
make volume to 1000 ml. 
Transfer buffer 3.03g Tris 
14.4 g Glycerin 
200 ml Methanol 
Add ddH2O to 1000 ml. 
Washing buffer inclusion bodies 0.5 %riton X-100 
1 mM EDTA pH 8.0 in ddH2O 
X‐Gal stock (25mg/ml) 250 mg of X-Gal dissolved in 10 ml N,N -
dimethylformamide, and protect from light 
with aluminium foil. Store at -20°C. 
 
2.1.9 Plasmids 
 
pGEM T-Easy 
The pGEM®-T Easy cloning vector is a high copy number linearized vector with a T added 
to both 3´-ends. Selection of recombinants is by Ampicillin resistance and Blue/White Selec-
tion (Figure 10). 
 
Figure 10: pGEM T-Easy vector map showing Ampicillin resistant gene and restriction 
sites (http://www.promega.com). 
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pGEX 4T-1 
This is a Glutathione-S-transferase (GST) tag high copy expression vector with an Ampicillin 
resistant gene for selection (Figure 11).  
Figure 11: pGEX-4T-1 expression vector represented with restrictions sites and ampicil-
lin resistant gene (http://www.biovisualtech.com/bvplasmid/pGEX-4T-1.htm). 
 
2.1.10 Genes investigated and oligonucleotides 
Table 7: List of genes and oligonucleotides used in this study 
PlasmoDB  ID Name/feature Sense and antisense primer (5‘---3‘) Annealing temp. (°C) 
RT-PCR primers 
PF3D7_0302100 CLK-4 
GCCATACGATCCGTCTGTTT 60 
CATGCATGCAAAGGACCATA 60 
PF3D7_1238900 PK2 
ATCCGAATGATCCAAGCTCA 60 
TTACCTCGGAAAGGTGGGTA 60 
PF3D7_0827800 SET3 TGGTGAGAAGTAGCGACGAG 60 
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TTACGACACCTCTCCCTTCG 60 
PF3D7_1115200 SET7 
TGGGTTCCAGAACCTGATAAA 60 
ATGATGGCCGAAAGCATTAT 60 
PF3D7_0815800 VPS9 
TGTTACCTTGTGCTGATGAA 60 
CAGCATTCGCTACTTTTTCT 60 
PF3D7_1136400 TPR 
TGTTGATCAAAATATCGTTCATGT 60 
AAAAAGTTCTTGAACTAGTTGCTCTTT 60 
PF3D7_0215400 WD40 
GCCAAATCACCAGCAAAAAT 60 
GCTGATGGGGACATATGGTT 60 
PF3D7_0818900 HSP70-1 
GAATCGGTTTGTGCTCCAAT 60 
CAACTGTTGGTCCACTTCCA 60 
PF3D7_0727400 Proteasome SU 
α5 
GTGCGATGAGTGGTTTGATG 60 
AAGCAACTCCGAATGGTCTG 60 
PF3D7_0807500 Proteasome SU 
α6 
GTTTTTGTGCGGGATATCGT 60 
GCTTCAATTGCCAAAATGGT 60 
PF3D7_0422300 Alpha -tubulinII 
GGCCATCTCCTCAAGTATCG 60 
TCAACATTCAAAGCACCATCA 60 
PF3D7_1246200 actinI 
AAAGAAGCAGCAGGAATCCA 60 
TTGATGGTGCAAGGGTTGTA 60 
PF3D7_1412500 actinII 
GGAATGTCCGGGTTTACACA 60 
TCTTTCAGGTGGAGCAATGA 60 
PF3D7_0918000 GAP50 
TCTTTGGGTGATTGGGGTAA 60 
TCCATGCTGGATCATTTAAGC 60 
PF3D7_1351700 ALV6 
TCAAAACATCTACTCGCACCA 60 
CCCGAATGAAAATTCGTACC 60 
PF3D7_1103500 CPW-WPC  
ATTCAGTGAAGGCACAAATC 60 
CGTCTGGAATATCATCTGCT 60 
PF3D7_0406200 Pfs16 
CAAGGTGGACTATCTCAAGG 60 
TTTATCATCATCTGCGTTCTT 60 
PF3D7_1218800 PSOP17 
ATTACCATCGGCAAAACCAT 60 
CCAATTCCTCCAAATCCAGA 60 
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PF3D7_1033200 ETRAMP10.2 
CTGCCCTTGTCGTTACAGGT 60 
CCGAATTTACGGTACGTGCT 60 
PF3D7_1031000 Pfs25 
AATGCGAAAGTTACCGTGGA 60 
CAAGCGTATGAAACGGGATT 60 
PF3D7_1444800 FBPA 
TGTACCACCAGCCTTACCAG 60 
TTCCTTGCCATGTGTTCAAT 60 
PF3D7_1457000 SPP 
CAGTATGCTTGGTTTAGGAGA 60 
TAAAGAAGAGCTGGTTGAGG 60 
PF3D7_0207700 SERA4 
ATACTGGTTCCCAAGGAGAT 60 
TTTCTGGTGGTGCTAATTCT 60 
PF3D7_0817600 PPLP6 
GGGAGTACCACCACCCTTTT 60 
GTCGTTTTATGGGCAGCACT 60 
PF3D7_1239400 SP 
TGTTCAAAAACAACAGTTCCAA 60 
TCCATTGGTTTGCTAGGTGA 60 
PF3D7_0704100 6 TMs 
TCAGACGATCACGCTATTGG 60 
TCCCGTCTGACTATTTCCTTG 60 
PF3D7_1021700 4 TMs 
AAACGAAAGGATGCCACAAG 60 
CGCTTGGGCTGCTACTACAT 60 
PF3D7_0417400 2 TMs 
TGCAAAGACGAAACATTCCA 60 
TGTCCGTATGCTTCAAGGAA 60 
PF3D7_1225600 - 
TGATGAAAAGTCCAAAGGGAAT 60 
TTTTCCGGTCCTCATCACTT 60 
PF3D7_1321000 - 
AGAAGATCATGTACATCTTCACAAA 60 
TCATCATTTGATGCAAGTACGAG 60 
PF3D7_0925700 HDAC1 
TGGTCTTTTTCAATTTCAGCAA 60 
GCTTCCTCAACACCATCTCC 60 
PF3D7_1133400  AMA1 
GGATTATGGGTCGATGGA 60 
GATCATACTAGCGTTCTT 60 
PF3D7_1455800 PfCCp2 
TCGGATGGAGAATCCGTT 60 
GTATCCCATGTCTTGTGA 60 
PF3D7_0708000 - GGTTGGAGAAGATACACTATGAGG 60 
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CAAAGAGGATTATTCTCGTCGGT 60 
PF3D7_1023000 - 
TGTCTACCTTCATACTCATGTTCG 60 
AAGATGCCTCCTGCTAATAACC 60 
PF3D7_1026600 - 
GATGATGACGCAGGACATACTC 60 
TGGCTGGGTAATTTAATATCTCCC 60 
PF3D7_1251200 Coronin 
TATCCTGATCCGTCAAATAACCTG 60 
GATAACTCCGATCATTCCTCCC 60 
PF3D7_1438800 - 
TGCCTGTTATGGAAGATGAGC 60 
GCAAATAGGATATACAACGTTCCC 60 
PF3D7_0818200 14-3-3 
CCGAAAGATATGATGAAATGGCAG 60 
TGCTCATCTCTTTCTGTTCAACAC 60 
PF3D7_1316700 
 - 
GTGGACATAAAGCCCTTATTTGAC 60 
GTTTCGAGACAATCTTGGTTCC 60 
PF3D7_0717700  Seryl-tRNA synthetase 
AAGTAGCAGGTCATCGTGGTT 60 
TTCGGCACATTCTTCCATAA 60 
Recombinant protein primers 
PF3D7_0818200 14-3-3 
TAGGATCC 45 GCAACATCTGAAGAATTAAA 
TAGCGGCCGC 45 TTATTCTAATCCTTCGTCTTTTGA 
Other primers 
T7 and SP6 pGEM-T Easy 
GTAATACGACTCACTATAGGG 45 
ATTTAGGTGACACTATAG 45 
27f and 1492r 16s rRNA gene 
AGAGTTTGATCATGGCTCAG 54 
TACGGCTACCTTGTTACGACTT 54 
341f and 907r 16s rRNA gene 
CCTACGGGAGGCAGCAG 54 
CCGTCAATTCMTTTGAGTTT      54 
341f +GC and    
907r 16s rRNA gene 
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCA    
CGGGGGGCCTACGGGAGGCAGCAG 
54 
CCGTCAATTCMTTTGAGTTT 54 
Underlined sequences indicate restriction site
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2.1.11 Miscellaneous materials 
• Human serum and blood from A+ group used for cell culture was purchased 
from Bayerisches Rotes Kreuz (BRK), Würzburg and the University Hospital 
Aachen. 
• NMRI female mice and Balb/ c mice were obtained from Charles River labora-
tories, Sulzfeld. 
• Gas bottles containing a mixture of 5% O2, 5% CO2 in 90% N2 used for in vitro 
Plasmodium culture was purchased from Westfalen AG, Münster. 
 
2.2 Methods 
 
2.2.1 Entomology methods 
2.2.1.1 Mosquito rearing and maintenance  
An. stephensi colonies were maintained under standard insectary conditions at 26 ± 
0.5°C, 80 ± 2% humidity and a 12/12 h light/dark cycle in gauze-covered, wire-framed 
cages. Eggs production was induced by allowing adult female mosquitoes to feed on 
blood from an anesthetized non-infected Balb/c mouse. Four days later eggs were col-
lected on filter paper in a beaker containing 0.1% sea salt solution which was placed in 
the cage a day before. The eggs were carefully transferred into a clean plastic tray con-
taining 0.1% sea salt solution for hatching and emergence of larvae over 2 days. 
Following emergence of larvae, they were reared at a fixed density of approximately 
300 larvae per 3 litres of 0.1% sea salt solution in tray. Larvae were fed on floating dry 
fodder pellets (cat food) daily and any surplus “old” food was remove and discarded. 
The larvae develop to pupae 6 to 8 d post emergence from eggs and were collected 
daily, washed with distilled water and placed in small beakers containing 0.1% sea salt 
solution then transferred to cages for adult mosquito emergence. Adult mosquitoes 
were fed via a pad soaked with sterile filtered 5% saccharose solution supplemented 
with 0.05% para-aminobenzoic acid (PABA). 
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Figure 12: Mosquito rearing and maintenance. The white plastic tray (below) contain eggs 
which subsequently hatch to larvae then to pupae and the pupae are then collected and trans-
ferred to the wire-framed cages (above) where adult mosquitoes emerge and are maintained. 
 
2.2.1.2 Mosquito preparation and feed for bacteria diversity determination  
An. stephensi eggs were surface-sterilized by washing in 70% ethanol and rinsed twice 
with PBS and then homogenized in 100 µl of PBS for DNA extraction. Instar stage IV 
larvae and pupae were collected, surface-sterilized for 5 min in 70% ethanol, then 
rinsed twice in PBS and the midguts were dissected under sterile conditions (see sec-
tion 2.2.1.5 for midgut dissection). Adult mosquitoes were collected and the females 
separated from the males. Adult male and female mosquitoes were fed on sterile sugar 
solution while a subset of female mosquitoes were fed on human and mouse blood in 
the absence and presence of Plasmodium gametocytes containing fresh blood. Mosqui-
toes were either fed on P. berghei-infected mice or on mature P. falciparum 
gametocyte cultures ex vivo, using a sterile membrane-feeding apparatus consisting of 
an artificial membrane stretched across the base of a water-jacketed glass cylinder at 
37°C (see section 2.2.1.3, Figure 14). At 24 h post-feeding, the mosquito midguts were 
dissected. Twenty-five midguts of each group were pooled and homogenized in 100 µl 
PBS for DNA extraction. One liter each of water prior to be used for larvae-rearing 
and water used for rearing of larvae and pupae were collected and filtered through a 
0.2 µm filter. Total DNA extracted from the filters was used for controls.  
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2.2.1.3 Transmission blocking assays using P. falciparum 
This was used to test the transmission blocking effect of harmonine and it was con-
ducted using the standard membrane feeding assay (SMFA) with mosquitoes which 
had been fed with 5% sterile saccharose solution supplemented with 0.05% PABA and 
0.04 mg/ml gentamycin. Three to five day old mosquitoes were starved on the day be-
fore feeding. The next day female mosquitoes were attracted to a bottle containing hot 
water (approximately 40°C) which served as bait. The mosquitoes were collected us-
ing a gun aspirator and were then placed on ice for about 2 mins and male mosquitoes 
were removed. A maximum of 60 female mosquitoes were transferred into a pre-made 
small carton pot (Figure 13). P. falciparum mature gametocytes were tested for their 
infectivity by in vitro exflagellation of male gametocytes. Cultures containing gameto-
cytes with greater than 5 exflagellation centres per field were used without purification 
while gametocytes were purified from cultures with 2-5 exflagellation centres per field 
using Percoll. The feeding system was then prepared by connecting glass feeders to-
gether with a tubing and to a circulating water bath to generate a continuous flow of 
hot water at 37°C through the jacket of the membrane feeders (Figure 14). A parafilm 
membrane was then stretched in both directions and place on the glass feeders main-
tained at 37°C. For the membrane feeding, the procedure was performed entirely at 
37°C and as quick as possible to prevent the in vitro exflagellation of male gameto-
cytes. The gametocytes were pelleted at 37°C by centrifugation at 1800 g for 5 min 
and the pellet mixed with an equal volume of freshly collected washed RBCs (A+). 
Then inactivated A+ human serum was added to the mixture in a ratio of 1:2 and the 
desired concentration of harmonine to be tested added, then mixed and immediately 
transferred to the feeders. The feeders were then placed on top of the mosquito pots for 
the mosquitoes to feed on the blood in the dark for 20 mins. After feeding, they were 
transferred to a sealed safety level three insectary where they were maintained at 26°C 
and fed with 5% sterile saccharose supplemented with 0.04 mg/ml gentamycin. The 
transmission blocking effect of the compound was determined by dissecting and 
counting the number of oocysts in the mosquito midgut 7-12 days after infection 
which represent the time in which oocysts become visible in the mosquito midgut. 
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Figure 13: Preparation of pot for maintenance of infected mosquitoes (Adapted from 
Carter al., 2008). A small hole of approximately 2 cm square was cut in the side of a paper 
carton and 2 squares of latex sheeting was used to cover the hole  with a slit cut into each one 
to allow for entry of the mosquito aspirator tube. Then a tape was used to secure over the hole. 
A circle filter paper was then fitted to the base of the pot and stretched netting was placed over 
the top of the pot and secured with an elastic band and tape. 
 
 
 
Figure 14: P. falciparium Standard membrane feeding assay. Adult mosquitoes were trans-
ferred into small pots and fed with blood containing mature gametocytes or blood alone 
through a membrane feeder. 
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2.2.1.4 Transmission blocking assays with P. berghei 
P. berghei constitutively expressing GFP throughout the life cycle was used to deter-
mine the transmission blocking effect of recombinantly produced peptides tested in 
this study. Three to 5 d old mosquitoes were collected as described in section 2.2.1.3 
and starved for one day prior to peptide feed. The mosquitoes were then fed with pep-
tides (5 ml of 0.5 mg/ml) containing 10% saccharose and food color (to determine 
peptide-fed mosquitoes) using cotton pads for 2 days after which they were allowed to 
feed on an anesthetized Plasmodium berghei infected mouse (1-10% parasitaemia) for 
15 min. Mouse were anesthetized by peritoneal injection of 100 µl of Keta-
min/Xylazine solution (150 μl of 2% Xylazin in methanol and 1 ml 10% Ketamin in 
H2O) per 10 g body weight of mouse. The mosquitoes were transferred to a safety 
level 3 insectary and maintained at 19-20°C with 5% sterile saccharose solution sup-
plemented with 0.05% PABA. The transmission blocking effect of the peptides were 
determined by dissecting and counting the number of oocysts in the mosquito midgut 
7-12 days after infection and or the number of sporozoites in the salivary glands 
greater than 14 days after infection. 
2.2.1.5 Mosquito midgut dissection for oocyst determination 
The numbers of oocysts in the mosquito midgut were counted 7-12 days post infection 
to determine the transmission blocking effect of substances tested in this study. To ob-
tain the midguts, mosquitoes were removed from the pots using a gun aspirator and 
anesthetized by placing the gun aspirator on ice. The anesthetized mosquitoes were 
transferred onto a petri dish embedded on ice and examined visually for the presence 
of eggs in the abdomen since this is proof of a previous blood meal. Mosquitoes with 
eggs in the abdomen were then dissected under a binocular light microscope using a 
40 x objective. Midguts were extricated by holding the anterior of the abdomen with 
tweezers whilst at the same time a second pair of tweezers was used to gently pull on 
the apex of the abdomen until the gut came out. The tweezers were used to cut through 
the alimentary canal at the junction of the midgut and the hindgut, simultaneously sev-
ering the malpighian tubules. The hindgut and malpighian tubules were discarded 
leaving only the midgut on the slide. For P. falciparum gametocyte-fed mosquitoes, 
oocysts in midgut were visualized following staining with of 0.2% mercurochrome 
and oocysts were counted under the light microscope at 40 x objective (Figure 15). For 
visualization of oocysts in P. berghei-fed mosquitoes, the midguts were immersed in 1 
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x PBS and the GFP expressing oocysts counted under a fluorescent microscope at 40 x 
objective. 
 
Figure 15: P. falciparum oocysts in mosquito midgut stained with mercurochrome. 
2.2.1.6 Mosquito salivary gland dissection for sporozoites determination  
In order to determine sporozoites in mosquito salivary glands, mosquitoes between 14-
17d post-feeds were dissected which represent the time in which the sporozoites be-
come visible in the salivary gland. The mosquitoes were aspirated from the pots, 
anesthetized as described in section 2.2.1.5, and placed on a  glass slide mounted un-
der a binocular light microscope  containing a drop of 1 x PBS. A dissecting needle 
was placed gently on the thorax of the mosquito below the region where the salivary 
glands lie and a second needle on the ‘neck’ of the mosquito (apex of head and thorax) 
and the head was gently detached without cutting. Then another needle was used to 
gently push down on the thorax to expose the salivary glands. Intact salivary glands 
are comprised of a pair of three lobes each, two lateral lobes and a medial lobe. The 
number of lobes obtained from each dissected mosquito was counted and salivary 
glands obtained for each group were pooled together in one tube containing 50 µl PBS 
on ice. To liberate the sporozoites from the glands, the glands were macerated using an 
eppendorf pestle and 10 µl of the sporozoite suspension was loaded onto a Neubauer 
counting chamber and a phase contrast microscope was used to count the number of 
sporozoites present in the 4 x 4 grid under the 40 x magnification. The number of 
sporozoites per salivary gland lobe was determined as: 
𝑁𝑁𝑁𝑁 𝑁𝑁𝑜𝑜 𝑠𝑠𝑠𝑠𝑁𝑁𝑠𝑠𝑁𝑁𝑠𝑠𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑔𝑔𝑠𝑠𝑠𝑠𝑔𝑔𝑔𝑔 𝑠𝑠𝑁𝑁𝑙𝑙𝑠𝑠= 𝑁𝑁𝑁𝑁 𝑁𝑁𝑜𝑜 𝑠𝑠𝑠𝑠𝑁𝑁𝑠𝑠𝑁𝑁𝑠𝑠𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠 µl × total volume ( 50µl)  
𝑇𝑇𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠 𝑔𝑔𝑛𝑛𝑛𝑛𝑙𝑙𝑠𝑠𝑠𝑠 𝑁𝑁𝑜𝑜 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑔𝑔𝑠𝑠𝑠𝑠𝑔𝑔𝑔𝑔 𝑠𝑠𝑁𝑁𝑙𝑙𝑠𝑠𝑠𝑠 𝑁𝑁𝑙𝑙𝑠𝑠𝑠𝑠𝑠𝑠𝑔𝑔𝑠𝑠𝑔𝑔 
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2.2.2 Cell biology methods 
 
2.2.2.1 Thawing of P. falciparum parasites 
To start a new P. falciparum culture, cryotubes containing frozen cultures in glycero-
lyte were allowed to thaw at RT. 1 ml of the culture was transferred into a 15 ml falcon 
tube, 200 µl of sterile 12 % NaCl was added, and the tube was swirled gently and in-
cubated for 2 min at RT. Afterwards, 10 ml of 1.6% NaCl was added drop wise and the 
culture centrifuged at 1000 g for 5 min. The supernatant was discarded and 10 ml of 
0.2% Glucose/0.9% NaCl solution was added drop by drop and the mixture centri-
fuged at 1000 g for 5 min. Then the supernatant was removed and the pellet 
resuspended in 5 ml of complete medium containing 500 µl of RBC and transferred to 
a 25 cm3 culture flask for cultivation. 
2.2.2.2 Freezing of P. falciparum parasites 
In order to store P. falciparum cultures, high parasitaemia cultures with greater than 
5%, mainly ring forms, were transferred into a 15 ml falcon tube and centrifuged at 
1000 g for 5 min. The supernatant was removed and 5 pellet volumes of glycerolyte 
was added and 1 ml aliquots were transferred into 2 ml cryotubes and allowed to stand 
at RT for 5 min then stored at -80°C till needed.  
2.2.2.3 Preparation of blood smears 
To prepare blood smears, 100 µl of cultures were transferred into 1.5 ml eppendorf 
tubes and the tubes were centrifuged at 3000 g for 1 min. Thereafter, 85 µl of the su-
pernatant was removed and the pellet resuspended with the remaining 15 µl of 
medium. Ten microlitres of the suspension was then placed on a glass slide towards 
the left side and the cells were smeared across the slide with the help of another slide 
placed at an angle of 45° to get a thin film (Figure 16). The slides were then allowed to 
air dry and the specimens on the dried slides fixed with methanol for 30s, allowed to 
dry and stained with Giemsa for 10-20 min. After staining, the slides were washed 
with distilled water to remove excess stain, dried and observed using 100 x objectives 
under oil immersion with a light microscope. 
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Figure 16: Parasite blood smear preparation. (A), Procedure for preparation of blood 
smears. (B), Giemsa stained blood smear from a P. falciparum mixed culture. 
2.2.2.4 Estimation of parasitaemia 
Percentage of infected erythrocytes (% parasitaemia) was estimated from Giemsa-
stained slides (section 2.2.2.3). To this end, an area of thin blood film where the eryth-
rocytes were uniformly distributed was observed using a 1000 fold magnification 
under oil immersion and the number of erythrocytes in the field was counted. Without 
changing the field, the number of infected erythrocytes was also counted. The same 
process was repeated for about 4-5 fields and the percentage parasitaemia calculated as 
follows: 
A = mean infected erythrocytes from field counted 
B = mean total erythrocytes (infected and non infected) from field counted 
𝑃𝑃𝑠𝑠𝑠𝑠𝑃𝑃𝑠𝑠𝑔𝑔𝑠𝑠𝑠𝑠𝑔𝑔𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑛𝑛𝑠𝑠𝑠𝑠 (%)  =  𝐴𝐴
𝐵𝐵  × 100 
2.2.2.5 Cultivation of P. falciparum 
Chloroquine (CQ)-sensitive strain 3D7 and CQ-resistant strain Dd2 were cultivated in 
human erythrocytes with Albumax II medium as previously described (Trager and Jen-
sen, 1976; Cranmer et al., 1997). RPMI medium 1640 was supplemented with 
hypoxanthine, 0.5% Albumax II and gentamycin. P. falciparum F12 asexual strain was 
cultivated in RPMI medium 1640 in vitro in the presence of 10% inactivated A+ human 
serum. To generate gametocytes, P. falciparum isolate strain NF54 was cultivated in 
RPMI medium 1640 in vitro in the presence of 10% inactivated human serum as de-
scribed (Ifediba and Vanderberg, 1981). For gametocytes used for qRT PCR  the 
culture medium was supplemented with 50 mM N-acetyl glucosamine for approxi-
mately 5 days to kill the asexual blood stages as soon as stage I gametocytes started to 
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emerge in the NF54 culture. The gametocyte culture was then maintained in normal 
culture medium without GlcNac until immature (stage III and IV) or mature stage V 
gametocytes were harvested and enriched by Percoll gradient purification. All cultures 
were maintained at 37°C in an atmosphere of 5% O2, 5% CO2, 90% N2 (Figure 17). 
Cultures were also synchronized by repeated sorbitol treatment (section 2.2.2.6). Con-
tinuous cultures were maintained in 25 cm3 flasks and every 48 h, a blood smear was 
prepared and the parasitaemia estimated. The parasitaemia was then maintained at less 
than 3% to avoid stressing the parasites by removing an aliquot of the culture with 
high parasitaemia into a new flask and adding fresh medium to 5ml and fresh erythro-
cyte to final haematocrit of 5%. Gametocytes were cultured in 75 cm3 flasks and the 
cultures were fed daily by removing spent medium and adding fresh medium. 
 
 
Figure 17: P. falciparum parasite culture. (A), clean working bench for manipulation of 
parasite cultures. Bench contains a hot plate which maintains the cultures at 37°C. (B), and 
(C), 37°C incubator for maintaining cultures in culture flasks. 
2.2.2.6 Synchronization of parasite cultures 
Parasite cultures which were mainly ring stages were transferred into a 15-ml falcon 
tube and the tube centrifuged at 1000 g for 2 min. The supernatant was removed and 
the pellet resuspended in 10 volumes of 5% sorbitol and kept at room temperature for 
10 min. Thereafter, the supernatant was removed following centrifugation at 1000 g 
for 2 min and the pellet was resuspended in 10 volumes of complete medium to wash. 
The supernatant was again removed after centrifugation at 1000 g for 2 min and the 
pellet resuspended in 5 ml of warm complete medium and transferred into a 25 cm3 
flasks for in vitro cultivation.   
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2.2.2.7 P. berghei maintenance 
Two P. berghei ANKA strains were used in this study, one wild type strain and the 
other constitutively expressing GFP throughout the life cycle. The parasites were 
maintained in Balb/c mice. For initial infection of mice, approximately 107 P. berghei-
parasitized red blood cells were injected intraperitoneally to a recipient mouse. Mice 
positive for mature gametocytes were used to infect An. stephensi mosquitoes. Follow-
ing 14-21 days post-infection, some mosquitoes were dissected and assessed for 
sporozoites. Infective mosquitoes were used to infect other mice by mosquito feeds. 
These mice were monitored as above and once the parasitaemia reached 10%, blood 
was collected via cardiac puncture and used for syringe blood-to-blood passages. 
Housing and handling of animals followed the guidelines of the animal welfare com-
mittee of Lower Franconia. 
2.2.2.8 Counting cells using a Neubauer counting chamber 
The Neubauer counting chamber was used to count HeLa cells required for seeding in 
the MTT assay and sporozoites from mosquito salivary glands. For the determination 
of cell number for the MTT assay, 50 µl of HeLa cell suspension was mixed with 450 
µl of 0.1% Trypan blue (prepared with PBS). A coverslip was placed over the grid of 
the chamber and 10 µl of mixture was loaded on one side of the grid by placing the tip 
of a pipette at the edge of the coverslip so that the mixture fills the chamber by capil-
lary action. The number of viable cells was counted (non viable cells were stained blue 
while viable cells were not) in the 4 corner squares which are subdivided into 16 terti-
ary squares omitting cells lying on the cancelled lines (Figure 18). The mean count of 
viable cells per the four corner squares was calculated and the viable cell concentra-
tion per ml was determined using the following formula: 
𝑁𝑁𝑛𝑛𝑛𝑛𝑙𝑙𝑠𝑠𝑠𝑠 𝑁𝑁𝑜𝑜 𝑃𝑃𝑠𝑠𝑠𝑠𝑠𝑠/𝑛𝑛𝑠𝑠 = 𝑀𝑀 × 𝑔𝑔𝑜𝑜 ×104 
M = mean count of 4 corner quares 
df = dilution factor( 10 ie 50 µl of HeLa cell suspension + 450 µl of 0.1% Trypan 
blue). 
104 = conversion factor for the counting chamber. 
For counting sporozoites, 10 µl of salivary gland suspension was loaded in the cham-
ber and the number of sporozoites per µl determined as above. 
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Figure 18: Neubauer counting chamber indicating counting grid and how cells were 
counted (Modified from http://elearning.studmed.unibe.ch). 
2.2.2.9 Purification of asexual blood stages 
Asexual blood stages were purified in order to isolate genomic DNA or to obtain para-
site lysates. To this end, cultures were transferred into falcon tubes and centrifuged at 
1000 g for 5 min. Afterwards the pellet was washed with 10 ml of ice cold PBS and 
the supernatant was discarded after another centrifugation at 1000 g for 5 min. To lyse 
red blood cells, pellets were resuspended in 0.15% saponin in PBS by gently pipetting 
up and down until the blood turned dark red and incubated on ice for 10 min. When 
lysis was completed, the tubes were centrifuged at 3000 g for 10 min and the superna-
tant was discarded. The pellet was then washed once with PBS and centrifuged at 3000 
g for 10 min. After discarding the supernatant, the parasite pellet was then stored at -
20°C or used immediately. 
2.2.2.10  Purification of gametocytes by Percoll 
Gametocytes were purified as previously described by Kariuki and coworkers (Kariuki 
et al., 1998). Spent medium was removed from culture flask containing gametocytes 
and 5 ml of 1 x ICM was added and transferred into a prewarmed 50 ml falcon tube. 
The tube was then centrifuged at 1800 g for 5 min and the pellet washed once with 1 x 
ICM medium and centrifuged at 1800 g for 5 min and the pellet resuspended to a final 
volume of 2 ml with 1 x ICM medium. Ninety percent Percoll was prepared by addi-
tion of one volume of 10 x ICM to nine volumes of stock Percoll solution (100%). The 
solution was then diluted with 1 x ICM to make 80%, 65%, 50% and 35% Percoll so-
lutions. Two millilitres (2ml) of each of these diluted solutions was run slowly down 
the side of a tilted 15-ml test tube, starting with the heaviest (80%), to form the layered 
gradient and the tube prewarmed at 37°C. The gametocyte suspension was carefully 
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layered over the discontinuous Percoll gradient and centrifuged at 1300 g for 10 min. 
The interface between the first and the second layer (Figure 19A) was collected and 
washed 2 times with 5-10 ml incomplete medium followed by centrifugation at 1300 g 
for 5 min. Purified gametocytes were checked for purity and infectivity by examining 
thin Giemsa-stained smears (Figure 19B) and checking for exflagellation respectively.  
 
 
Figure 19: P. falciparum gametocyte purification. (A), gametocyte layer following percoll 
gradient separation. (B), Giemsa stained smear of gametocytes following purification with 
percoll. 
 
2.2.2.11 Malstat assay 
Harmonine and E. meningoseptica extracts were screened for growth inhibition activ-
ity against erythrocytic stages of P. falciparum at concentrations between 0.39 to 50 
μM and 2.5 to 0.02 mg/ml respectively using the Malstat assay which measures the 
activity of the Plasmodium-specific enzyme lactate dehydrogenase as earlier described 
(Makler and Hinrichs; 1993, Makler et al., 1993). Synchronized ring stages of P. falci-
parum strains 3D7 and Dd2 were plated in triplicates in 96-well plates (200 μl/well) at 
a parasitaemia of 1% in the presence of the compounds. Harmonine was dissolved in 
dimethyl sulfoxide (DMSO) while E. meningoseptica extracts were dissolved in 
methanol. Chloroquine, disolved in double-distilled water, served as a positive control 
in the experiments. Incubation of parasites with DMSO or methanol alone at a concen-
tration of 0.5% vol. served as negative. Parasites were cultivated in vitro for 72 h. 
Aliquots of 20 μl were removed and added to 100 μl of the Malstat reagent in a 96-
well microtiter plate. The assessment of pLDH activity was obtained by adding a 20 μl 
  Materials and Methods 
51 
of a mixture of NBT (Nitro Blue Tetrazolium)/Diaphorase (1:1; 1mg/ml stock each) to 
the Malstat reaction, and optical densities were measured at 630 nm. Each compound 
was tested 2 to 4 times and the IC50 (50 % inhibitory concentration) values were calcu-
lated from variable-slope sigmoidal dose-response curves using the GraphPad Prism 
program version 4. 
2.2.2.12 MTT cytotoxicity test  
HeLa cells (1.3 x103 cells per well) were plated in 96-well microtiter plates and cul-
tured at 37°C overnight. Harmonine was added to the cultures in concentrations of 0.2- 
100 μM in triplicate, and the cells were incubated for 48 h. DMSO at a final concen-
tration of 0.5 % vol. was used as negative control and a toxic concentration of 15% 
vol. DMSO as positive control. After 48 h of drug treatment, Twenty microlitres of 
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2,5 Diphenyltetrazoliumbromid; 5 mg/ml) was 
added to each well and incubated for 3 h at 37°C.  The medium was subsequently re-
placed by 100 μl solubilization solution (5% SDS, 0.1M HCl in 100 %vol. DMSO) 
incubated for 30 min under rotation at RT to solubilize the formazan crystals and the 
optical density of the solution was measured at 550 nm (Multiscan Ascent). The 
OD550 values of compound-treated cultures were normalized to the OD550 values of 
DMSO control (set to 100%). 
2.2.2.13 Gametocyte toxicity test 
P. falciparum NF54 parasites were grown at high parasitaemia to favor gametocyte 
formation. Upon appearance of gametocytes stage II, 1 ml of culture was aliquoted in 
triplicate in a 24-well plate in the presence of harmonine at IC50 (4.8 µM) and IC90 (50 
µM) concentrations and E. meningoseptica extract at IC50 concentrations (0.25 mg/ml, 
as determined by Malstat assay). The gametocytes were cultivated for 7 d and the me-
dium was replaced daily. For the first 48 h of cultivation, the gametocytes were treated 
with test compound; subsequently the medium was compound free. After 7 d, Giemsa-
stained blood smears were prepared and the gametocytemia was evaluated by counting 
the number of gametocytes stages IV and V in a total number of 1000 erythrocytes.  
2.2.2.14 Erythrocyte lysis test 
To investigate the effect of harmonine on erythrocyte integrity, a volume of 1 ml of 
washed uninfected erythrocytes was resuspended in regular medium at a final haema-
tocrit of 5 % and plated in triplicates in a 96-well plate (200 μl/well) in the presence of 
  Materials and Methods 
52 
harmonine at different concentrations. Medium supplemented with 0.15% saponin was 
use for lysis control and 0.5%vol. DMSO was used for negative control. After 48 h of 
incubation at 37°C, the plate was centrifuged at 500 g for 2 min. A volume of 100 µl 
of the resulting supernatant was carefully transfered to another plate and the optical 
density was measured at 550 nm with a spectrophotometer. 
2.2.2.15 Exflagellation inhibition assay 
Inhibition of microgametogenesis was investigated by the exflagellation inhibition as-
say. A volume of 100 μl of mature NF54 gametocyte cultures was pre-incubated with 
harmonine in concentrations ranging between 0.39 µM and 100 µM for 15 min at 
37°C. The sample was then transferred to RT and xanthurenic acid (XA) was added at 
a concentration of 100 μM for activation. After another 15 min, the numbers of exflag-
ellation centers (Figure 20) were counted in 30 optical fields using a Leica DMLS 
microscope by 400-fold magnification. Three independent experiments were per-
formed and the inhibition of exflagellation was calculated as a percentage of the 
number of exflagellation centers in compound-treated cultures in relation to the num-
ber of exflagellation centers in untreated controls. The IC50 values were calculated 
from variable-slope sigmoidal dose-response curves using the GraphPad Prism pro-
gram version 4. 
 
Figure 20: Exflagellation centre following gametocyte activation (red circle) 
2.2.2.16   Zygote development assay 
Inhibition of zygote formation was investigated using the Zygote development assay. 
Mature gametocyte cultures were pre-incubated for 15 min at 37°C in the presence of 
Harmonine at IC50 (4.8 µM) and IC90 (50 µM) concentrations. The cultures were then 
activated as described above and incubated for another 12 h at RT. Unfixed specimens 
were fluorescently labeled with antibodies against Pfs25 in combination with a fluoro-
chrome-conjugated secondary antibody, and the number of zygotes was counted in 90 
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optical fields using a Leica DMLS microscope by 400-fold magnification. Two inde-
pendent experiments were performed. 
2.2.2.17 Indirect immunofluorescence assay  
Asexual F12 blood stage parasites, non-activated NF54 gametocytes and gametocytes 
at 30 min post-activation were air dried on glass slides and fixed for 10 min in −80°C 
methanol. For membrane permeabilization and blocking of non-specific binding, fixed 
cells were incubated for 30 min in 0.01% saponin/0.5% BSA/PBS and 1% neutral goat 
serum in PBS. Preparations were then successively incubated for 1.5 h each at 37°C 
with the primary antibody diluted in 0.01% saponin/0.5% BSA/PBS. Binding of pri-
mary antibody was visualized using fluorescence-conjugated goat anti-mouse or anti-
rabbit secondary antibodies (Alexa Fluor 488 or Fluor 596) diluted in 0.01% 
saponin/0.5% BSA/PBS. Nuclei were highlighted by incubating the specimens with 
Hoechst nuclear stain for 1 min and cells were mounted with anti-fading solution AF2 
and sealed with nail varnish. Digital images were taken using a Leica TCS SP5 confo-
cal laser scanning microscope and processed using Adobe Photoshop CS software.  
 
Figure 21: Indirect immunofluorescent assay (modified from http://www.mgormerod.com). 
The secondary detection antibody (fluorescein conjugated) binds to the primary antibody 
which is specific to the protein of interest on the parasite. 
2.2.2.18 Fluorescent signal quantification 
For quantitative evaluation of signal strength, digital images of 15-20 randomly se-
lected mature and activated gametocytes were taken using a LSM Zeiss confocal laser 
scanning microscope under the same optimal laser scanning microscopy settings for 
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each antibody. The average fluorescence signal intensity of each cell, as indicated by a 
line edging the respective cell was measured using the LSM 510 image software and 
recorded. 
2.2.2.19 An. stephensi midgut histology 
Whole larvae and dissected midguts of female adult An. stephensi mosquitoes were 
fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in cacodylate buffer for one 
day. Specimens were embedded in Epon as previously described (Sologub et al., 
2011). Semi-thin sections were obtained using an ultramicrotome RMC MT-7000. 
Semi-thin sections were dried on slides at 60°C, stained with a mixture of 0.5% me-
thylene blue and 0.5% AzurII for 1 min, and investigated using an Olympus BX41 
fluorescence microscope at 100-fold and 1000-fold magnifications in combination 
with a Jenoptik ProgRes Speed XT5 camera. Digital images were processed using 
Adobe Photoshop CS software. 
2.2.2.20 Electron microscopy of E. meningoseptica isolate 
E. meningoseptica was cultured for 48 h. A volume of 2 ml of the culture was pelleted, 
fixed in 2.5% glutaraldehyde in PBS overnight. The next day, the pellet was washed 3 
times for 20 min with PBS and incubated overnight in 2% osmium tetroxide / PBS. 
The cells were then dehydrated with increasing concentrations of ethanol (50%, 70%, 
90% and 100%) and incubated two times for 30 min in propylene oxide then embed-
ded in Epon for two days at 60°C. Sections were obtained using an ultramicrotome 
RMC MT-7000. Post-staining of sections was performed with 1% of uranyl acetate for 
30 min. Photographs were taken with a Zeiss EM10 transmission electron microscope. 
2.2.2.21 Organic extract preparation from E. meningoseptica isolate 
The E. meningoseptica isolate was cultured in 100-ml Erlenmeyer flasks containing 50 
ml of LB medium. The liquid cultures were grown for 2 days at 37°C, while shaking at 
150 rpm. A volume of 250 µl of each liquid culture was used to inoculate 10 LB agar 
plates and the plates were grown at 37°C for 48 h. LB agar plates without bacteria 
were used as negative control. Colonies on agar plates were controlled for purity, then 
cut into small pieces and macerated overnight with a double volume of ethyl acetate 
with continuous shaking for 2 days. The ethyl acetate macerate was filtered and the 
filtrate was collected. A double volume of acetone was added to the agar macerate, and 
this mixture was shaken for 3 h for extraction of metabolites and then filtered. The 
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ethyl acetate and acetone filtrates were dried under vacuum at 40°C and the dry weight 
was determined. The extracts (agar ethyl acetate and agar acetone) were dissolved in 
methanol, and then stored at 4°C for the bioassays. For extraction of metabolites from 
broth cultures, 1 ml of the 48 h E. meningoseptica isolate culture was added to 350 ml 
LB medium and grown for 48 h at 37°C. The culture was filtered and metabolites from 
the cell pellet were extracted in a double volume of methanol. The mixture was shaken 
for 2 h and then filtered. The aqueous layer (spend medium) was extracted two times 
with the triple volume of ethyl acetate. The extracts (broth ethyl acetate and broth 
methanol) were concentrated under vacuum, their dry weights determined, dissolved 
in methanol and stored at 4°C for the bioassays. 
2.2.2.22 Standard disk diffusion assay  
The in vitro antimicrobial activity testing of E. meningoseptica extracts was carried 
out using the standard disk diffusion assay (Inderlied et al., 1995) against gram-
positive bacteria (Staphylococcus aureus strain 8325), gram-negative bacteria (Es-
cherichia coli strain 536) and yeast (Candida albicans strain S314). Sterile filter disks 
(6 mm) each impregnated with 25 µl of 250 mg/ml extract 3 times and allow to dry 
were placed on agar plates that had been inoculated with the test bacterium. After 24 h 
incubation at 37°C for bacteria and 30°C for fungus, the antimicrobial and antifungal 
potential was quantitatively assessed as diameter of the inhibition zone. Gentamicin as 
antibacterial and nystatin as antifungal agents served as positive controls while 50 
vol% methanol served as negative control. The antibiotic susceptibility test on the E. 
meningoseptica midgut isolate was performed using the standard disk diffusion assay 
as described above, using 1:2 serial dilutions of the respective antibiotics (ampicillin, 
kanamycin, streptomycin and gentamicin) at concentrations of 7.8, 15.6, 31.25, 62.5, 
125.0 and 250.0 µg/ml. Water used for dissolving the antibiotics served as negative 
control while gentamicin at a concentration of 10 mg/ml was used as positive control. 
 
2.2.3 Molecular biology methods 
 
2.2.3.1 DNA extraction  
For bacterial diversity determination in midgut tissues, total DNA was extracted using 
the MasterPure DNA purification kit in accordance with the manufacturer’s instruc-
tions. Genomic DNA (gDNA) from P. falciparum was isolated from purified asexual 
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blood stages following lysis with 0.15% saponin using the QIAamp Blood Mini Kit as 
recommended by the manufacturer. The isolated DNAs were eluted with distilled wa-
ter and their concentration determined using a NanoDrop spectrophotometer. 
DNA fragments from agarose gels were purified using the NucleoSpin® Extract II us-
ing the protocol as recommended by the manufacturer. The kit is based on the 
principle that DNA binds in the presence of chaotropic salt to a silica membrane. The 
binding mixture is then loaded directly onto NucleoSpin® Extract II columns and con-
taminations are removed by a simple washing step. DNA was eluted with ddH2O. 
2.2.3.2 Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to amplify total 16S rRNA gene from mid-
gut tissue samples for bacteria diversity determination. PCR was also used in Real-
time RT-PCR (qPCR), the amplification of genomic DNA sequences for checking 
qPCR primers and also for the amplification of coding sequences for recombinant pro-
tein production. Two distinct polymerases were used during this study: Go-Taq 
polymerase for 16S rRNA gene amplification and primer check and PHUSION poly-
merase for recombinant protein production because of the proof reading function. 
a) 16S rRNA gene amplification 
Bacterial 16S rRNA gene amplification for library construction and DGGE were per-
formed using a PCR mix of 50 µl using the following ingredients: 
Reaction Mix 
10 µl Go-Taq buffer (5x) 
2.5 µl MgCl2 (25 mM) 
  1 µl dNTPs (10 mM) 
  1 µl Forward primer (100 pmol/ µl)  
  1 µl Reverse primer (100 pmol/ µl)  
  1.25 U Go-Taq polymerase 
  50-100 ng DNA   
  Add dd H2O to 50 µl 
For 16S rRNA gene library construction, the universal 27f and 1492r primers (Lane, 
1991) were used and PCR reactions were performed under the following conditions: 
Initial denaturation:   
PCR Condition 
94°C for 5 mins  
Denaturation: 94°C for 30 s  
Annealing: 54°C for 30 s      30 cycles 
Extension: 72°C for 1 min 30 s  
Final extension: 72°C for 10 min.  
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16S rRNA gene amplification for DGGE and excised DGGE bands were performed 
using the universal 16S rRNA gene primers 341f with GC-clamp and 907r (Muyzer et 
al., 1998) and the 341f without GC-clamp and 907r primers respectively. The condi-
tions were as follows: 
Initial denaturation:   
PCR Condition 
95°C for 5 mins  
Denaturation: 95°C for 1 min  
Annealing: 54°C for 1 min 30 cycles 
Extension: 72°C for 45 s  
Final extension: 72°C for 10 min.  
Plasmid DNA  containing  16S rRNA gene  of correct insert size was verified by PCR 
amplification using T7 and SP6 pGEM-T Easy primers flanking the insert using the 
following conditions: 
Initial denaturation:   
PCR Condition 
95°C for 2 mins  
Denaturation: 95°C for 30 s  
Annealing: 45°C for 30 s 30 cycles 
Extension: 72°C for 2 min  
Final extension: 72°C for 3 min.  
PCRs without DNA templates were used as negative controls and the PCR products 
were determined on a 1% agarose gel using electrophoresis. 
b)  Genomic and plasmid DNA amplification 
For the amplification of genomic DNA for qPCR primer check, the following master 
mix and PCR condition was used: 
Reaction  Mix 
4 µl Go-Taq buffer (5x) 
2.5 µl MgCl2 (25 mM) 
0.6 µl dNTPs (10 mM) 
0.6 µl Forward primer (10 pmol/ µl)  
0.6 µl Reverse primer (10 pmol/ µl)  
1.25 U GoTaq polymerase 
50 ng DNA   
Add dd H2O to 20 µl 
Initial denaturation:   
PCR Condition 
95°C for 10 mins  
Denaturation: 95°C for 15 s  
Annealing: 60°C for 1min 35 cycles 
Extension: 60°C for 1 min  
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Final extension: 95°C for 3 min.  
Others PCR reactions using Go-Taq polymerase and PHUSION polymerase were con-
ducted using the following mix and conditions. 
Go-Taq reaction 
5 µl Go-Taq buffer (5x) 
1.25 µl MgCl2 (25 mM) 
0.5 µl dNTPs (10 mM) 
0.5 µl Forward primer (100 pmol/ µl)  
0.5 µl Reverse primer (100 pmol/ µl)  
1.25 U GoTaq polymerase 
50 -100 ng DNA (or 2 µl from a colony diluted in 20 µl of dH2O) 
Add dH2O to 25µl 
Initial denaturation:   
PCR Condition 
94°C for 2 mins  
Denaturation: 94°C for 30 s  
Annealing: 45°C for 30 s  35 cycles 
Extension: 72°C for 60 s/1Kbp  
Final extension: 72°C for 2 min.  
PHUSION reaction 
10 µl Phusion buffer (10x) + MgCl2 
1 µl dNTPs (10mM) 
1 µl Forward primer (100pmol/ µl)  
1 µl Reverse primer (100pmol/ µl)  
5 U Phusion polymerase 
50 -100 ng DNA or cDNA 
Add ddH2O to 25µl 
Initial denaturation:   
PCR Condition 
98°C for 30 s  
Denaturation: 98°C for 20 s  
Annealing: 45°C for 30 s  35 cycles 
Extension: 60°C for 60 s/1Kbp  
Final extension: 60°C for 2 min.  
 
2.2.3.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate and analyze DNA fragments. For gel 
preparation, agarose was dissolved in concentrations of 1 to 3 % (w/v) in 1xTAE 
buffer. The mixture was boiled in a microwave until the agarose was completely dis-
solved and was allowed to cool at RT to about 50-60°C. The gel mixture was then 
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poured on a gel tray and the combs inserted and allowed to solidify. After gel solidifi-
cation, the combs were removed and the tray was placed in a clean gel tank filled with 
1 x TAE buffer. Samples were mixed with loading dye in the ratio of 5:1 and loaded in 
appropriate wells together with markers and the appropriate controls. DNA on gels 
was separated at 110V for about 30-60 min and then stained in Ethidium bromide and 
visualized using a UV transilluminator. 
2.2.3.4 Ligation of PCR products into cloning vectors 
For subcloning and construction of 16s rRNA gene libraries, the PCR products were 
ligated into the pGEM®-T Easy vector as recommended by the manufacturer. The 
plasmid is a linearized vector with a single 3´-terminal thymidine at both ends which 
greatly improve the efficiency of ligation of PCR products by preventing recirculariza-
tion of the vector and a compatible overhang for PCR products generated by certain 
thermostable polymerases. When Phusion polymerase was used, a 3´-A overhang was 
added to the PCR product since the enzyme does not generate 3´-A-tailed amplicon. 
Adding for the 3´A overhang was done as follows: 
Component                                     
Purified PCR product   
Volume (μl) 
2-6 
5x Go-Tag polymerase buffer 2 
25 mM MgCl2 1 
Go Taq polymerase                                  1 
Add ddH2O to                                          10 
 
The mixture was incubated at 70°C for 15- 20 min and the A-overhang product was 
then ligated into the pGEM®-T Easy vector as follows: 
Component                                    
2 x rapid ligation buffer                         
Volume (μl) 
5 
pGEM-T Easy vector (50 ng/ μl)           1 
A-tailed product                                      2 
T4 DNA ligase (3 U/ μl)                         1 
ddH2O 1 
The mixture was then incubated for 2-3h at RT or at 4°C overnight and 2 μl of the 
ligated product was used for transformation. 
In order to clone into the target vector the amount of insert required was calculated 
using the following formula: 
𝐴𝐴𝑛𝑛𝑁𝑁𝑛𝑛𝑔𝑔𝑠𝑠 𝑁𝑁𝑜𝑜 𝑠𝑠𝑔𝑔𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 (𝑔𝑔𝑔𝑔) = 5 × 𝑠𝑠𝑛𝑛𝑁𝑁𝑛𝑛𝑔𝑔𝑠𝑠 𝑁𝑁𝑜𝑜 𝑠𝑠𝑠𝑠𝑃𝑃𝑠𝑠𝑁𝑁𝑠𝑠(𝑔𝑔𝑔𝑔) × 𝑠𝑠𝑠𝑠𝑔𝑔𝑔𝑔𝑠𝑠ℎ 𝑁𝑁𝑜𝑜 𝑠𝑠𝑔𝑔𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠(𝑙𝑙𝑠𝑠)
𝐿𝐿𝑠𝑠𝑔𝑔𝑔𝑔𝑠𝑠ℎ 𝑁𝑁𝑜𝑜 𝑠𝑠𝑠𝑠𝑃𝑃𝑠𝑠𝑁𝑁𝑠𝑠 (𝑙𝑙𝑠𝑠)  
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The ligation reaction was as follows: 
Component                                    
10 x ligation buffer                                
Volume (μl) 
5 
Ligation vector (100 ng/ μl)                   1 
Digested product                                    X 
T4 DNA ligase                                       1 
ddH2O to 20 
 
The mixture was then incubated for 2-3h at RT or at 16°C overnight and 2 μl of the 
ligated product was used for transformation. 
2.2.3.5 Transformation of chemically competent E. coli cells 
To transform chemically competent E. coli cells, 2 μl of a ligation reaction or 2μl 
plasmid (50-100 ng)  was mixed with 30-50 μl of chemically competent E. coli  
(TOP10 , Nova Blue or BL21). After pre-incubation for 30 min on ice, cells were sub-
jected to a heat shock for 40-50 seconds at 42°C. Cells were chilled for 2 min on ice 
and resuspended in 500 μl SOC medium. Recovery was carried out for 60 min at 
37°C, 220 rpm before selection on L-broth agar plates with the appropriate antibiotics. 
2.2.3.6 Plasmid DNA purification 
For purification of plasmid mini-preps the NucleoSpin Plasmid Quick Pure kit was 
used as recommended by the manufacturer. One bacterium colony was incubated with 
3-5 ml of LB medium supplemented with ampicillin overnight at 37°C, 220 rpm. The 
next day the bacteria were pelleted at 16000 g for 1 min and plasmid DNA purified as 
recommended by the manufacturer. DNA was eluted with 50 μl of double distilled wa-
ter and concentration determined using a NanoDrop machine. 
2.2.3.7 Restriction digestion and 16s rRNA gene restriction fragment length 
polymorphism (RFLP) 
Restriction digestion otherwise stated was carried out as follows: 
Component                                    
pDNA (up to 2 µg)                                  
Volume (μl) 
X 
10 x NEB 4 buffer                                  5 
10 x BSA (if required)                           5 
Restriction enzymes (20000 U/ml)        1 
ddH2O to 50 
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For 16s rRNA gene RFLP, the 16s rRNA gene was amplified from the pGEM-T vector 
using the T7 and SP6 vector primers flanking the insert. The PCR product was then 
digested with Msp I in a 10 μl reaction mixture as follows: 
Component                                    
PCR product                                           
Volume (μl) 
5 
10 x NEB 4 buffer                                  1 
Msp I (20000 U/ml 0.25 
ddH2O to 10 
 
The mixture was then incubated for 1 h at 37°C. Afterwards 0.5 μl of Hae III (10000 
U/ml) was added and incubated again for 2 h at 37°C. Fragments were separated by 
electrophoresis using a 3% gel at 110V for 45 mins and the restriction patterns ana-
lysed. 
2.2.3.8 DNA Sequencing 
Sequencing was done using cloning vector primers by the Seqlab – sequence laborato-
ries Göttingen, Germany (http://www.seqlab.de) and the Fraunhofer Institute for 
Molecular Biology and Applied Ecology (Fraunhofer IME) sequencing facility. The 
sequencing mixture was made up of 600-700 ng of DNA plus 20 pmol of primer (for-
ward or reverse) in a total volume of 7 μl. Suppresive subtraction hybridization inserts 
were sequenced using GATC Biotech, Konstanz, Germany. 
2.2.3.9 Denaturing gradient gel electrophoresis (DGGE) 
Denaturing gradient gel electrophoresis (DGGE) is a molecular fingerprinting method 
that separates PCR-generated DNA products based on the denaturing characteristics of 
their DNA. Therefore, different sequences of DNA (from different bacteria) will dena-
ture at different denaturant concentrations resulting in a pattern of bands with each 
band theoretically representing a distinct bacterial population present in the commu-
nity. If PCR products from a given reaction are of similar size (bp), conventional 
separation by agarose gel electrophoresis results only in a single DNA band that is 
largely non-descriptive. DGGE can overcome this limitation by separating PCR prod-
ucts based on sequence differences that results in differential denaturing characteristics 
of their DNA.  DGGE was used to get a fingerprint of the bacteria diversity in An. ste-
phensi mosquitoes during development and under different diet (Figure 22). The 
universal 16S rRNA gene primers 341f with GC-clamp and 907r (Muyzer et al., 1998) 
were used for PCR amplification of bacterial 16S rRNA genes with the PCR mix and 
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conditions shown in section 2.2.3.2. Denaturing gradient gel electrophoresis (DGGE) 
was performed as described in Schmitt et al. (Schmitt et al, 2007). Lint-free tissues 
were used to wash glass plates, spacers and combs with 1% SDS and then 70% etha-
nol. The gel sandwich was then assembled by placing the small glass plate on top of 
the large one and a 0.75 mm spacer was placed along each edge of the plate assembly 
(Figure 23). The plate clamps were then attached and tightened and the entire assem-
bly was placed into the rear slot of a pouring stand. The clamps were let loose slightly 
and a spacing card was used to assure the proper spacer alignment. If properly aligned, 
the clamps were tighten and plate assembly was removed from the pouring stand and 
inspected to make sure that the two plates and the spacer form a flush surface across 
the bottom of the assembly. The plate assembly was then clamped into place on a foam 
gasket placed into one of the two front slots of the pouring stand. A 20% and 80% de-
naturing solution using 10% acrylamide/bisacrylamide was then prepared from a 
100% denaturant containing 7 M urea and 40% (vol/vol) formamide and a 0% dena-
turing solution lacking the denaturant urea and formamide. A gradient wheel maker 
was then used to produce the 10% (wt/vol) polyacrylamide gel using a 20 - 80% dena-
turing gradient. Fourty microlitres of samples with loading dye were then loaded on 
the gel and DGGE electrophoresis was performed with a Bio-Rad DCode universal 
mutation detection system for 6 h at 150V or 16 h at 70V and 60°C. The gels were 
stained for 30 min in 3x GelGreen before taking an image with a GelDoc EQ Station. 
Selected bands were excised with an ethanol-sterilized scalpel and incubated in 25 µl 
ddH2O overnight at 4°C. A total volume of 4 µl of eluted DNA was subsequently used 
for reamplification with primers 341f and 907r using the PCR conditions described in 
section 2.2.3.2. The DNA obtained from the excised DGGE bands were ligated into 
the pGEM-T Easy vector and transformed into competent E.coli nova blue cells. 
 
  Materials and Methods 
63 
 
 
Figure 22: Schematic depicting the experimental set-up of the 16S rRNA fingerprinting 
analysis by DGGE. The * indicate samples from which 16s rRNA libraries were constructed. 
 
 
 
Figure 23: Setting up the DGGE apparatus  
(Adapted from www.zjpostdoctor.com/userfiles/file/13093318829705.pdf). (A). Com-
ponents of the gel sandwich; gel clamps and spacers between two glass plates. (B), gradient 
wheel, the two syringes hold the high denaturant-concentration solution (back syringe) and 
low denaturant-concentration solution (front syringe). (C), gel assembly with comb inserted. 
(D), the DGGE apparatus in action.  
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2.2.3.10 Construction of 16S rRNA gene clone library 
16S rRNA gene libraries were constructed from DNA obtained from An. stephensi 
eggs, larvae midguts, pupae midguts, as well as from midguts of female An. stephensi 
mosquitoes that were sugar-fed, skin-fed on human blood, and feeder-fed on P. falci-
parum infected blood (Figure 22 marked in asterisks). Additionally, 16S rRNA gene 
libraries were created from the water in which the developmental stages were raised as 
well as from the water tray prior to mosquito addition. The PCR products from the 
amplified 16S rRNA genes were ligated into the pGEM-T Easy vector and trans-
formed into competent E. coli nova blue cells. Plasmid DNA was isolated using the 
Nucleospin plasmid extraction kit and the correct insert size was verified by PCR am-
plification using T7 and SP6 pGEM-T Easy primers flanking the insert followed by 
agarose gel electrophoresis. Fifty clones from each of the eight 16S rRNA gene librar-
ies were characterized by double digestions with the restriction endonucleases MspI 
and HaeIII (RFLP; see section 2.2.3.7). The clones with identical restriction patterns 
were grouped, and one randomly chosen clone per group was sequenced. Sequencing 
was performed in both directions using the T7 and SP6 primers flanking the insert. 
The sequences were assembled using the program BioEdit (v7.1.3) 
(http://www.mbio.ncsu.edu/bioedit/bioedit.html) and controlled for chimeras and for 
other amplification and sequencing artifacts using the program Pintail (Ashelford et 
al., 2005). The sequences were compared with 16S rRNA gene sequences available in 
the GenBank databases by BLASTn search (http://blast.ncbi.nlm.nih.gov/). Sequences 
with identities above 99.0% were considered to belong to the same operational taxo-
nomic unit (OTU). All 16S rRNA gene sequences were deposited in GenBank under 
the accession numbers (JX067925 - JX067934, JX110443). 
2.2.3.11 Phylogenetic tree construction 
The phylogentic tree was constructed with the help of Volker Glöckner. It was done in 
order to determine the phylogentic relationship between the Elisabethkingia sequences 
obtained from the different mosquito developmental stages and feeding regimes. The 
16S rRNA gene sequences were automatically aligned using the web-based SINA 
aligner (v.1.2.9) (Pruesse et al., 2012) and afterwards imported into the 16S rRNA 
ARB-Silva database (SSURef_108). Manual corrections of the alignment and phy-
logenetic analysis were performed using the ARB software package (Ludwig et al., 
2004). Tree construction was conducted using neighbour-joining algorithm (Jukes-
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Cantor correction) with bootstrap values based on 1000 replications. DGGE derived 
sequences were added to the tree without altering the trees topology using the parsi-
mony tool.  
2.2.3.12  Construction of a subtracted cDNA library using the SSH method 
The SSH experiment was conducted by our collaborators in the University of Giessen. 
The total RNA used here was isolated by Matthias Scheuermayer from Percoll-
enriched mature stage V gametocytes before and at 30 min p.a., using Trizol reagent as 
described by the manufacturer. Subsequently, mRNA was isolated from total RNA us-
ing the Oligotex mRNA Mini Kit according to manufacturer's instructions, and the 
SSH method was conducted as previously described (Altincicek and Vilcinskas, 2007, 
2008) using the PCR-Select cDNA Subtraction Kit from Clontech according to the 
manufacturer´s protocol. Two hundred and twenty nanograms (220) ng of purified 
mRNA were reverse-transcribed into cDNA using a cDNA synthesis primer; subse-
quently double-stranded cDNA was generated and digested with RsaI. The double-
stranded cDNA from activated gametocytes was ligated in separate aliquots to adaptor 
1 or adaptor 2R and were denaturated at 98°C for 90 s and then hybridized at 68°C for 
8 h with a 30-fold excess of double-stranded cDNA of non-activated gametocytes. 
Subsequently, both samples were mixed together with a 10-fold excess of freshly de-
natured double-stranded cDNA from non-activated gametocytes and hybridized at 
68°C for 16 h. The sample was then subjected to two rounds of suppression PCR with 
PCR-primer 1 and nested primers supplied with the kit. PCR amplifications were per-
formed in a total volume of 25 μl using a PCR cycler with a heated lid and the 5´Prime 
PCR Extender System. An initial adapter extension at 75°C for 5 min was followed by 
a denaturation step at 93°C for 30 s and by 27 cycles of denaturation at 93°C for 15 s, 
annealing at 66°C for 30 s, and extension at 72°C for 90 s. A final 7 min 72°C step was 
added to allow complete extension of the products. The secondary PCR was performed 
with nested primer 1 and 2R on 1 µl of the primary PCR products for 15 cycles with 
an initial denaturation step at 93°C for 1 min, followed by denaturation at 93°C for 
15s, annealing at 68°C for 30s and extension at 72°C for 90 s, plus a final extension 
step at 72°C for 7 min. Resulting PCR products of the secondary subtractive PCR 
were purified using the NucleoSpin Extract II kit, ligated into the pGEM-T easy vector 
and transformed into NEB 5-alpha competent E. coli ). The library was plated on 
2×YT agar plates containing 100 μg/ml of ampicillin and incubated at 37°C for 16 h.  
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2.2.3.13 Colony PCR and analysis of cDNA sequence data from SSH 
A preliminary colony PCR screen on 20 colonies was performed with vector-specific 
primers, i.e. T7 and SP6, using the following conditions: denaturation at 95°C for 5 
min followed by 30 cycles of denaturation at 95°C for 15 s, annealing at 43°C for 20 s, 
and extension at 72°C for 60 s. A final 7 min 72°C step was added to allow complete 
extension of the products. The colony PCR showed that 75% of clones contained an 
insert in the vector. Subsequently, 288 randomly picked clones were screened for the 
presence of the vector. Plasmid isolation of 134 positively screened colonies was per-
formed with the Fast Plasmid Mini kit and the inserts were sequenced by GATC 
Biotech, Sequences were used to identify similar sequences of the National Center for 
Biotechnology Information databases using BLASTX program (BLASTX 2.2.13; 
http://www.ncbi.nlm.nih.gov/BLAST/) and to predict signal sequences, transmem-
brane regions and features, using the PlasmoDB program (www.plasmodb.org) 
(Aurrecoechea et al., 2009). 
2.2.3.14 E. meningoseptica isolation and species identification  
Adult female mosquitoes were dissected and 25 midguts pooled and homogenized, 
then diluted 1:10 in LB medium. A volume of 100 µl of the diluted homogenate was 
plated on an LB agar plate and incubated at 37°C for 48 h. Four random colonies were 
picked and bacterial genomic DNA was amplified by colony PCR using 16S rRNA 
gene universal primers as described above. The PCR product was separated a 1% aga-
rose gel by electrophoresis and the purified product was cloned in the pGEM T-easy 
vector, sequenced and preliminarily identified by BLASTn. The corresponding E. 
meningoseptica isolate from the midgut homogenate was cultured in 3 ml of LB sup-
plemented with 100 µg/ml ampicillin and stored in glycerol at -80°C. The 
corresponding 16S rRNA gene sequences were deposited in GenBank under the acces-
sion number JX110443. 
2.2.3.15 Total RNA isolation 
Total RNA was isolated from the mixed asexual F12 cultures, enriched immature 
NF54 gametocytes (stage III and IV), non-activated mature gametocytes and gameto-
cytes at 30 min p.a. using the Trizol reagent. The samples were dissolved in 20 pellet 
volumes of prewarmed trizol and incubated shaking at 37°C for 5 min then stored at -
80°C till use. The stored samples were thawed at 37°C and transferred to  15 ml falcon 
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tubes and 0.2 Trizol vol of chloroform was added, mixed well  by shaking and allow to 
stand for 2-3 min at RT then centrifuged (30 min, 4 °C at 1400 g). The aqueous phase 
was then removed carefully and transferred to a fresh reaction tube and the RNA was 
precipitated by addition of 0.5 volumes of isopropanol. The samples were transferred 
to 1.5 ml eppendorf tubes and precipitation was carried out for at least 2 h at 4°C. 
RNA was pelleted by centrifugation for 30 min at 15,000 g at 4°C. After a wash step 
with 500 μl of 75% ethanol and additional centrifugation for 5 min, the supernatant 
was discarded, the pellets air-dried, and subsequently dissolved in 50 μl of DEPC 
H2O, heated at 60°C for 30 min and placed on ice for 2 min then stored at -80°C. 
2.2.3.16 Removal of genomic DNA and RNA clean up 
Up to 5 μg of RNA preparations were treated with RNAse-free DNAse I to remove 
gDNA contamination. The reaction mixture was composed of up to 5μg of RNA, 10 μl 
of buffer RDD, 2.5 μl of DNAse I stock solution and 100 μl of  RNAse free water. The 
samples were then incubated on the benchtop for 10 min. To clean up the RNA, 250 μl 
of diethylpyrocarbonate (DEPC) water mixed with 150 μl phenol and 150 μl chloro-
form was added, well shaken and incubated for 3 min at RT. The mixtures was then 
centrifuged at 12000 g for 10 min at 4°C, then the aqueous phase transferred to a new 
tube and the RNA precipitated at -20°C for at least 30 min by adding 0.1 volumes of 
cold 3M NaOAc (pH 4.8-5.2) and 2.5 volumes cold 100 % ethanol. After centrifuga-
tion for 30 min at 12000 g at 4°C, the pellet was washed with ice cold RNase free 75% 
ethanol and centrifuged at 12000 g for 10 min at 4°C. The pellet was air dried and sub-
sequently dissolved in 25 μl of DEPC H2O, heated at 60°C for 30 min and placed on 
ice for 2 min. Aliquots were then taken and the RNA concentration determined using a 
NanoDrop spectrophotomer. All RNA samples had A260/A280 ratios greater than 2.1. 
2.2.3.17 cDNA synthesis and reverse transcriptase PCR 
Two µg of a pure total RNA sample from mixed asexual F12 cultures, enriched imma-
ture NF54 gametocytes (stage III and IV), non- activated mature gametocytes and 
gametocytes at 30 min p.a. were used for cDNA synthesis using the SuperScript III 
First-Strand Synthesis System, following the manufacturer's instructions. The reaction 
mixture was composed of the following: 2 μg of RNA, 1 μl of Random hexamers (50 
ng), 1 μl of 10 mM dNTP mix and DEPC water was added to 10 μl. Two reaction mix-
tures for each sample were prepared one for “sample” and the other as “no RT”control. 
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The samples were incubated at 65 °C for 5 min and incubated on ice for at least 1 min. 
The RNA-primer mix was then prepared while the samples were incubating  and 9 μl 
of the primer mix made up of  2 μl of 10X RT buffer, 4 μl of 25 mM MgCl2, 2 μl of  
0.1 M DTT and 1 μl of RNAse OUT inhibitor was added to each tube. The tubes were 
incubated for 2 min at 25°C and 1 μl of superscript III reverse transcriptase (50U) was 
added to the samples except “no RT” control samples. Thereafter, the samples were 
incubated at 50°C for 50 min followed by inactivation of the enzyme with 15 min in-
cubation at 70°C. The samples were then treated with 1 μl of RNAse H and incubated 
for 20 min at 37°C. 
Controls without reverse transcriptase were used to investigate potential gDNA con-
tamination by diagnostic RT-PCR using hdac (histone deacetylase 1; 
PF3D7_0925700)-specific primers. RNA quality was further verified for contamina-
tion by monitoring transcripts of stage-specific genes, i.e. ama1 (Apical membrane 
antigen 1) and pfccp2 by diagnostic RT-PCR. 
2.2.3.18 Quantitative RT-PCR (qPCR) 
Primers for real-time RT-PCR were designed using the Primer 3 software 
(http://frodo.wi.mit.edu/primer3/) and were initially tested on gDNA in conventional 
PCR with the same conditions subsequently used for real-time RT-PCR (for primer 
sequences see table 7). Primers for the reference gene encoding for seryl- tRNA syn-
thetase were obtained from Salanti et al., 2003. The PCR products were subsequently 
separated by agarose gel electrophoresis. Primers with high specificity were further 
validated by testing amplification efficiency on 10-fold dilutions of gDNA using real-
time RT-PCR followed by analysis of their melt curves since specific primers will pro-
duce a melt curve with a single peak. Primers with low specificity, efficiency and poor 
melt curves were redesigned.  
Real-time RT-PCR measurements were performed using the Bio-Rad CFX96 Real-
Time Detection System. The test reactions were prepared in triplicates in a total vol-
ume of 20 μl using the maxima SyBR green qPCR master mix with 20 ng of cDNA 
and primer concentrations of 0.3 μM. The following PCR cycling conditions were 
used: an initial denaturation step at 95°C for 10 min, followed by 40 cycles of denatu-
ration at 95°C for 15 s and annealing/extension at 60°C for 60 s, followed by a final 
extension at 95°C for 10 s and a final melt-curve analysis of 55-95°C. Controls with-
out template and without reverse transcriptase were included in all real-time RT-PCR 
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experiments. Transcript expression levels were calculated by the 2-ΔCt method (Livak 
et al., 2001, Sugden et al., 2009). 
 
2.2.4 Protein biochemistry methods 
2.2.4.1 Recombinant protein expression  
Recombinant proteins were expressed as fusion proteins with a GST-tag using the 
pGEX 4T-1 vector. The E. coli BL21 (DE3) RIL cells were transformed using the vec-
tor construct (section 2.2.3.5) and recombinant proteins expression was initially tested 
by carrying out a mini-expression. To this end, four colonies were picked randomly 
and grown in LB medium containing 100 µg/ml ampicillin at 37°C. After 2 h, temper-
ature was lowered to 30°C and the expression was induced by adding isopropyl-β-
thiogalactopyranoside (IPTG) with a final concentration of 0.75 mM. Five hours later, 
cells were collected and mixed with 2 × SDS buffer (1:2), boiled for 10 min at 95°C 
and loaded on a 12% SDS gel (see section 2.2.4.2)  
Bacterial colonies with induced protein expression were then used for maxi-
recombinant protein expression. To this end, the bacterial colony was grown overnight 
in 100 ml of LB medium containing 100 µg/ml ampicillin at 37°C with shaking to ob-
tain a starter culture. The next day, fresh medium was added to a final volume of 1500 
ml and incubated with shaking at 37°C for 2 h. The temperature was then lowered to 
25°C and 1500 μl of 0.75M IPTG was added to the culture to induce protein expres-
sion and incubated for 3-5 h at 25°C. After incubation the culture was centrifuged at 
5000 xg at 4°C for 10 minutes, after which the supernatant was discarded and bacterial 
pellet stored at -20°C till use or lysed immediately for protein purification. 
2.2.4.2 Purification of recombinant proteins 
GST purification of soluble protein 
Bacteria were lysed by resuspending pellet in 60 ml of lysis buffer followed by incu-
bation with shaking for 1 h at 4°C. Afterwards the cells were sonicated (50 % 
intensity, 50 % duty cycle) on ice for 2 min to shear DNA and the lysate was centri-
fuged at 30000 x g for 1.5 h. The supernatant was collected and filtered through a 0.25 
µm syringe filter and 1.5 ml of washed glutathione-sepharose beads added and al-
lowed to bind to the recombinant protein while rotating overnight at 4°C. The next 
day, the solution was loaded onto a PolyPrep® column whereby unbound proteins 
passed through the matrix and the recombinant protein is bound to the beads. After 
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washing the column 3 times with cold PBS, the protein was eluted from the column 
using the elution buffer (50 mM Tris pH 8/10 mM reduced glutathione) and 8 fractions 
of 1ml each was collected. The fractions were then analysed on a 12% SDS-PAGE and 
fraction with high amount of proteins were combined and filtered through an Amicon 
filter tube 30000 MWCO to exchange the buffer and concentrate the protein.  
Inclusion bodies purification 
The bacterial pellet was resuspended in 80 ml of inclusion bodies lysis buffer and 
placed on ice. Twenty ml of lysis buffer containing 200 mg of lysozyme was added 
and the suspension was incubated on ice for 10 min. The mixture was then sonicated 
(50 % intensity, 50 % duty cycle) on ice for 10 min and the lysate resuspended in 200 
ml detergent buffer followed by centrifugation at 5,000 x g for 10 min at 4°C. Thereaf-
ter, the pellet was resuspended in 250 ml of washing buffer and centrifuged at 5,000 x 
g for 10 min. This step was repeated several times, until a tight pellet was obtained. 
The tight pellet of inclusion bodies was then washed in 250 ml of 70 % ethanol and 
resuspended in 2-5 ml of sterile PBS. The pellet was sonicated until the protein solu-
tion was able to pass through a 23 G needle for subsequent immunization of mice. 
Protein concentration was estimated by comparison of stained SDS-gels showing a 
dilution series of BSA proteins of known concentration. Inclusion body proteins were 
stored at -20°C. 
SDS polyacrylamide gel electrophoresis (PAGE) 
SDS-PAGE was used in this study to separate proteins and usually a 10 % or 12 % gel 
was prepared as follows: 
Table 8: Preparation of SDS-PAGE gel 
Components Resolving gel Stacking gel 
10 % 12 % 5 % 
H2O 1.9 ml 1.6 ml 1.4 ml 
30 % acrylamide 1.7 ml 2.0 ml 0.33 ml 
1.5 M Tris pH 8.8 1.3 ml 1.3 ml   - 
0.5 M Tris pH 6.8     -     -  0.25 ml 
10 % SDS 0.05 ml 0.05 ml 0.02 ml 
10 % ammonium persulfate (APS) 0.05 ml 0.05 ml 0.02 ml 
TEMED 0.002 ml 0.002 ml 0.002 ml 
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The resolving gel was casted on a pre-made gel cassette up to the level of about 1 cm 
below the comb height and allowed to polymerise. After polymerization of the resolv-
ing gel, the stacking gel was immediately prepared and poured and then a comb 
carefully fitted to avoid air bubbles. The gel was then allowed to polymerise. Samples 
were prepared and mixed in a ratio of 1:2 with sample buffer and boiled at 95°C for 10 
min then cooled down on ice for 2 min and loaded on the gel allowing a lane for load-
ing a protein marker. The proteins were separated in 1 x SDS-PAGE running buffer for 
approximately 20 min at 85 V until the front dye had passed through the stacking gel 
and entered the resolving gel. The voltage was then switched to 125 V. When electro-
phoresis was complete, the gels were washed 2 times with distilled water and used for 
western blot or stained directly with either Coomassie staining solution or the Stain 
Reagent for visualization. After staining, gels were destained with Coomassie destain-
ing solution in case of staining with Coomassie or distilled water in case of GelCode® 
Blue staining, and then transferred to a solution of 20% ethanol/10 % Glycerol for 1 d 
at RT. Thereafter the gel was sealed in a plastic foil and allowed to dry at RT. Estima-
tion of protein sizes was done by comparison to the size of the protein marker. 
Immunization of mice and generation of polyclonal antisera 
Specific immune sera were generated by immunizing 6-week-old female NMRI or 
Balb/c mice with 100 µg recombinant protein emulsified in Freund’s incomplete adju-
vant, followed by a boost after 4 weeks with same amount of protein in Freund’s 
incomplete adjuvant. Sera were collected 10 days after the boost. The housing and 
handling of the animals followed the guidelines of the animal welfare committee of 
Lower Franconia. 
Western blot analysis 
Parasite lysates from different parasite stages were prepared following lyses of the pa-
sites using the NETT buffer and the lysates were separated by SDS-PAGE and 
transferred to a Hybond ECL nitrocellulose membrane (Amersham Biosciences, Mün-
chen) using a sandwich. The sandwich was built on the black side of the cassette 
holder with all its components put in place in the following order; a fiber pad, fol-
lowed by 2 Whatman papers on top, the gel on top of the whatman papers, then the 
nitrocellulose membrane, afterwards 2 Whatman papers and finally a fiber pad (Figure 
24). The holder cassette was then placed in a Mini-Trans-Blot-Apparatus from Bio-
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Rad containing transfer buffer and ice Proteins were transferred onto the nitrocellulose 
membrane at 25 V for 2 h or 15 V overnight. When transfer was complete, the mem-
branes were briefly rinsed in 1 x TBS and non specific binding sites were blocked by 
incubating the membrane with a solution containing 0.5 % BSA/5 % milk in TBS for 1 
h at RT or overnight at 4°C on a rocker. After blocking, membranes were washed twice 
with 1 x TBS and incubated for 2 h at RT or overnight at 4°C with primary antibody 
diluted in 3 % milk/TBS. After washing for 10 min at RT, one time with 3 % milk 
/TBS, twice with 3 % milk/0.1 %Tween/ TBS and once again with 3 % milk /TBS, the 
membranes were incubated with the corresponding alkaline phosphatase-conjugated 
secondary antibody in 3 % TBS/milk for 1 h at RT. To remove unbound antibody, fur-
ther washes were performed with 1 x 10 min with 1 x TBS, 2 x 10 min with 1 x 
TBS/0.1 % Tween and 1 x 10 min with 1 x TBS followed by addition of equilibration 
buffer for 3 min. Nitrocellulose membrane was developed in a solution of NBT/BCIP 
(nitroblue tetrazolium chloride and 4-chlor-3-indoxylphosphate) for 1-20 min and the 
reaction was stopped with stop buffer. 
 
 
Figure 24: The western blot apparatus, the cassette sandwich preparation and the pro-
tein detection on nitrocellulose membrane (adapted from http://www.leinco.com) 
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3. Results 
3.1 Interplay between midgut bacteria and the malaria parasite 
In this study we aimed at investigating the bacteria diversity in the midgut of lab-
reared An. stephensi during development and under different feeding regimes. We fo-
cused on determining; 
1) The influence of malaria parasites on the mosquito microbiota.  
2)   Gut bacteria which could be exploited as vehicles for the generation of paratrans-
genic Anopheles mosquitoes. 
 
3.1.1 Bacteria diversity of lab-reared Anopheles stephensi during development 
and under different feeding regimes 
In order to determine the bacteria diversity in lab-reared An. stephensi mosquitoes dur-
ing development and under different diet including Plasmodium infected blood, we 
first of all carried out a DGGE on total 16S rRNA obtained from the different midgut 
tissue samples (shown on Figure 22). The results of DGGE indicated that the An. ste-
phensi eggs and midguts of larvae as well as the water in which larvae and pupae had 
developed had the highest bacteria diversity, while a significant reduction in midgut 
bacteria diversity during the mosquito development from larvae to adult was observed 
(Figure 25). There were neither any significant differences observed in the 16S rRNA 
band patterns between sugar-fed male and female mosquitoes nor between sugar-fed 
and blood-fed female mosquitoes. Also, there were neither any significant differences 
observed in the 16S rRNA band patterns between female mosquitoes skin-fed on hu-
man or mouse blood, nor between mosquitoes fed on non-infected blood or 
Plasmodium-infected blood (P. berghei or P. falciparum). Noteworthy, one prominent 
16S rRNA band was observed in the 16S rRNA samples of all development stages and 
under all diet conditions. The respective band was excised from An. stephensi larvae 
and P. falciparum fed mosquito lanes (bands 1 and 2 on Figure 25). Sequencing fol-
lowing cloning showed nearest relation to E. meningoseptica (100%), a gram-negative 
rod-like bacterium of water and soil (Steinberg and Burd, 2010).  
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Figure 25: DGGE analysis of midgut microbiota from lab-reared An. stephensi in differ-
ent developmental stages and following sugar, blood and Plasmodium feeds. The bands 1 
and 2 were excised, their DNA extracted, cloned and sequenced and showed closest relation to 
E. meningoseptica. 
 
Apart from investigating the midgut bacteria diversity, we also investigated the distri-
bution of bacteria in the midguts of larvae and sugar-fed adult mosquitoes via semi-
thin sectioning of the respective tissues following tissue embedding in Epon. The 
stained semi-thin sections revealed that the larvae midgut is homogenously filled with 
a gelatinous material interspersed with bacteria (Figure 26). The epithelial cells of the 
larvae gut form short microvilli on their apical sites. A peritrophic membrane, separat-
ing the meal from the midgut epithelial layer, is visible (Figure 26). The midgut 
epithelium of the adult, on the other hand, exhibits long microvilli protruding into the 
gut lumen. Bacteria can be predominantly found forming biofilms associated to the 
microvilli surface and were detected in all areas of the midgut (Figure 27). The fact 
that the peritrophic membrane is not visible indicates that the mosquito has not taken a 
meal prior to preparation (Figure 27). The data indicate that midgut microbes are 
evenly distributed over the midgut epithelium of larvae and adult and here preferen-
tially adhere to the epithelial microvilli in the absence of the meal. 
1
Developmental stages Female mosquito feeding regimes
1 2
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Figure 26: Longitudinal semi-thin section of an An. stephensi larvae midgut (picture taken 
by Gabriele Pradel). The anterior pole is located on the left site of the section. The overview 
was taken at 100 x magnification, details of the midgut epithelium were taken at 1000x magni-
fication. Arrows indicate bacteria. EC, epithelial cell; MV, microvilli; PM, peritrophic 
membrane.  
 
Figure 27: Longitudinal semi-thin section of a midgut of an adult female A. stephensi 
mosquito (picture taken by Gabriele Pradel). The anterior pole is located on the left site of the 
section. The overview was taken at 100 x magnification, details of the midgut epithelium were 
taken at 1000 x magnification. Arrows indicate bacteria. EC, epithelial cell; MV, microvilli.  
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In order to further characterize the microbial diversity in the different developmental 
stages, we constructed 16S rRNA gene libraries for several experimental groups (Fig-
ure 22, marked with asterisks) and analyzed 50 clones of each library based on 
restriction fragment length polymorphism, sequencing and BLASTn analysis (Table 
9). Sequences with similarity greater than 99.0 % were considered to belong to the 
same operational taxonomiy unit (OTU). As a result, 36 nearly full length 16S rRNA 
gene sequences were retrieved from the 8 libraries. Of those, 9 sequences were most 
closely affiliated with E. meningoseptica (phylum Bacteroidetes) (99% sequence simi-
larity over > 1480 bp) (Figure 28, Table 9). Phylogenetic analyses placed DGGE- and 
clone library-derived sequences into one closely related phylogenetic clade along with 
the isolate obtained in this study and named as E. meningoseptica strain Che01. The 
closest relatives were E. meningoseptica phylotypes derived from other mosquitoes, 
i.e. Culex quinquefasciatus, the vector of lymphatic filariasis (NCBI accession number 
HQ154560), and the African malaria vector An. gambiae (Kämpfer et al., 2011), as 
well as from termites (Reticulitermes speratus, Cho et al., 2010), frogs (Rana catesbe-
iana, NCBI accession number GU180606) and the digestive fluid of carnivorous 
pitcher plants (Nephentes sp., NCBI accession number GQ360070). E. meningoseptica 
phylotypes were present in all developmental stages and in mosquito midguts from all 
feeding regimes. E. meningoseptica was further found in the water used for rearing of 
larvae, but not in tray water that had not come into contact with mosquitoes. Also, E. 
meningoseptica was present in the midguts of sugar-fed and blood-fed mosquitoes in 
the presence and absence of the malaria parasite, indicating that this bacterium is not 
affected by the mosquito diet. 
The remaining 19 mosquito-derived sequences were affiliated with the α- (n = 7) and 
β-Proteobacteria (n = 3), the Bacteroidetes (n = 4), Cytophaga (n = 2), Firmicutes (n = 
1), and the Actinobacteria (n = 2) (Table 9). The microbial midgut diversity decreased 
during mosquito development from egg to adult, and here the gut was largely domi-
nated by E. meningoseptica. The microbial diversity of the water sample in which the 
larvae and pupae had developed was quite diverse with 7 different phylotypes, includ-
ing E. meningoseptica. The fact that E. meningoseptica is present in all developmental 
stages as well as in the rearing water indicate that the bacteria are transmitted between 
developmental stages and generations. Furthermore, the bacteria diversity in lab-
reared adult female An. stephensi mosquitoes fed on sugar or on human blood in the 
presence and absence of P. falciparum was very low and there were no significant dif-
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ferences between the bacteria diversities in these mosquitoes. E. meningoseptica was 
the dominant bacterium in the midguts of sugar-fed and blood-fed mosquitoes in the 
presence and absence of the malaria parasite indicating that this bacterium is not af-
fected by the mosquito diet. 
 
Figure 28: Neighbor-joining phylogenetic tree (constructed by Volker Glöckner) E. menin-
goseptica 16S rRNA gene sequences obtained in this study are shown in bold letters. Filled 
circles indicate bootstrap values over 90% open circles over 70%. 
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Clone  
library 
 source 
Clone       
designation 
Sequence  
length (bp) 
Closest relative by BLAST  
(Accession number) 
Sequence 
 Similarity 
 (%) 
Prevalence  
 in 16S rRNA 
 gene library (%) 
Order, Phylum/Subphylum 
Eggs (n = 6 seqs) 
ASE-2 1480 Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
99 17.1 Flavobacteriales, Bacteroidetes 
 ASE-33 1469 Flectobacillus major 
(NR_044736.1) 
96 4.9 Cytophagales, Cytophaga 
ASE-1 1487 Pelomonas saccharophila strain DSM 654 
(NR_024710.1) 
99 43.9 Burkholderiales, Betaproteobacteria 
ASE-11 1491 Sediminibacterium salmoneum strain NJ-
44 (NR_044197.1) 
94 26.8 Sphingobacteriales,Bacteroidetes 
ASE-21 1494 Undibacterium pigrum strain CCUG 
49009 (NR_042557.1) 
97 4.9 Burkholderiales, Betaproteobacteria 
ASE-44 1499 Brevibacillus formosus strain DSM 9885 
(NR_040979.1) 
97 2.4 Bacillales, Firmicutes  
larvae mg 
(n = 9 seqs) 
ASLM-1 1480 Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
99 12.1 Flavobacteriales, Bacteroidetes 
 
ASLM-12 1481 Flectobacillus major 
(NR_044736.1) 
94 18.2 Cytophagales, Cytophaga  
 
ASLM-2 1486 Microbacterium dextranolyticum strain 
DSM 8607 (NR_044934.1) 
99 21.2 Actinomycetales, Actinobacteria  
 ASLM-3 1452 Bradyrhizobium japonicum strain 3I1b6 
(NR_036865.1) 
88 15.2 Rhizobiales, Alphaproteobacteria  
 ASLM-5 1491 Nubsella zeaxanthinifaciens strain TDMA-
5 (NR_041478.1) 
95 12.1 Sphingobacteriales Bacteroidetes 
 ASLM-9 1481 Lishizhenia caseinilytica strain 
UST040201-001 (NR_041043.1) 
85 3.0 Flavobacteriales, Bacteroidetes 
 ASLM-13 1449 Rhizobium daejeonense strain L61 KCTC 
12121 (NR_042851.1) 
98 3.0 Rhizobiales, Alphaproteobacteria 
 ASLM-17 1448 Rhizobium huautlense strain SO2 
(NR_024863.1) 
97 9.1 Rhizobiales, Alphaproteobacteria 
 ASLM-42 1448 Mesorhizobium loti strain NZP 2213 
(NR_025837.1) 
99 6.1 Rhizobiales, Alphaproteobacteria 
pupae mg 
(n = 5 seqs) 
ASPM-12 1480 Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
99 88.1 Flavobacteriales, Bacteroidetes 
 ASPM-4 1448 Rhizobium daejeonense strain L61; KCTC 
12121 (NR_042851.1) 
98 2.4 Rhizobiales, Alphaproteobacteria 
 ASPM-6 1486 Microbacterium dextranolyticum strain 
DSM 8607 (NR_044934.1) 
99 2.4 Actinomycetales, Actinobacteria  
Table 9: 16s rRNA gene sequences from different developmental stages of An. stephensi and after different feeding regimes 
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 ASPM-16 1442 Rhizobium daejeonense strain L61; KCTC 
12121 (NR_042851.1) 
97 4.7 Rhizobiales, Alphaproteobacteria 
 ASPM-43 1492 Aquabacterium parvum strain B6 
(NR_024874.1) 
99 2.4 Burkholderiales, Betaproteobacteria  
Adult female mg, 
sugar-fed 
(n = 3 seqs) 
ASFM-1,  
ASFM -34 
1480, 
1484 
Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
99 84.6 
13.2 
Flavobacteriales, Bacteroidetes 
 ASFM-30 1496 Sphingobacterium siyangense strain SY1 
(NR_044391.1) 
98 2.2 Sphingobacteriales, Bacteroidetes 
Adult  female 
mg, human 
blood-fed 
(n = 3 seqs) 
ASHBF-27, 
ASHBF-5 
1486, 
1481 
Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
98 97.5 Flavobacteriales, Bacteroidetes 
 ASHBF-42 1452 Asaia siamensis strain S60-1 
(NR_024738.1) 
99 2.5 Rhodospirillales, Alphaproteobacteria  
Adult female mg, 
Pf-fed 
(n = 2 seqs) 
ASPF-2, 
ASPF-16 
1485, 
1480 
Elizabethkingia meningoseptica strain 
ATCC 13253 (NR_042267.1) 
96 100 Flavobacteriales, Bacteroidetes 
Water larvae 
culture 
(n = 7 seqs) 
WLP-21 1477 Elizabethkingia meningoseptica strain : 
ATCC 13253 (NR_042267.1) 
99 2.4 Flavobacteriales, Bacteroidetes 
 WLP2 1466 Flectobacillus major 
(NR_044736.1) 
96 73.7 Cytophagales, Cytophaga  
 
 WLP-9 1494 Roseateles depolymerans strain 61A 
(NR_036813.1) 
99 4.8 Burkholderiales, Betaproteobacteria  
 WLP 10 1527 Legionella fallonii strain LLAP10 
(NR_036805.1) 
94 11.9 Legionellales, Gammaproteobacteria  
 WLP 1 1445 Mesorhizobium loti strain NZP 2213 
(NR_025837.1) 
99 2.4 Rhizobiales, Alphaproteobacteria  
 WLP-19 1473 Rhizobium selenitireducens strain B1 
(NR_044216.1) 
95 2.4 Rhizobiales, Alphaproteobacteria 
 WLP-32 1428 Asticcacaulis taihuensis strain T3-B7 
(NR_042933.1) 
97  Caulobacterales, Alphaproteobacteria  
Water before 
breeding 
(n = 1 seq) 
WBF-7 1491 Methylibium petroleiphilum PM1 strain 
PM1(NR_041768.1) 
97 100 Burkholderiales, Betaproteobacteria  
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3.1.2 Isolation, identification and characterisation of E. meningoseptica 
Due to the fact that E. meningoseptica phylotypes were found to be dominant in our 
16s rRNA gene libraries, we attempted to isolate the bacteria from the midgut of fe-
male An. stephensi mosquitoes. Midgut content of pooled female mosquitoes was 
cultured on LB agar plates and an isolate was identified by 16S rRNA sequencing to 
be E. meningoseptica and was named E. meningoseptica Che 01.  
In order to characterize the isolate, a sample was prepared for transmission electron 
microscopy. The electron micrographs confirmed the isolate as a rod with a cell wall 
typical for gram-negative bacteria (Figure 29A). Higher magnifications revealed the 
double membrane structure of the cell wall (Figure 29B). Transmission electron mi-
croscopy thus confirmed that the isolate contained the gram-negative rod E. 
meningoseptica and that it was devoid of any contaminations by other midgut mi-
crobes. 
 
 
Figure 29: Transmission electron micrograph of cultured E. meningoseptica isolated from 
the A. stephensi midgut. (A), shows the rod-like structure of the bacterium. (B), shows the 
bacterium cell wall. IMC, inner membrane complex; OMC, outer membrane complex. Bar 1 
µm (A), 0.5 µm (B). 
 
Also, because a multi-resistance of E. meningoseptica to antibiotics was previously 
reported (Lin et al., 2004; Hung et al., 2008), we tested the resistance of Che 01 to se-
lected antibiotics, using the standard disk diffusion assay. Che 01 showed resistance to 
ampicillin, kanamycin and streptomycin at concentrations of up to 250 µg/ml (Table 
10). Furthermore, it was resistant to gentamicin at concentrations of up to 
A B
IMC
OMC
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 62.5 µg/ml while concentrations of 125 µg/ml and 250 µg/ml resulted in inhibition 
zones of 10.0 and 13.5 mm diameters, respectively. Water, which was used as a nega-
tive control, did not inhibit growth of Che 01.  
 
Table 10: Resistance of E. meningoseptica to selected antibiotics 
Antibiotics tested Concentration 
[µg/ml] 
Inhibiting areola [mm] 
Ampicillin ≤ 250 0 
Kanamycin ≤ 250 0 
Streptomycin ≤ 250 0 
Gentamicin ≤ 62.5 0 
 125 10.0 ± 0.0 
 250 13.5 ± 0.71 
Water (negative control) - 0 
Gentamicin (positive control) 10 mg/ml 25 ± 1.41 
 
3.1.3 Antibacterial and antifungal activities of organic extracts from E. menin-
goseptica  
The dominance of E. meningoseptica in our 16S rRNA gene libraries led us to suspect 
that the bacterium may produce antimicrobial substances ensuring its dominance over 
other midgut inhabitants (bacteria and fungi). To prove this, Che 01 was cultured for 
48 h in solid and liquid media to produce secondary metabolites which were extracted 
using different organic solvents. The extracts were subsequently tested against gram-
positive Staphylococcus aureus strain 8325 and gram-negative Escherichia coli strain 
536 as well as against the yeast Candida albicans strain S314, using the standard disk 
diffusion assay. The diameters of the inhibition zones were measured, and compared to 
solvents alone (negative control) as well as to gentamicin (antibacterial positive con-
trol) or nystatin (antifungal positive control). The screening showed that the ethyl 
acetate and acetone extracts exhibited antibacterial and antifungal activities against the 
three microbes tested in the assays (Table 11), indicating that E. meningoseptica pro-
duces antimicrobial substances to defeat other mosquito midgut inhabitants thereby 
explaining its dominance. 
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Table 11: Antibacterial and antifungal activities of organic extracts from E. meningosep-
tica 
Pathogen Extract Inhibition zone 
[mm] 
Staphyloccocus aureus 8325 Agar ethyl acetate 14.5 ± 1.41 
 Agar acetone 8.0  ± 0.71 
 Broth ethyl acetate 11.0 ± 0.0 
 Broth methanol  0 
 Gentamicin* (positive 
control) 
25.0 ± 0.0 
Eschericha coli 536 Agar ethyl acetate 12.0 ± 0.0 
 Agar acetone 8.0 ± 0.0 
 Broth ethyl acetate 9.0 ± 0.0 
 Broth methanol  0 
Candida albicans S314 Agar ethyl acetate 10.0 ± 0.0 
 Agar acetone 0 
 Broth ethyl acetate 12.0 ± 0.0 
 Broth methanol  0 
 Nystatin* (positive 
control) 
17.0 ± 0.0 
Negative control Agar  ethyl acetate 
(without bacteria ) 
0 
 50 vol% methanol  0 
 *For positive controls, gentamicin was tested at 10 µg/µl and nystatin was tested at 25µg/µl. 
3.1.4 Antiplasmodial and gametocytocidal activity of organic extracts of E. men-
ingoseptica 
E. meningoseptica extracts were tested for their effect on P. falciparum parasites of 
strain 3D7. First, the extracts were tested for their effect on growth of blood stage 
parasites, using the Malstat viability assay as previously described (Aminake et al., 
2011). The ethyl acetate extract from broth and agar cultures exhibited moderate ac-
tivities against the P. falciparum asexual blood stages in the assays with IC50 
concentrations of 0.25 mg/ml and 0.89 mg/ml, respectively, while the acetone extract 
showed very low activity (Table 12). Chloroquine was used as a reference control in 
the assays and inhibited parasite growth with an IC50 value of 14.4 nM and the solvent 
control (0.5% methanol) had no inhibitory effect on the parasites. 
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Table 12: Antiplasmodial activity of organic extracts from E.meningoseptica 
against P. falciparum blood stages 
Extracts tested IC50 
Broth ethyl acetate  0.25 ± 0.014 mg/ml 
Agar ethyl acetate  0.89  ± 0.049 mg/ml 
Agar acetone  2.9 mg/ml* 
Chloroquine (negative control) 14.4 ± 2.19 nM 
Tested in triplicate; *, tested once. 
We also investigated the effect of the extract from E. meningoseptica on the develop-
ment of gametocytes, thus on the stages that are taken up during the mosquito blood 
meal and which then undergo gametogenesis in the mosquito midgut. The gametocy-
tocidal effect of a compound would block transmission of parasites that escaped the 
blood stage killing and thus counteract the propagation of malaria parasites by the 
mosquito. The broth ethyl acetate extract of E. meningoseptica reduced the number of 
mature P. falciparum NF54 gametocytes by 58% at IC50 concentrations, when com-
pared with the 1% methanol negative control (set to 100%). A similar concentration of 
the agar ethyl acetate extract had no effect on gametocyte development. The antimalar-
ial primaquine was used as a positive control in the test and exhibited a 
gametocytocidal activity of 55% (Table 13). 
 
Table 13: Gametocytocidal activity of organic extracts from E. meningoseptica against P. 
falciparum gametocytes 
Extracts tested Concentration Gametocytemia 
[‰] 
Rel. GC 
no. [%] 
Broth ethyl acetate 0.25 mg/ml 27.3 ± 0.74 58 
Agar ethyl acetate 0.25 mg/ml 43.3 ± 3.10 92 
Primaquine ( positive control) 3 µM 25.7 ± 5.51 55 
Methanol (negative control) 1 vol% 47.0 ± 6.56 100 
Tested in triplicate; GC, gametocyte. 
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3.2 Changes in the transcriptome during the initial phase of malaria parasite 
transmission from human to mosquito 
Here, we investigated the changes in the in P. falciparum gametocyte transcriptome 
during the first half hour following gametocytes activation in the mosquito with prin-
ciple aim of identifying plasmodial proteins which could be exploited as targets for 
transmission blocking strategies. 
3.2.1 Determination of transcriptome changes by Suppressive Subtractive Hy-
bridization (SSH) 
Changes in the transcriptome of malaria parasites during the initial phase of transmis-
sion from the human  to the mosquito was determined by SSH on mRNA isolated from 
mature non-activated gametocytes and from gametocytes at 30 min after in vitro acti-
vation, which had completed gametogenesis (Sologub et al., 2011). A subtracted 
cDNA library was constructed and the resulting cDNA was assigned to the respective 
plasmodial genes. 
We identified a total number of 126 genes, for which expression levels changed in the 
gametocytes during activation. The majority of genes can be assigned to six major on-
tology groups (Figure 30, Table 14): 22 genes (17.5%) have putative functions in 
signaling, 18 genes (14.3%) are assigned to processes linked to cell cycle and gene 
regulation, 11 genes (8.7%) can be linked to the cytoskeleton or the inner membrane 
complex (IMC), 10 genes (7.9%) have putative functions in protein trafficking, stabili-
zation and degradation (proteostasis), eight genes (6.4%) are linked to general 
metabolic functions, and 16 genes (12.7%) are proteins of the cell surface or PVM. 
Furthermore, 15 genes (11.9%) can be assigned to other functions, including protein 
synthesis and processing. A total of 26 genes (20.6%) encode for proteins with un-
known function, nine of which have sequences for transmembrane domains and five of 
which encode for a signal peptide. 
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Figure 30: Depiction of ontology groups of P. falciparum genes with changes in transcript 
expression during gametocyte activation. The changes in transcript abundance were deter-
mined by SSH between mRNA of mature non-activated gametocytes and gametocytes at 30 
min p.a.. A total number of 126 genes were identified (the numbers of genes per group are in-
dicated). 
 
3.2.2 Comparison of genes identified by SSH with Plasmodium proteome data  
We compared the genes with changes in transcript with P. falciparum and P. berghei 
gametocytes transcriptome data which already exists (Florens et al., 2002, Silvestrini 
et al., 2005, Silvestrini 2010, Khan et al., 2005). This analysis was done by Gunnar R. 
Mair. The results showed that about 60% (76/126) of the SSH genes have been de-
tected in the currently available P. falciparum gametocyte proteomes, while for 40% of 
the genes, there is as yet no protein evidence (Table 15). Also, almost identical num-
bers apply to the 113 orthologs of the rodent malaria parasite P. berghei; the 13 P. 
falciparum genes without P. berghei orthologs include amongst others the three etramp 
genes, pfs16 and resa. 
 
 
 
 
22
18
11
108
16
15
26
signalling
cell cycle and gene expression
cytoskeleton, IMC
proteostasis
metabolism
cell surface and PVM
others
unknown
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Table 14: Genes of the Plasmodium falciparum gametocyte transcriptome as identified by SSH (comparing mature non-activated 
gametocytes and gametocytes at 30 min p.a. Anotation done by Gabriele Pradel) 
 Plasmodb ID Protein Predicted features pred. MW 
Signaling 
PF3D7_0214600 serine/threonine protein kinase  204.3 
PF3D7_1356800 serine/threonine protein kinase ARK3  475.7 
PF3D7_0302100 serine/threonine protein kinase PfCLK-4/SRPK1 Phosphorylation of SR splicing factors 157.4 
PF3D7_1230900 atypical protein kinase, RIO family  111.5 
PF3D7_1238900 calcium/calmodulin-dependent protein kinase, PK2  58.9 
PF3D7_0624000 hexokinase, HK  55.3 
PF3D7_0515300 phosphatidylinositol 3-kinase, PI3K  255.9 
PF3D7_1113100 protein tyrosine phosphatase, PRL  25.1 
PF3D7_1403900 phosphatase  35.2 
PF3D7_1464600 phosphatase SP 170.5 
PF3D7_0210600 conserved Plasmodium protein SP, calcium-lipid-binding domain CaLB 53.7 
PF3D7_1238100 calcyclin binding protein Calcyclin-binding domain 266.4 
PF3D7_1442200 GTP binding protein  118.7 
PF3D7_1358600 zinc finger protein Zinc-Finger domain 118.3 
PF3D7_0927200 zinc finger protein Zinc-Finger domain 189.7 
PF3D7_1004300 zinc finger, C3HC4 type  131.7 
PF3D7_1433400 conserved Plasmodium membrane protein 7 TMs, PHD C4HC3 zinc-finger-like motifs 682.5 
PF3D7_1463900 conserved Plasmodium membrane protein SP, 7 TMs, EF hand calcium-binding domain 127.1 
PF3D7_1233600 asparagine and aspartate rich protein 1, AARP1 Zinc-finger domain, Ring/U-Box 146.3 
PF3D7_0530200 triose phosphate transporter iTPT SP, 7 TMs 59.8 
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PF3D7_0303900 conserved Plasmodium protein SP, phosphatidyl-ethanolamine-binding protein PEBP do-
main 
23.2 
PF3D7_0818200 14-3-3 protein Regulative protein, binds signaling enzymes like kinases or 
TM receptors 
30.2 
Cell cycle and gene expression 
PF3D7_1445900 DEAD/DEAH box ATP-dependent RNA helicase  60.0 
PF3D7_1019000 eukaryotic translation initiation factor subunit eIF2A  280.8 
PF3D7_1417200 NOT family protein Regulation of transcript 519.8 
PF3D7_1103800 CCR4-NOT transcription complex subunit 1, NOT1 4 TMs 392.0 
PF3D7_0622900 ApiAP2 protein Transcription factor 237.4 
PF3D7_0420300 ApiAP2 protein Transcription factor 400.2 
PF3D7_0615400 ribonuclease  323.2 
PF3D7_0811300 CCR4-associated factor 1, CAF1  200.2 
PF3D7_1034900 methionine-tRNA ligase  101.2 
PF3D7_1469700 conserved Plasmodium protein Homology to the transcriptional mediator subunit Med6 24.6 
PF3D7_0513600 deoxyribodipyrimidinephotolyase  129.2 
PF3D7_1105500 centrin-4 (CEN4)  20.1 
PF3D7_1018500 PHF5-like protein mRNA splicing factor RDS3 domain 12.5 
PF3D7_0827800 SET domain protein SET3 Chromatin regulator, nuclear protein, in male gametocytes 283.6 
PF3D7_1115200 SET domain protein, SET7 Chromatin regulator 94.3 
PF3D7_1360900 polyadenylate-binding protein RNA-binding domain 44.8 
PF3D7_1011800 QF122 antigen KH domain type 1, RNA binding 131.6 
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PF3D7_1347500 DNA/RNA-binding protein Alba 4, ALBA4  42.2 
Cytoskeleton, IMC, Motor complex 
PF3D7_0422300 alpha-tubulin II Cytoskeletal element 49.7 
PF3D7_1246200 actin I IMC component 41.2 
PF3D7_0503400 actin-depolymerizing factor 1, ADF1  13.7 
PF3D7_1020200 kinesin  99.1 
PF3D7_0724900 kinesin-like protein  222.6 
PF3D7_1246400 myosin A tail domain interacting protein, MTIP IMC component 23.5 
PF3D7_1251200 coronin Actin-binding protein 69.0 
PF3D7_0708000 cytoskeleton-associated protein Cap-Gly domain 103.6 
PF3D7_0515700 glideosome-associated protein 40, GAP40 10 TMs, IMC component 51.8 
PF3D7_0918000 glideosome-associated protein 50, GAP50 SP, 2 TMs, IMC component 44.6 
PF3D7_1351700 alveolin, ALV6 IMC component 151.2 
Proteostasis (Protein trafficking, stabilization and degradation) 
PF3D7_0807500 proteasome subunit alpha type 6 Component oft he proteasome core particle 29.5 
PF3D7_1466300 proteasome subunit RPN2 Proteasome non-ATPase regulatory subunit 1 132.8 
PF3D7_0815800 Vacuolar sorting protein, VPS9 Ortholog of Saccharomyces cerevisae vacuolar sorting pro-
tein 9 
214.7 
PF3D7_1136400 conserved Plasmodium protein TPR domain, mediates protein interactions and multi-
protein complexes 
107.1 
PF3D7_0215400 conserved Plasmodium protein WD40-domain protein, assembly and stabilization of 
MPCs 
110.8 
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PF3D7_0818900 heat shock protein 70, HSP70-1  73.9 
PF3D7_0917900 heat shock protein 70, HSP70-2  72.4 
PF3D7_0306200 activator of Hsp90 ATPase, AHA1  41.6 
PF3D7_0708400 heat shock protein 90, HSP90  86.2 
PF3D7_0102200 ring-infected erythrocyte surface antigen, RESA PHIST and DnaJ domains 126.5 
Metabolism, general 
mal_mito_2 cytochrome c oxidase subunit I, cox1 SP, 12 TMs, component of the respiratory chain in mito-
chondria 
53.0 
PF3D7_1444800 fructose 1,6-biphosphate aldolase Glycolysis pathway 40.1 
PF3D7_0806800 vacuolar proton translocating ATPase subunit A 6 TMs 123.0 
PF3D7_0922200 S-adenosylmethioninesynthetase, SAMS  44.8 
PF3D7_0801900 conserved Plasmodium protein FAD/NADP-binding domain 552.0 
PF3D7_0403200 conserved Plasmodium protein Possibly acetyl-CoA-synthetase 69.4 
PF3D7_0511800 myo-inositol 1-phosphate synthase  69.1 
PF3D7_0104400 4-hydroxy-3-methylbut-2-enyl diphosphatereductase, 
LytB 
1 TM, protein export domain, non-mevalonate pathway 62.5 
cell surface and PVM 
PF3D7_1035300 glutamate-rich protein; GLURP SP, on parasite surface 141.1 
PF3D7_1335300 reticulocyte binding protein 2, RH2b 1 TM, on parasite surface, involved in erythrocyte binding 382.9 
PF3D7_1228600 merozoite Surface Protein 9, MSP-9 SP, on merozoite surface, involved in erythrocyte binding 86.6 
PF3D7_1028700 merozoite TRAP-like protein, MTRAP SP, 1 TM, belongs to TRAP family, in micronemes and on 
merozoite surface 
58.1 
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PF3D7_0731500 erythrocyte binding antigen 175, EBA-175 SP, 1 TM, Duffy binding domain, on merozoite surface 174.6 
PF3D7_0102500 erythrocyte binding antigen-181, EBA-181 SP, 2 TMs, Duffy binding domain, on merozoite surface 181.2 
PF3D7_1035700 duffy binding-like merozoite surface protein, 
DBLMSP 
SP, Duffy binding domain, SPAM 80.3 
PF3D7_0202500 early transcribed membrane protein 2, ETRAMP2 SP, 1 TM, integral PVM protein 11.5 
PF3D7_0423700 early transcribed membrane protein 4, ETRAMP4 SP, 2TMs, integral PVM protein 10.2 
PF3D7_1033200 early transcribed membrane protein 10.2, ETRAMP 
10.2 
SP, 2TMs, integral PVM protein 38.9 
PF3D7_1103500 CPW-WPC family protein SP, adhesin, cysteine-rich CPW-WPC domain 67.3 
PF3D7_0406200 Pfs16 SP, 2 TMs, integral PVM protein of gametocytes 16.7 
PF3D7_0930300 merozoite surface protein 1, MSP1 SP, GPI anchor, EGF domain, on merozoite surface, part of 
MSP complex 
195.7 
PF3D7_1218800 conserved Plasmodium protein, PSOP17 SP, lectin domain, laminin G2 domain 39.6 
PF3D7_0707300 rhoptry-associated membrane antigen, RAMA GPI anchor, involved in erythrocyte binding 103.6 
PF3D7_1021900 10b antigen Ankyrin repeat region, PHAX RNA-binding domain, inter-
acts with surface proteins like PfEMP1 (Y2H) 
267.4 
Others 
PF3D7_1103100 60S ribosomal protein P1  13.0 
PF3D7_1027800 60S ribosomal protein L3  44.2 
PF3D7_1408600 40S ribosomal protein S8e  25.1 
PF3D7_1358800 40S ribosomal protein S13  17.3 
PF3D7_0206200 metabolite/drug transporter 11 TMs, Major facilitator superfamily 62.7 
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PF3D7_1207700 blood stage antigen 41–3 precursor SP 43.4 
PF3D7_1457000 signal peptide peptidase, SPP 8 TMs 47.6 
PF3D7_0320700 signal peptidase complex subunit 2, SPC2 2 TMs, SPC25 domain 21.0 
PF3D7_0207700 serine repeat antigen 4, SERA-4 SP, papain family cysteine proteinase 108.7 
PF3D7_1033800 plasmepsin VII SP, 1 TM, aspartyl protease 52.3 
PF3D7_0930000 procollagen lysine 5-dioxygenase 2 TMs 66.8 
PF3D7_0817600 conserved Plasmodium protein  112.2 
PF3D7_0403800 conserved Plasmodium protein Alpha/beta-hydrolase 83.4 
PF3D7_0709900 conserved Plasmodium membrane protein 4 TMs, alpha/beta-hydrolase 274.0 
PF3D7_0311600 conserved Plasmodium protein, unknown function SP, 1 TM, ribophorin-I domain,putativedolichyl-
diphospho-oligosaccharide-protein 
84.0 
Unknown 
PF3D7_0904200 conserved Plasmodium protein SP, 1 TM 34.0 
PF3D7_1024800 conserved Plasmodium protein SP, 2 TMs 171.1 
PF3D7_1239400 conserved Plasmodium protein SP 22.0 
PF3D7_0730800.1 Plasmodium exported protein SP 32.1 
PF3D7_1316700 conserved Plasmodium protein SP 73.4 
PF3D7_0601900 conserved Plasmodium protein 1 TM 14.7 
PF3D7_0704100 conserved Plasmodium membrane protein 6 TMs 425.3 
PF3D7_1023000 conserved Plasmodium membrane protein 5 TMs 48.9 
PF3D7_1439600 conserved Plasmodium protein 1 TM 22.6 
PF3D7_1021700 conserved Plasmodium membrane protein 4 TMs 830.2 
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PF3D7_0417400 conserved Plasmodium protein 2 TMs, interacts with PF3D7_1021700 (Y2H) 822.4 
PF3D7_1026600 conserved Plasmodium protein Interacts with RNA-associated proteins (Y2H) 196.5 
PF3D7_1362600 conserved Plasmodium protein Interacts with splicing factor 3B subunit 2 (Y2H) 32.1 
PF3D7_0202400 conserved Plasmodium protein Pfg27 domain 141.9 
PF3D7_1124200 conserved Plasmodium protein UAS domain 49.3 
PF3D7_1452400 conserved Plasmodium protein  107.5 
PF3D7_1225600 conserved Plasmodium protein  93.1 
PF3D7_1451200 conserved Plasmodium protein  176.2 
PF3D7_1438800 conserved Plasmodium protein  84.0 
PF3D7_1114600 conserved Plasmodium protein  39.6 
PF3D7_1026100 conserved Plasmodium protein  23.9 
PF3D7_1230100 conserved Plasmodium protein  61.5 
PF3D7_1321000 conserved Plasmodium protein  80.6 
PF3D7_0411000 conserved Plasmodium protein  179.7 
PF3D7_1126700 conserved Plasmodium protein  110.1 
PF3D7_0508900 conserved Plasmodium protein  370.2 
           IMC, inner membrane complex; PVM, parasitophorous vacuole membrane; SP, signal peptide; TM, transmembrane; Y2H, yeast-two-hybrid. 
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 PF P. falciparum GC P. berghei male/female GC  total 
 
PF_ID 
Gene On-
tology MW troph 
I & 
II 
IV & 
V V I.II.IV.V FG1 FG 3 
FG 
(1+3) MG1 MG3 
MG 
(1+3) 
FG 
+MG FG.MG.PF PB_ID 
PF3D7_0210600 signalling 53.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_030750 
PF3D7_0214600 signalling 204.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_031140 
PF3D7_0302100 signalling 157.4 2 3 1 7 11 0 0 0 0 0 0 0 11 PBANKA_040110 
PF3D7_0303900 signalling 23.2 0 4 4 11 19 0 0 0 0 0 0 0 19 PBANKA_040250 
PF3D7_0515300 signalling 255.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_111490 
PF3D7_0530200 signalling 59.8 0 0 0 3 3 0 0 0 0 0 0 0 3 PBANKA_124460 
PF3D7_0624000 signalling 55.3 17 20 2 24 46 6 13 19 11 10 21 40 86 PBANKA_112290 
PF3D7_0818200 signalling 30.2 18 21 14 25 60 11 20 31 9 11 20 51 111 PBANKA_071260 
PF3D7_0927200 signalling 189.7 0 13 2 5 20 0 0 0 0 0 0 0 20 PBANKA_082800 
PF3D7_1004300 signalling 131.7 3 5 1 0 6 0 0 0 0 0 0 0 6 PBANKA_120260 
PF3D7_1113100 signalling 25.1 1 2 1 3 6 0 0 0 0 0 0 0 6 PBANKA_093450 
PF3D7_1230900 signalling 111.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144560 
PF3D7_1233600 signalling 146.3 0 4 0 8 12 0 0 0 0 0 0 0 12 PBANKA_144820 
PF3D7_1238100 signalling 266.4 7 9 3 9 21 2 6 8 8 7 15 23 44 PBANKA_145260 
PF3D7_1238900 signalling 58.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_145340 
PF3D7_1356800 signalling 475.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113310 
PF3D7_1358600 signalling 118.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113490 
PF3D7_1403900 signalling 35.2 6 9 5 12 26 × × × × × × × 26 × 
PF3D7_1433400 signalling 682.5 0 0 2 0 2 0 0 0 0 0 0 0 2 PBANKA_101150 
PF3D7_1442200 signalling 118.7 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_130610 
PF3D7_1463900 signalling 127.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_132710 
PF3D7_1464600 signalling 170.5 23 31 0 3 34 0 0 0 0 0 0 0 34 PBANKA_132800 
PF3D7_0420300 
cell cycle & 
gene expr. 400.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_052170 
PF3D7_0513600 
cell cycle & 
gene expr. 129.2 10 29 0 10 39 0 0 0 0 0 0 0 39 PBANKA_111330 
Table 15: Comparison of genes identified by SSH with P. falciparum and P. berghei gametocyte proteome data (analysis done by Gunnar Rudolf Mair). 
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PF3D7_0615400 
cell cycle & 
gene expr. 323.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_123010 
PF3D7_0622900 
cell cycle & 
gene expr. 237.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_112180 
PF3D7_0811300 
cell cycle & 
gene expr. 200.2 0 2 1 2 5 0 0 0 0 0 0 0 5 PBANKA_142620 
PF3D7_0827800 
cell cycle & 
gene expr. 283.6 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_070290 
PF3D7_1011800 
cell cycle & 
gene expr. 131.6 41 22 6 17 45 4 11 15 14 0 14 29 74 PBANKA_121020 
PF3D7_1018500 
cell cycle & 
gene expr. 12.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050270 
PF3D7_1019000 
cell cycle & 
gene expr. 280.8 7 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050320 
PF3D7_1034900 
cell cycle & 
gene expr. 101.2 21 31 0 49 80 6 0 6 3 0 3 9 89 PBANKA_051870 
PF3D7_1103800 
cell cycle & 
gene expr. 392.0 7 12 0 23 35 0 0 0 0 0 0 0 35 PBANKA_094310 
PF3D7_1105500 
cell cycle & 
gene expr. 20.1 1 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_094140 
PF3D7_1115200 
cell cycle & 
gene expr. 94.3      0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_093250 
PF3D7_1347500 
cell cycle & 
gene expr. 42.2 18 15 30 22 67 11 0 11 7 10 17 28 95 PBANKA_136030 
PF3D7_1360900 
cell cycle & 
gene expr. 44.8 8 11 11 12 34 × × × × × × × 34 × 
PF3D7_1417200 
cell cycle & 
gene expr. 519.8 5 6 0 6 12 0 0 0 0 0 0 0 12 PBANKA_102550 
PF3D7_1445900 
cell cycle & 
gene expr. 60.0 16 25 3 21 49 0 0 0 1 0 1 1 50 PBANKA_130970 
PF3D7_1469700 
cell cycle & 
gene expr. 24.6 0 2 0 3 5 0 0 0 0 0 0 0 5 PBANKA_133290 
PF3D7_0422300 
IMC, cy-
toskeleton 49.7 11 25 13 30 68 0 0 0 0 0 0 0 68 PBANKA_052270 
PF3D7_0503400 
IMC, cy-
toskeleton 13.7 6 5 1 8 14 0 0 0 0 1 1 1 15 PBANKA_110310 
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PF3D7_0515700 
IMC, cy-
toskeleton 51.8 3 0 0 7 7 1 0 1 0 0 0 1 8 PBANKA_111530 
PF3D7_0708000 
IMC, cy-
toskeleton 103.6 0 0 2 12 14 0 0 0 1 0 1 1 15 PBANKA_080520 
PF3D7_0724900 
IMC, cy-
toskeleton 222.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_062240 
PF3D7_0918000 
IMC, cy-
toskeleton 44.6 14 12 1 23 36 0 0 0 0 0 0 0 36 PBANKA_081900 
PF3D7_1020200 
IMC, cy-
toskeleton 99.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050430 
PF3D7_1246200 
IMC, cy-
toskeleton 41.2 23 28 13 29 70 12 19 31 6 6 12 43 113 PBANKA_145930 
PF3D7_1246400 
IMC, cy-
toskeleton 23.5 1 0 0 3 3 0 0 0 0 0 0 0 3 PBANKA_145950 
PF3D7_1251200 
IMC, cy-
toskeleton 69.0 1 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_146410 
PF3D7_1351700 
IMC, cy-
toskeleton 151.2 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_136440 
PF3D7_0102200 proteostasis 126.5 33 3 1 0 4 × × × × × × × 4 × 
PF3D7_0215400 proteostasis 110.8 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_031210 
PF3D7_0306200 proteostasis 41.6 4 7 0 8 15 0 0 0 0 0 0 0 15 PBANKA_040460 
PF3D7_0708400 proteostasis 86.2 54 60 17 82 159 7 0 7 8 10 18 25 184 PBANKA_080570 
PF3D7_0807500 proteostasis 29.5 11 11 2 20 33 3 8 11 4 2 6 17 50 PBANKA_122310 
PF3D7_0815800 proteostasis 214.7 0 3 0 0 3 0 0 0 0 0 0 0 3 PBANKA_071500 
PF3D7_0818900 proteostasis 73.9 45 46 33 57 136 34 40 74 31 28 59 133 269 PBANKA_071190 
PF3D7_0917900 proteostasis 72.4 45 40 42 51 133 24 46 70 16 16 32 102 235 PBANKA_081890 
PF3D7_1136400 proteostasis 107.1 0 3 0 11 14 1 0 1 0 0 0 1 15 PBANKA_091220 
PF3D7_1466300 proteostasis 132.8 23 26 3 34 63 4 9 13 4 0 4 17 80 PBANKA_132970 
mal_mito_2 
metabolism 
general 53.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_MIT0002 
PF3D7_0104400 
metabolism 
general 62.5 0 1 1 3 5 0 0 0 0 0 0 0 5 PBANKA_020870 
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PF3D7_0403200 
metabolism 
general 69.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_100080 
PF3D7_0511800 
metabolism 
general 69.1 36 29 2 40 71 2 0 2 0 0 0 2 73 PBANKA_111140 
PF3D7_0801900 
metabolism 
general 552.0 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_122830 
PF3D7_0806800 
metabolism 
general 123.0 11 9 4 29 42 0 0 0 0 3 3 3 45 PBANKA_122380 
PF3D7_0922200 
metabolism 
general 44.8 25 16 0 4 20 1 2 3 0 0 0 3 23 PBANKA_082310 
PF3D7_1444800 
metabolism 
general 40.1 21 23 11 35 69 17 23 40 22 22 44 84 153 PBANKA_130860 
PF3D7_0102500 
cell surface 
& PVM 181.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_133270 
PF3D7_0202500 
cell surface 
& PVM 11.5 1 0 0 0 0 × × × × × × × 0 × 
PF3D7_0406200 
cell surface 
& PVM 16.7 3 9 34 17 60 × × × × × × × 60 × 
PF3D7_0423700 
cell surface 
& PVM 10.2 0 5 0 2 7 × × × × × × × 7 × 
PF3D7_0707300 
cell surface 
& PVM 103.6 3 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_080450 
PF3D7_0731500 
cell surface 
& PVM 174.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_133270 
PF3D7_0930300 
cell surface 
& PVM 195.7 77 0 3 0 3 0 0 0 0 0 0 0 3 PBANKA_083100 
PF3D7_1021900 
cell surface 
& PVM 267.4 11 26 4 31 61 0 0 0 0 0 0 0 61 
PBANKA_112590/ 
PBANKA_141230 
PF3D7_1028700 
cell surface 
& PVM 58.1 0 0 1 11 12 0 0 0 0 0 0 0 12 PBANKA_051280 
PF3D7_1033200 
cell surface 
& PVM 38.9 11 16 0 4 20 × × × × × × × 20 × 
PF3D7_1035300 
cell surface 
& PVM 141.1 0 0 1 0 1 × × × × × × × 1 × 
PF3D7_1035700 
cell surface 
& PVM 80.3 10 0 0 0 0 × × × × × × × 0 × 
  Results 
97 
PF3D7_1103500 
cell surface 
& PVM 67.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_094340 
PF3D7_1218800 
cell surface 
& PVM 39.6 0 0 2 5 7 0 0 0 0 0 0 0 7 PBANKA_143440 
PF3D7_1228600 
cell surface 
& PVM 86.6 23 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144330 
PF3D7_1335300 
cell surface 
& PVM 382.9 0 0 0 0 0 0 0 0 0 0 0 0 0 
PBANKA_000220 + 
10 more 
PF3D7_0206200 others 62.7 0 0 0 2 2 0 0 0 0 0 0 0 2 PBANKA_030390 
PF3D7_0207700 others 108.7 11 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_030480 
PF3D7_0311600 others 84.0 0 0 0 5 5 0 0 0 0 0 0 0 5 PBANKA_040960 
PF3D7_0320700 others 21.0 0 0 0 8 8 0 0 0 0 0 0 0 8 PBANKA_121780 
PF3D7_0403800 others 83.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_100150 
PF3D7_0709900 others 274.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_122050 
PF3D7_0817600 others 112.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_071320 
PF3D7_0930000 others 66.8 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_083070 
PF3D7_1027800 others 44.2 17 9 14 18 41 0 0 0 0 0 0 0 41 PBANKA_051190 
PF3D7_1033800 others 52.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_051760 
PF3D7_1103100 others 13.0 2 2 5 4 11 1 0 1 0 0 0 1 12 PBANKA_094360 
PF3D7_1207700 others 43.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_060620 
PF3D7_1358800 others 17.3 8 6 4 9 19 8 5 13 1 0 1 14 33 PBANKA_113510 
PF3D7_1408600 others 25.1 8 8 7 12 27 2 5 7 2 0 2 9 36 PBANKA_103390 
PF3D7_1457000 others 47.6 0 0 0 0 0 2 0 2 0 1 1 3 3 PBANKA_132070 
PF3D7_0202400 unknown 141.9 27 0 0 0 0 × × × × × × × 0 × 
PF3D7_0411000 unknown 179.7 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_061240 
PF3D7_0417400 unknown 822.4 0 0 1 0 1 0 0 0 0 0 0 0 1 PBANKA_071950 
PF3D7_0508900 unknown 370.2 0 2 0 0 2 0 0 0 0 0 0 0 2 PBANKA_110850 
PF3D7_0601900 unknown 14.7 0 0 0 1 1 × × × × × × × 1 × 
PF3D7_0704100 unknown 425.3 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_080180 
  Results 
98 
PF3D7_0730800.1 unknown 32.1 5 0 0 0 0 × × × × × × × 0 × 
PF3D7_0904200 unknown 34.0 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_041720 
PF3D7_1021700 unknown 830.2 0 0 0 1 1 1 0 1 0 0 0 1 2 PBANKA_050590 
PF3D7_1023000 unknown 48.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_050720 
PF3D7_1024800 unknown 171.1 4 33 15 33 81 0 0 0 0 0 0 0 81 PBANKA_050900 
PF3D7_1026100 unknown 23.9 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_051030 
PF3D7_1026600 unknown 196.5 0 0 0 0 0 × × × × × × × 0 × 
PF3D7_1114600 unknown 39.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_093310 
PF3D7_1124200 unknown 49.3 0 0 0 7 7 0 0 0 1 0 1 1 8 PBANKA_092410 
PF3D7_1126700 unknown 110.1 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_092170 
PF3D7_1225600 unknown 93.1 0 1 0 0 1 0 0 0 0 0 0 0 1 PBANKA_144050 
PF3D7_1230100 unknown 61.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_144480 
PF3D7_1239400 unknown 22.0 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_145390 
PF3D7_1316700 unknown 73.4 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_141520 
PF3D7_1321000 unknown 80.6 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_141930 
PF3D7_1362600 unknown 32.1 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_113860 
PF3D7_1438800 unknown 84.0 0 0 0 2 2 0 0 0 0 0 0 0 2 PBANKA_130270 
PF3D7_1439600 unknown 22.6 0 6 0 10 16 1 0 1 0 0 0 1 17 PBANKA_130350 
PF3D7_1451200 unknown 176.2 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_131490 
PF3D7_1452400 unknown 107.5 0 0 0 0 0 0 0 0 0 0 0 0 0 PBANKA_131610 
PF troph, peptide hits for gametocyte-less P.falciparum trophozoite (Silvestrini  et al., 2005; 2010); I &II, stage I & II P. falciparum gametcoytes (Silvestrini  
et al., 2005; 2010); V, stage V  P. falciparum gametocytes  (Florens et al. 2002) ; I.II.IV.V, sum of all P. falciparum gametocyte data; FG1, peptide hits from 
highly purified female P. berghei gametocyte sample 1 (Khan et al., 2005); FG3, peptide hits from highly purified female P. berghei gametocyte sample 3 
(Khan et al., 2005); FG(1+3), sum of both; MG1, peptide hits from highly purified male P. berghei gametocyte sample 1(Khan et al., 2005); MG3, peptide 
hits from highly purified male P. berghei gametocyte sample 3 (Khan et al., 2005);MG(1+3), sum of both; FG+MG, total number peptide hits from all four P. 
berghei gametocyte samples; total FG.MG.PF, total number of P. falciparum  and P. berghei gametocyte peptide hits. 
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3.2.3 Genes with transcript changes regulated by DOZI and CITH 
We further wanted to know which of the genes with changes in transcripts levels fol-
lowing gametocyte activation were regulated by DOZI and CITH. DOZI and CITH 
regulated genes are candidate genes for translational repression in non-activated game-
tocytes and may play important roles in zygote to ookinete development in the 
mosquito. To this end, we compared the P. berghei orthologs of the identified P. falci-
parum genes with a global gametocyte transcriptome analysis of P. berghei DOZI and 
CITH gene deletion mutants; destabilized mRNAs are candidates for translational re-
pression in non-activated gametocytes (Mair et al., 2006; 2010). The comparison was 
done with the help of Gunnar R. Mair. A total of 11 of the SSH identified genes (9.7%) 
were identified regulated by DOZI and CITH (Table 16); 8 of those lack any gameto-
cyte protein evidence. One of the destabilized genes was identified as a single peptide 
hit while the remaining two destabilized genes had 19 and 74 peptide hits in total.  
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PF _ID P Protein Predicted feature MW P. berghei ortholog gene ID DOZI CITH 
PF3D7_1011800 74 QF122 antigen KH domain type 1, RNA binding 131.6 PBANKA_121020 1.4 1.1 
PF3D7_0724900 0 kinesin-like protein  222.6 PBANKA_062240 2.4 1.2 
PF3D7_1033800 0 plasmepsin VII SP, 1 TM, aspartyl protease 52.3 PBANKA_051760 2.1 1.3 
PF3D7_1316700 0 conserved Plasmodium protein SP 73.4 PBANKA_141520 2.1 1.4 
PF3D7_1321000 0 conserved Plasmodium protein  80.6 PBANKA_141930 1.8 1.6 
PF3D7_0303900 19 conserved Plasmodium protein 
SP, phosphatidyl-ethanolamine-binding pro-
tein PEBP domain  
23.2 PBANKA_040250 2.2 1.8 
PF3D7_1103500 0 CPW-WPC family protein SP, CPW-WPC domain 67.3 PBANKA_094340 1.3 2.3 
PF3D7_1115200 0 SET domain protein, SET7 Chromatin regulator 94.3 PBANKA_093250 2.5 2.3 
PF3D7_1207700 0 blood stage antigen 41-3 precursor SP 43.4 PBANKA_060620 2.5 2.8 
PF3D7_0904200 1 conserved Plasmodium protein SP, 1 TM 34 PBANKA_041720 1.9 3.2 
PF3D7_1362600 0 conserved Plasmodium protein Interacts with splicing factor 3B subunit 2 32.1 PBANKA_113860 3.4 3.5 
P, total number of peptides identified in P. falciparum and P. berghei gametocytes (Florens et al., 2002; Khan et al., 2005; Silvestrini et al., 2005; 2010); DOZI 
and CITH, log2 values of transcript abundance WT compared to DOZI-KO, or WT compared to CITH KO (Mair et al., 2010). 
 
Table 16:  Genes identified by SSH with P. berghei orthologs showing destabilization in the absence of DOZI and CITH (analysis done by Gunnar R. Mair).   
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3.2.4 Quantification of transcript levels by qRT-PCR 
In order to confirm transcript changes in gametocytes during activation and to deter-
mine if these genes become up or down regulated following gametocyte activation, 
qRT-PCR was conducted on a subset of the genes identified by SSH. Total RNA was 
isolated from immature (stages III and IV) and mature (stage V) gametocytes of P. 
falciparum strain NF54 and from activated gametocytes at 30 min post-activation 
(p.a.). Furthermore, we isolated RNA from mixed asexual blood stages of the gameto-
cyte-less P. falciparum strain F12. Initially, the synthesized cDNA of each sample was 
tested for its stage-specificity by diagnostic RT-PCR, using primers for the asexual 
blood stage gene ama-1 (Peterson et al., 1989; Narum et al., 1994) and for the gameto-
cyte-specific gene pfccp2 ( Pradel et al., 2004). The tests confirmed that no pfccp2 
transcript was present in the F12 sample, while no ama-1 expression was detected in 
the purified gametocyte samples of strain NF54 (Figure 31). The absence of ama-1 
signals in the gametocyte samples and the absence of pfccp2 in the F12 asexual blood 
stage sample further showed that these were devoid of any contamination by genomic 
DNA (gDNA). An additional test for gDNA contamination was performed using pri-
mers specific for the gene hdac1, a gene expressed in all the stages studied. In all 
parasite samples, i.e. in samples of F12 asexual blood stages as well as in NF54 imma-
ture, mature and activated gametocytes, hdac1 transcript was present (Figure 31), as 
shown by diagnostic RT-PCR. In sample preparations lacking reverse transcriptase, on 
the other hand, no hdac1-specific PCR bands were detected. 
 
Figure 31: Diagnostic RT-PCR to check for gDNA contamination and stage specific pu-
rity of samples (PCR done by Matthias Scheuermayer).The diagnostic RT-PCR revealed the 
presence of stage-specific transcript in the asexual blood stages of the gametocyte-less strain 
F12 (F12 ABS) as well as in immature (stage III/IV) and mature (stage V) non-activated ga-
metocytes (GC) and in gametocytes at 30 min p.a. in vitro. ama-1, marker for ABS; pfccp2, 
marker for GC. Transcript of gene hdac1 was detected in all stages investigated, while no 
hdac1-specific PCR product was detected in samples lacking reverse transcriptase (RT). 
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For qRT-PCR, we chose 34 genes from the SSH analysis for comparison of transcript 
abundance, with representatives from all ontology groups. The gene Pfs16 was se-
lected as an internal control, because it is known to be highly expressed in 
gametocytes throughout development, while it is absent in the gametes (Sologub et al., 
2011; Eksi et al., 2011; 2012). We also added two sexual stage-specific genes, actinII 
and pfs25 as external controls and the gene su α5, encoding for subunit (SU) α5 of the 
α-ring of the proteasome core particle (Aminake et al., 2012) was also included in the 
investigations to see if the proteosome plays an important role following gametocytes 
activation. 
Transcript expression levels were measured via real-time RT-PCR and calculated by 
the 2-ΔCt method (Livak et al., 2001; Sugden et al., 2009) in which the threshold cycle 
number (Ct) was normalized to the Ct of the endogenous control gene encoding for P. 
falciparum serylt RNA synthetase (PF3D7_0717700) as reference gene (Salanti et al., 
2003, Wang et al., 2010). We considered transcript levels with 2-ΔCt values below 0.5 
as negligible. The results of the qRT-PCR are shown on Figure 33. Real-time RT-PCR 
revealed transcription in mature gametocytes for 29 out of the 34. Out of these, 20 
genes showed increased transcript expression in gametocytes compared to asexual 
blood stage parasites.  
We identified 8 genes i.e. PF3D7_0827800 (set3), Pf3D7_1246200 (actin1), 
PF3D7_1218800 (psop17), PF3D7_1239400, PF3D7_0704100, PF3D7_0417400, 
PF3D7_1321000 and PF3D7_1316700 for which transcript levels were increased in 
activated gametocytes as compared to asexual blood stages, immature gametocytes 
and non-activated gametocytes, indicating that these genes may play an important role 
downstream of gametocyte activation in the mosquito midgut. Twelve genes had an 
increased transcript expression in gametocytes compared to asexual blood stage para-
sites, and transcript levels either remained constant, decreased or increased following 
activation. These include PF3D7_0302100 (clk4), PF3D7_0818200 (14-3-3), 
PF3D7_1115200 (set7), PF3D7_0422300 (α-tubulin II), PF3D7_0708000, 
PF3D7_1103500 (encoding for a CPW-WPC protein), PF3D7_406200 (pfs16), 
PF3D7_1457000 (spp), PF3D7_0817600 (unknown protein termed PPLP6 because it 
was initially predicted to posses a MAC/PC domain which no more exist following the 
recent anotation), PF3D7_1225600, PF3D7_1438800 and PF3D7_1023000. Five 
genes were predominantly expressed in the asexual blood stages and showed a resur-
gence in transcript expression in gametocytes during maturation, i.e. PF3D7_1238900 
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(pk2), PF3D7_1136400 (encoding for a tetratrico peptide repeat region; TPR), 
PF3D7_1021700, PF3D7_1026600 and PF3D7_1251200 (coronin). For four genes, 
PF3D7_0818900 (hsp70-1), PF3D7_080700 (su α6), PF3D7_0807500 (gap50), and 
PF3D7_1444800 (encoding for fructose 1,6 bisphosphate aldolase, FBPA) expression 
was high in asexual blood stages and decreased during gametocyte development and 
following activation. Transcript expression for five genes, PF3D7_0815800 (vsp9), 
PF3D7_0215400 (encoding for a WD40 motif), PF3D7_1351700 (alv6), 
PF3D7_1033200 (etramp10.2), and PF3D7_0207700 (sera4), was negligible in game-
tocytes. 
3.2.5 Changes in protein expression of SSH selected genes 
In order to determine the changes in protein expression for selected SSH genes, we 
used polyclonal anti-sera which were already generated in our labouratory against 
some of the proteins. Also, we generated polyclonal antibodies against 
PF3D7_0818200 (14-3-3) in this study. This was done together with Olivier Levy (Di-
ploma student). Full length of the 14-3-3 gene was cloned in the pGEX‐4T1 plasmid 
and the GST‐tagged protein was expressed in E.coli BL21 (DE3) RIL. The purified 56 
KDa GST fusion protein (Figure 32A) was used to generate antibodies against P. fal-
ciparum 14.3.3 protein by immunization of mice. The recognition of 14.3.3 protein by 
the generated anti-sera was investigated by western blot analysis using parasite lysates 
of F12 asexual, immature gametocytes, mature gametocytes and activated gameto-
cytes. Western blotting detected one prominent protein band in the F12 mixed asexual 
stages (F12), immature gametocytes (IMG), non anctivated mature gametocytes 
(naGC) and activated gametocyte (aGC) lysate with a molecular weight approximately 
32 KDa (Figure 32B) which is 2 KDa bigger than the expected molecular weight of 
the 14-3-3 protein. Similar results have been obtained by Al-Khedery and colleagues 
(Al-Khedery et al., 1999) who reported that despite the fact that the P. knowlesi 14-3-3 
and P. falciparum 14-3-3 have equal sizes, the P. knowlesi protein migrates at the right 
size of 30 KDa as compared to the P. falciparum counterpart which migrates on SDS-
PAGE gel at a molecular weight of 32 KDa.  
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Figure 32: Purification 14-3-3 fusion protein and its protein expression in Plasmodium 
stages (Levy 2013). (A), showing the 56 kDa GST-14-3-3 purified fusion protein on SDS-
PAGE gel. (B), western blot analysis of protein expression in different parasite stages using 
polyclonal antisera against 14-3-3 protein. Pf39 was used as control. F12 represent mixed 
asexual blood stages, IMG; immature gametocytes, naGC; mature non- activated gametocytes, 
aGC; activated gametocytes, Ery; erythrocyte lysate, NMS; neutral mouse serum. 
The 14-3-3 antibody together with already produced antibodies in our laboratory was 
then used to investigate the expression changes at the protein level.  Antibodies against 
the proteins PK2, CLK-4, actinI and actinII, GAP50, proteasome SU α5, Pfs16, Pfs25, 
PPLP6 and 14-3-3 were used to immunolabel the respective proteins in samples of P. 
falciparum F12 asexual blood stages, non-activated NF54 gametocytes and gameto-
cytes at 30 min p.a. via indirect immunofluorescence assay (Figure 34A). Asexual 
blood stage parasites were highlighted by MSP-1 labeling and gametocytes were high-
lighted by labeling with Pfs25 or Pfs230. The abundance of the respective proteins in 
gametocytes before and after activation was quantified by measuring the average fluo-
rescence signal intensity of a total number of 15-20 plotted cells per setting. The 
results showed a significant up-regulation in the expression of PK2, actinII and Pfs25 
following gametocyte activation (Figure 34B). While PK2 is also expressed in asexual 
blood stage parasites, actinII and Pfs25 cannot be detected in these stages. On the 
other hand, CLK4, proteasome SU α5, and PPLP6 were detected in asexual blood 
stage parasites and gametocytes during maturation, but the proteins were down-
regulated in gametocytes at 30 min p.a. (Figure 34B). The 14-3-3 protein was highly 
expressed in asexual, gametocytes and 30 min. post activated gametocytes. While la-
beling of 14.3.3, CLK4 and SU α5 revealed a homogenous expression of these 
proteins in the parasite cytoplasm and nucleus, PPLP6-labeling exhibited a punctuated 
expression (Figure 34A).  
A 
 
 
 
B 
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Figure 33: Changes in transcript expression levels during the formation and activation of 
P. falciparum gametocytes.  Real-time RT-PCR analysis showed changes of transcript expres-
sion of 34 of the SSH-identified genes between ABS, immature and mature non-activated GCs 
and in GCs at 30 min p.a. in vitro. Transcript expression levels were calculated by the 2-ΔCt 
method; the threshold cycle number (Ct) was normalized with the Ct of the gene encoding for 
seryl tRNA synthetase as reference. 
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Figure 34: Changes in protein expression during formation and activation of P. falcipa-
rum gametocytes. (A) Immunofluorescence assays, using specific antibodies, detected the 
proteins of interest (in green) in asexual blood stage (ABS) parasites, in gametocytes (GC) and 
in gametocytes at 30 min p.a. (aGC). The parasite stages were highlighted with antibodies 
against stage-specific markers (in red; MSP1 for ABS; Pfs230 or Pfs25 for GCs and aGCs). 
Nuclei were highlighted by Hoechst nuclear stain (in blue). Bar, 5 μm. (B) Diagram showing 
the average signal intensity of the immunolabeled proteins in gametocytes before and at 30 
min p.a.. Measurements were performed on 15-20 plotted cells per setting via quantitative 
confocal microscopy. Mean ± SD. *p < 0.05;**p < 0.01; ***p < 0.001 (student’s t-test). 
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3.3 Role of antimicrobial molecules as transmission blocking agents 
In this study, we evaluated the effect of antimicrobial molecules as transmission block-
ing agents to prevent the spread of malaria. The effect of harmonine, an antimicrobial 
defence molecule isolated from the hemolymph of the Asain ladybug Harmonia axy-
ridis was tested again P. falciparum for its use as a transmission blocking drug. The 
transmission blocking effect of recombinant produced peptides (SM1, PcFK1, PcFK2) 
as transmission blocking agents were also investigated using the P. berghei model. 
 
3.3.1 Transmission blocking effect of harmonine 
Here, we tested the transmission blocking effect of harmonine which was isolated 
from the hemolyphm of the Asain lady bug, Harmonia axyridis and shown to display 
antimicrobial activities (Röhrich et al., 2012). 
3.3.1.1 Antiplasmodial effect of harmonine 
We initially tested the effect of the harmonine against the asexual stages of P. falcipa-
rum chloroquine-sensitive strain (3D7) and chloroquine-resistant strain (Dd2). The 
results showed that harmonine inhibits the growth of the asexual parasites with half-
inhibitory concentration (IC50) values of 4.8 and 7.6 µM for the chloroquine-sensitive 
strain 3D7 and the chloroquine resistant strain Dd2, respectively (Table 17). In com-
parison, chloroquine treatment resulted in parasite growth inhibition with IC50 values 
of 24 (3D7) and 158 nM (Dd2).  
 
Table 17:  Antimalarial and cytoxicity effect of harmonine 
 
                         IC50 (µM) 
        Harmonine        Chloroquine  
Plasmodium falciparum strain       
3D7 (asexual blood stages)   4.8 ± 0.2  0.024 ± 0.008  
Dd2 (asexual blood stages)       7.6 ± 0.7  0.158 ± 0.001  
NF54 (exflagellating microgameto-
cytes)       5.8 ± 1.9      N/A  
Human cells     
HeLa cells     37.0 ± 1.7    N/A  
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3.3.1.2 Effect of harmonine on gametocytes development and mosquito midgut 
stages 
In order to determine the transmission blocking effect of harmonine in vitro, we ini-
tialy tested the toxic effect of the compound on gametocyte development. Harmonine 
at 4.8 µM (IC50 concentration) reduced the number of P. falciparum NF54 gameto-
cytes to 18 % compared to 0.5 % DMSO control, 100 % reduction of gametocytes 
were achieved at a concentration 50 µM (Table 18). The positive control substance 
primaquine (IC50 activity on asexual blood stages 3 µM) reduced gametocyte numbers 
to 42%. 
We further tested the effect of the harmonine on the ability of male gametocytes to ex-
flagellate (microgemetogenesis). Exflagellation is the process by which male 
gametocytes become activated in the mosquito midgut after being taken up by the 
mosquito due to external stimuli. This process resuts in the formation of eight motile 
flagella-like structures which stick around red blood cells and female gametes. Exflag-
ellation was inhibited by harmonine with an IC50 value of 5.8 µM (Table 17, Figure 
35A).  
The effect of harmonine on zygote formation was also investigated using the zygote 
development test. The compound reduced zygote formation to 17, 8.8 and 1.2 % at 5, 
10 and 50 µM, respectively as compared to 1 % DMSO set to 100 % as control (Fig-
ure 35B). 
 
Table 18: Gametocytocidal activity of harmonine  
 
Compound     Concentration 
 
Mean number of gametocytes per 
1,000 RBCs 
 
DMSO (negative control)              0.5 %  23.7 ± 2.5  
Primaquine (positive control)             3.0 µM  10.0 ± 1.0  
Harmonine            4.8 µM   4.3 ± 1.5  
Harmonine           50.0 µM        0  
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Figure 35: Effect of harmonine on microgametogenesis and zygote development. (A), 
Curve showing the inbitory effect of harmonine on the ability of male gametocytes to exflagel-
late.The relative number of exflagellation centers was determined in comparison to 
experiments without compound. From three independent experiments an IC50 of 5.8 ± 1.9 µM 
was determined.  (B), the effect of different concentrations of harmonine on zygote formation. 
1% DMSO was used as control. 
3.3.1.3 In vivo transmission blocking effect of harmonine 
To determine the in vivo transmission blocking effect of harmonine, An. stephensi 
mosquitoes were fed on gametocyte cultures containing either 10 µM harmonine or 
1% DMSO as control and the transmission blocking effect of the compound was de-
termined by counting the amount of oocysts in the mosquito midgut following staining 
with mercurochrome.  The results showed that the mean oocyte numbers were 1.0 ±1.6 
and 5.1 ± 5.3% in the harmonine and control groups, respectively. Also, only 45 % of 
the mosquitoes were found to be infected in the harmonine group compared with 91 % 
in the control group (Table 19), indicating a significant reduction in parasite transmis-
sion (p < 0.05, Mann–Whitney test). 
 
Table 19:  In vivo transmission blocking activity of harmonine 
Treatment of game-
tocytes  
No. mos-
quitoes 
dissected 
Infected   
mosquitoes 
[%] 
Oocyst no.  
range 
Mean  
oocyst no. 
Inhibtion     
[%] 
DMSO (1 %)  11 91   0 - 17 5.1 ± 5.3 100 
Harmonine (10 µM) 20 45 0 - 6 1.0 ± 1.6 49.5 
p < 0.05, Mann–Whitney test 
3.3.1.4 Cytotoxic effect of harmonine  
We also investigated the toxic effect of harmonine on human cells. The compound 
showed moderated toxicity to HeLa cells with IC50 values of 37.0 ± 1.7 µM (Table 17) 
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and a selectivity index (SI) of 7.7 and 4.8 for the CQ-senstive strain (3D7) and CQ-
resistant strain (Dd2) respectively. Regarding the effect of the compound on the inter-
grity of RBCs, harmonine showed no significant effect on RBCs intergrity at 
concentrations of up to 100 µM as compared to 0.15% saponin which was used as 
positive control (Figure 36). 
   
Figure 36: Hemolytic effect of harmonine at different concentrations.  RBC at 5% hema-
tocrit was plated in triplicate in 96 well plates and harmonine at different concentrations 
added. After 48 h of incubation at 37°C, the plate was centrifuged at 500 g for 2 min. A vol-
ume of 100 µl of the resulting supernatant was carefully transfered to another plate and the 
optical density was measured at 550 nm with a spectrophotometer (Multiscan Ascent). Me-
dium supplemented with 0.15% saponin was used for lysis control and 0.5% vol. DMSO or 
medium only was used for negative control. 
 
3.3.2 Transmission blocking effect of recombinantly produced peptides 
The general idea for testing these recombinant peptides was to be able to determine a 
peptide expressed in plants with transmission blocking activity which can able used to 
generate a modified plant which is present in malaria endemic areas that expresses a 
transmission blocking agent on its nectar in a stable form.  
3.3.2.1 Transmission blocking effect of SM1 
We tested the transmission blocking effect of SM1, a peptide already shown to exhibit 
transmission blocking activity by binding either to the mosquito midgut or salivary 
gland (Ghosh et al., 2001; 2009). 
The transmission blocking effect of different variants of the recombinant peptide was 
tested using the P. berghei system. We initially tested the effect of the recombinant 
GFP-fused SM1 proteins which was attached to the McoTi scafford (MC), with the 
expression of the recombinant protein targated either to the cytosol (15879) or the 
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Apoplast/ER (17620) of the tobacco plant (Nicotiana benthamiana). Neither the cyto-
solic nor Apoplast/ER targeted produced protein had a significant transmission 
blocking effect on P. berghei by either reducing oocyst or sporozoite counts (Figure 
37) 
 
  
Figure 37: Transmission blocking effect of recombinant SM1 produced in tobacco. An 
stephensi mosquitoes were fed with 0.5mg/ml recombinant peptide together with a sugar solu-
tion containing food color for 2 days and then the mosquitoes were allowed to feed on 
P.berghei infected mice (1-10% parasitaemia). (A), shows the number of oocyst counted in 
mosquito midgut 7-12 d post infection.( B), the mean number of sporozoites per salivary gland 
lobe counted greater than 14 d post infection. The numbers 15789 indicate expression of the 
protein was targeted at the cytosol and 17620 the Apoplast/ER. GFP and GFP-MC served as 
controls. No significant differences were obtained between controls and peptide fed mosqui-
toes (P > 0.05 Mann-Whitney test). 
Due to the fact that the tobacco-produced SM1 peptites had no transmission blocking 
effect and some preliminary results showed transmission blocking activity of the pep-
tide produced in bacteria (personal communication, Heribert Wazecha). We decided to 
test the effect of the recombinant peptide produced in bacteria fused with either thiore-
doxin and McoTi or thioredoxin and agouti related protein (AGRP) or thioredoxin 
tandem repeats of 8 times SM1. Still, the results showed no significant reduction in 
Oocyst count between peptide fed mosquitoes and controls (Figure 38). 
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Figure 38: Transmission blocking effect of recombinant SM1 peptide produced in bacte-
ria. (A), Oocyst count from dissected midguts of mosquitoes fed with 0.5mg/ml thioredoxin 
McoTi SM1 fusion (TRX:MC-SM1) peptide or thioredoxin agouti related protein SM1 fusion 
(TRX:AGRP-SM1) peptide.(B) Oocysts count from midgut of mosquitoes fed with 0.5mg/ml 
of thioredoxin containing 8 times tandem repeats of SM1 fusion peptide. No significant differ-
ences were obtained between controls and peptide fed mosquitoes (P > 0.05 Mann-Whitney 
test). 
3.3.2.2 Transmission blocking effect of PcFK derivatives 
Here, the transmission blocking activity of tobacco-produced recombinant Psalmopo-
eus cambrigei falciparium killers (PcFK1 and PcFK2) were tested. The peptides were 
first isolated from the venom of the Trinindad chevron tarantula Psalmopoeus cam-
brigei by Choi et al. and  shown to exhibit antiplasmodial activity against the intra-
erythrocytic stage of P. falciparun in vitro (Choi et al., 2004). 
The transmission blocking effect of total extracts of PcFK1 and PcFK2 were tested. 
Both PcFK1 and PcFK2 had no significant transmission blocking effect on P.berghei 
in the mosquito. No significant reduction in either oocyst count or sporozoite count in 
the mosquito midgut and salivary gland respectively was obtained (Figure 39). 
 
 
A 
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Figure 39: Transmission blocking effect of PcFK derivatives. (A), oocyst count following 
feeding of mosquitoes with PcFK recombinant extracts with peptide expression targeted to the 
Apoplast/ER (17620).(B), oocyst count following feeding of mosquitoes with PcFK recombi-
nant extracts with peptide expression targeted to the cytosol.(C), oocyst count following 
feeding of mosquitoes with PcFK recombinant extracts with peptide expression targeted to the 
chloroplast (20030).(D), mean sporozoite per salivary gland lobe following feeding of  mos-
quitoes with extracts whose peptide expression  was targeted to cytosol (15879). No 
significant differences were obtained in oocyst or sporozoite counts (p > 0.05, Mann-Whitney 
test).
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4. Discussion 
4.1 Interplay between midgut bacteria and the malaria parasite 
4.1.1 Bacteria diversity in An. stephensi during development and different feed-
ing regimes 
In order to investigate the interplay between the mosquito midgut microbiota and the 
malaria parasite, we initially used the culture independent 16S rRNA gene sequencing 
method to investigate the bacterial diversity in the midgut of the Asian malaria vector 
An. stephensi during development and under different feeding regimes with special 
focus on the presence of the malaria parasite in the gut. We showed that the diversity 
of the midgut microbiota drastically decreased during mosquito development from egg 
to adult. Such “sterilization” of the mosquito midgut has been reported before and was 
assigned to the sequestration of larval gut bacteria within the confines of the meco-
nium and the meconial peritrophic membranes and also due to the bactericidal effect 
of molting fluid which is ingested during the process of metamorphosis from larvae to 
adult (Moll et al., 2001). However, this sterilization appears to be incomplete as some 
bacteria (Acinetobacter, Bacillus, Enterobacter, Staphylococcus, Pseudomonas, Cry-
seobacterium (Elizabethkingia) and Serratia species) are able to be transferred from 
larvae to adult (Rani et al., 2009). We found the highest bacteria diversity in An. ste-
phensi larvae. The high bacteria diversity in larvae midgut is probably due to the fact 
that microorganisms represent an important food source to mosquito larvae (Merrit et 
al., 1992; Walker et al., 1988; Straif et al. 1998). It has been shown that Anopheles lar-
vae stopped growing following the addition of antibiotics (Wotton et al., 1997).  We 
also observed that the bacteria diversity in lab-reared adult female An. stephensi mos-
quitoes fed on sugar and blood in the presence and absence of the malaria parasite was 
very low. Low bacterial diversity in lab-reared and field collected Anopheles mosqui-
toes has been reported (Lindh et al., 2005; Rani et al., 2009). Furthermore, no 
significant differences were observed between the bacteria diversity in sugar, blood 
and Plasmodium-fed female mosquitoes as revealed by DGGE and 16s RNA gene 
analysis indicating that the malaria parasite probably does not affect the mosquito 
midgut bacteria diversity. 
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4.1.2 Dominance of E. meningoseptica in An. stephensi midgut 
In corroboration with previous studies (Lindh et al., 2005; Rani et al., 2009; Dong et 
al., 2009; Boissiere et al., 2012) we identified the rod-shaped gram negative bacterium 
E. meningoseptica (previously known as Chryseobacterium meningoseptica or Flavo-
bacterium meningoseptica (King 1959)) as dominant in all developmental stages of 
An. stephensi, i.e. in eggs and in the midguts of larvae, pupae and male and female 
adults. The bacterium still remained dominant in the midgut of blood-fed and malaria 
parasite-fed mosquitoes indicating that it is not affected by the diet of the mosquito. 
Interestingly, we were able to obtain and identify an isolate of E. meningoseptica from 
the midgut of female An. stephensi mosquitoes which we named E. meningoseptica 
Che 01. Phylogenetic analysis of E. meningoseptica Che 01 and the other E. meningo-
septica phylotypes which were obtained in this study placed them in a single clade of 
E. meningoseptica phylotypes derived from other host-associated environments such 
as mosquitoes, termites, frogs and carnivorous plants (Kämpfer et al., 2010). In accor-
dance with an isolate from the midgut of An. gambiae whose name was proposed as 
Elizabethkingia anophelis, the isolate showed natural resistance to a range of antibio-
tics (Kämpfer et al., 2010). 
Several other studies have reported the dominance of E. meningoseptica in either field 
or lab-reared Anopheles mosquitoes. Dong and others (Dong et al., 2009) reported the 
dominance of Chryseobacterium meningosepticum (E. meningoseptica) within all five 
generations in the midgut of lab reared An. gambiae mosquitoes studied. They also 
observed that when E. meningoseptica became the dominant bacterium of the midgut 
flora, the growth of other bacterial species, that could be cultured on LB agar, was 
usually limited suggesting that the species may possess some competitive advantages 
in the gut environment. In a recent study, which investigated the midgut bacteria from 
lab-reared An. gambiae mosquitoes collected in natural breeding sites in Cameroon, 
the authors identified Elizabethkingia species to be present in >95% of the  mosquitoes 
(Boissière et al., 2012). Also, Boissière et al. identified Elizabethkingia species in field 
collected mosquitoes, although at low densities. They then suggested that the predo-
minance of Elizabethkingia spp. in the midguts of the insectary-reared mosquitoes 
reflects that the bacterium has found a thriving niche in this environment where com-
petition with other bacterial species is limited (Boissière et al., 2012). Rani et al. also 
reported a dominance of Serratia marcescens and E. meningoseptica in lab-reared An. 
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stephensi mosquitoes (Rani et al., 2009). In an earlier study, Lindh and coworkers 
(Lindh et al., 2008) identified E. meningoseptica and Pantoea stewartii to be dominant 
in lab-reared An. gambiae mosquitoes. 
We now show that organic extracts of metabolites from cultured E. meningoseptica 
exhibit activities against gram positive and negative bacteria and also against yeast 
Candida albicans which probably account for the dominance of the bacterium in the 
mosquito midgut. It should be noted that yeasts such as Wickerhamomyces anomalus 
(Pichia anomala) have been isolated from mosquito midgut (reviewed in Ricci et al., 
2011) and could therefore be a competitor for food and nutrients with E. meningosep-
tica in the mosquito midgut. The differences in the antimicrobial activities of acetone 
and ethyl acetate extracts observed in this study is probably due to the difference in the 
polarity of the two solvents; since acetone is more polar than ethyl acetate, it would 
preferentially dissolve compounds with higher polarity. 
We also demonstrated that the predominance of E. meningoseptica in the midgut of the 
female An. stephensi is not altered by the blood meal, because differences between the 
midgut microbiota of sugar-fed and blood-fed female mosquitoes were not observed. 
Furthermore, the gut microbiota was not altered by the presence of human or rodent 
malaria parasites, because feeds with P. berghei- and P. falciparum-infected blood did 
not result in any significant changes in the bacterial populations, indicating the malaria 
parasites do not represent a threat for E. meningoseptica. Also, the frequent isolation 
of the bacterium in other studies (indicated above) further confirmed that the bacte-
rium is not affected by the mosquito diet. 
 E. meningoseptica extracts also had an effect on P. falciparum parasites in vitro and 
exhibited in vitro toxicity on gametocytes. The antiplasmodial and gametocytocidal 
activities of E. meningoseptica metabolites might enable the bacteria to harm the ma-
laria parasites, once these have entered the mosquito midgut with the blood meal, 
thereby outrivaling a potential competitor for nutrition and space. Midgut bacteria 
have been shown to produce compounds with potential antimalarial activites. Entero-
bacter bacterium isolated from wild mosquitoes in Zambia has been shown to produce 
reactive oxygen intermediates that kill developing parasites in the midgut lumen, inhi-
biting the development of the parasite in the mosquito (Cirimotich et al., 2011). 
Noteworthy, it has also been shown that midgut bacteria can also stimulate the mos-
quito´s innate immune response to produce antimicrobial peptides which act on both 
the bacteria and the malaria parasite in the gut. Because mosquito gut bacteria drasti-
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cally proliferate after the blood meal, the uptake of Plasmodium- infected blood trig-
gers immune defense mechanisms in the mosquito that are directed against both 
bacteria and parasites (Meister et al. 2009). In a recent study by Eappen and col-
leagues, (Eappen et al., 2013), they were able to show that Enterobacter cloacae 
strongly induces the expression of a putative serine protease inhibitor in An. stephensi 
(AsSRPN6) which is a vital component of the E. cloacae- mediated immune response 
that restricts Plasmodium development in the mosquito. Also, a global transcription 
profiling of septic and aseptic mosquitoes identified a significant subset of immune 
genes that were mostly up-regulated by the mosquito´s microbiota, but that also in-
clude several anti-Plasmodium factors (Dong et al., 2009). Antimicrobial factors 
which are also up-regulated by bacterial infections, which have implications on mala-
ria parasites, include members of the fibrinogen-related protein FREP family (Dong 
and Dimopoulos 2009) and the gram-negative bacteria-binding protein (GNBP) family 
(Warr et al., 2008). It is still to be determined whether E. meningoseptica is also able 
to activate the mosquito´s innates response against the malaria parasite. 
4.1.3 Transstadial and vertical transmission E. meningoseptica 
The presence of E. meningoseptica phylotypes in all development stages and from the 
analysis of the bacterial content in the water used for rearing of the larvae before and 
after the water had come in contact with the mosquitoes led us to the conclusion that 
E. meningoseptica is transstadially transmitted and also vertically transmitted between 
mosquito generations. Transstadial and vertical transmission of bacteria has been 
shown to take place in Anopheles mosquitoes. Damiani and coworkers investigated the 
colonization of the African malaria vector An. gambiae by the α-proteobacterium 
Asaia and were able to show by fluorescent visualization of the bacterium that it was 
localized in the guts, salivary glands and reproductive organs of male and female mos-
quitoes (Damiani et al., 2010). The localization of the bacterium in the mosquito´s 
reproductive organ relates to vertical transmission routes whereby Asaia is transmitted 
from mother to offspring by a mechanism of egg-smearing. A study in An. gambiae 
using GFP-expressing Pantoea stewartii reported that the bacteria are not transferred 
from pupae to adults, but that the adult mosquitoes take up bacteria from the water 
they emerged from and transfer the same bacteria to the water during egg laying 
(Lindh et al., 2008). Other studies have suggested the transstadial transfer of bacteria 
from larvae to adults (Jadin et al. 1966, Pumpuni et al. 1996). An. quadrimaculatus 
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larvae were fed with a Pseudomonas sp., and the bacterial species was later isolated 
from adult guts, suggesting that transstadial transmission had occurred.(Jadin et al. 
1966) Pumpuni et al. fed An. gambiae larvae with Escherichia coli HS5 and later re-
covered this species from one adult in an open system (Pumpuni et al. 1996). 
However, the mechanism by which E. meningoseptica is transmitted across genera-
tions is not known.  
4.1.4 E. meningoseptica as a potential paratransgenic weapon 
The fact that E.meningoseptica is well adapted to the mosquito midgut, is able to com-
pete with other mosquito midgut inhabitants, is vertically or transstadially transmitted, 
is cultivable in the laboratory, is not affected by the diet of the mosquito makes 
E.meningoseptica a potential candidate vehicle for the generation of paratransgenic 
mosquitoes. Its also has an additional paratransgenic advantage by its ability to pro-
duce metabolites which act against the Plasmodium gametocytes which come in 
contact with the mosquito midgut during a blood meal. Paratransgenesis which is a 
novel tool to fight insect pests and vector-infectious diseases has been shown to be 
feasible in malaria-transmitting Anopheles mosquitoes (reviewed in Coutinho-Abreu et 
al., 2010). E. coli expressing cecropin A fusion protein has been shown to inhibited the 
development of P. berghei midgut stages when fed to lab-reared An. stephensi mosqui-
toes (Yoshida et al. 2001). Furthermore, Riehle at al. genetically engineered E. coli to 
display two anti-Plasmodium effector molecules, SM1 and phospholipase A2, on their 
outer membrane surfaces and showed that the bacteria significantly inhibited P. berg-
hei development in An. stephensi mosquitoes (Riehle at al., 2007). However, the 
transgenic E. coli survived poorly in the mosquito midgut, excluding this bacterial 
species as a paratransgenic tool. Contrary to E. coli, however, the cultivable E. menin-
goseptica strain Che01 is well adapted to the mosquito gut and demonstrates 
dominance over other midgut inhabitants and thus might represent an ideal paratrans-
genic vehicle to deliver peptides with transmission blocking properties to the malaria 
vector. 
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4.2 Changes in the transcriptome during malaria parasite transmission from hu-
man to mosquito 
4.2.1 Changes in gene expression by SSH following gametocyte activation  
In this study, we initialy used the SSH method to determine changes in the transcrip-
tome of the malaria parasites during the initial phase of transmission from the human 
to the mosquito. The SSH method amplifies differentially expressed cDNAs while si-
multaneously suppressing amplification of common cDNAs has been shown to be a 
suitable tool for identification of differentially expressed genes (Altincicek et al., 
2007; Zhu et al., 2003). We identified a total number of 126 genes, for which expres-
sion levels changed in the gametocytes during activation with a majority of genes 
assigned to have functions in  signaling, cell cycle and gene regulation, and proteosta-
sis, or they are cytoskeletal and IMC or cell surface proteins. The regulated expression 
of proteins involved in signaling is not doubtful since the induction of gametogenesis 
by the external stimuli i.e. temperature drop and the mosquito-derived molecule XA 
results in the initiation of a number of signaling events in the parasite (McRobert et al., 
2008; (reviewed in Kuehn and Pradel, 2010; Baker, 2011)). At least three effector 
pathways exist; a cGMP-dependent protein kinase (PKG) calcium-independent path-
way that mediates rounding up of activated gametocytes, a calcium-dependent 
pathway that initiates microgamete formation and a calcium-dependent pathway that 
regulates emergence of activated gametocytes of both sexes (McRobert et al., 2008). 
The differential expression of cell cycle and gene regulation protein is probably due to 
the fact that following gametocyte activation their gene products are highly needed. 
Following activation of gametocytes, they are release from the cell cycle arrest state 
and the male gametocytes enter the cell cycle and undergo a rapid transformation fol-
lowing three rounds of DNA replication during gametogensis (Janse et al., 1986). 
Janse et al., observed that during gametogenesis microgametocytes within 8-10 min 
synthesize DNA steadily and at a very high rate to more than the octoploid value 
(Janse et al., 1986). 
It should be noted also that following activation of gametocytes in the mosquito, both 
male and female gametocytes round up and then escape from the enveloping erythro-
cyte. The egress from the enveloping RBC is crucial for gamete formation and 
requires the role of proteases to execute this task (reviewed in Wirth and Pradel, 2012) 
which probably accounts for the high number for regulated proteostasis genes. The 
role of proteases in gametocyte egress from RBCs has been shown indirectly through 
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the use of protease inhibitors on microgametogenesis. It was shown that exflagellation 
of activated P. berghei and P. falciparum gametocytes can be blocked by the cysteine/ 
serine protease inhibitors TLCK and TPCK (Torres et al., 2005; Rupp et al., 2008; So-
logub et al., 2011). 
The adoption of the crescent or banana shape of mature gametocytes and the rounding 
up of gametocytes following activation require the active participation of cytoskeletal 
and IMC proteins (Dixon et al., 2012; Kono et al., 2012). Also, following activation of 
gametocytes, they are able to form filamentous cell to cell connections which allow for 
communication between cells (Rupp et al., 2011). The high need of these proteins fol-
lowing activation is the probable reason for the regulated cytoskeletal and IMC protein 
expression. 
The high expression changes of surface proteins following activation can be explained 
by the fact that these proteins cover the surface of gametes to protect them from the 
aggressive environment of the mosquito midgut. In a recent study, Simon and col-
leagues (Simon et al., 2013) showed how the IMC protein PfGAP50 is able to relocate 
to the gamete surface where it binds to factor H and uses surface bound FH to inacti-
vate the complement system thereby preventing the gametes from complement lysis in 
the blood meal. Also, it is suspected that surface adhesion proteins form complexes 
which cover the macrogamete in the form of sticky coat and that they are involved in 
important processes during malaria transmission to the mosquito (reviewed in Kuehn 
and Pradel, 2010). 
Noteworthy, about  60% of the SSH genes have been detected in the currently availa-
ble P. falciparum gametocyte proteomes, while for 40% there is as yet no protein 
evidence indicating the identification of more gametocyte specific proteins in this 
study. We also found that only 8.7% of the SSH genes have P. berghei orthologs regu-
lated by DOZI and CITH indicating that the majority of genes identified via SSH, 
which change in transcript expression levels during gametocyte activation, are not 
translationally controlled in non-activated gametocytes, while many such genes have 
been identified to function in zygote to ookinete transformation (Sebastian et al., 
2012). Therefore it is probable that gene regulation is important for the early events of 
gametocyte activation, i.e. for gametogenesis and fertilization, while translational re-
pression particularly plays a role for the expression of proteins important for ookinete 
development. 
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4.2.2 Changes in transcript levels by qRT-PCR 
We wanted to confirm transcript changes in gametocytes during activation and deter-
mine if these genes become up or down regulated following gametocyte activation. We 
performed qRT-PCR on a subset of genes from the different ontology groups whose 
transcript levels changed following gametocyte activation as determined by SSH. We 
quantified the transcript levels from mixed asexual F12 gametocyte- less P. falciparum 
strain, immature (stages III and IV) and mature (stage V) gametocytes of P. falciparum 
strain NF54 and from activated gametocytes at 30 min post-activation. 
The results showed transcription in mature gametocytes for 29 out of the 34 genes ana-
lyzed and 20 genes showed increased transcript expression in gametocytes compared 
to asexual blood stage parasites. The presence of gametocyte transcripts in most of the 
genes studied confirm the purity of the gametocyte samples used in the SSH method 
and also to some extent validates the usefulness of the method.  
4.2.2.1 Genes with high transcript levels in activated gametocytes as compared to 
other stages 
We identified 8 genes i.e. PF3D7_0827800 (set3), Pf3D7_1246200 (actin1), 
PF3D7_1218800 (psop17), PF3D7_1239400, PF3D7_0704100, PF3D7_0417400, 
PF3D7_1321000 and PF3D7_1316700 for which transcript levels were increased in 
activated gametocytes as compared to asexual blood stages, immature gametocytes 
and non-activated gametocytes, indicating that these genes may play an important role 
downstream of gametocyte activation in the mosquito midgut. Among these genes, 
only set3, actin 1 and psop17 have been studied previously to some extend. SET pro-
teins have been identified as  multifunctional  proteins associated to different processes 
such as chromatin remodelling (Matsumoto et al., 1999), regulation of epigenetic 
marking of histones (Cervoni et al., 2002), transcription (Shikama et al., 2000) and 
viral DNA replication (Nagata et al., 1995). 
SET3 has been described to accumulate in male gametocytes of Plasmodium, where it 
is suspected to contribute to a prompt entry and execution of S/M phases in the deve-
lopmentally arrested male gametocytes once taken up into the mosquito (Pace et al., 
2006). SET domains are assigned to chromatin dynamics and are often found in his-
tone methyltransferases, thus they play a role in the epigenetic control of gene 
regulation. The P. falciparum genome encodes for at least nine SET-domain-
containing genes which exhibit five different types of substrate specificities (Cui et al., 
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2008). The up regulated expression of set3 following gametocytes activation is an in-
dication of a role of the gene product in the epigenetic control of gene regulation 
during gamete formation. 
ActinI forms part of the plasmodial motor complex (reviewed in Baum et al., 2008; 
Nono et al., 2012) and recently have been also reported to be present in gametocytes 
(Deligianni et al., 2011; Simon et al., 2013). PSOP17 (putative secreted ookinete pro-
tein 17) was previously reported to be expressed in mature gametocytes of P. 
falciparum (Florens et al., 2002; Silvestrini et al., 2010 ) and in ookinetes of P. berghei 
(Ecker et al., 2008). However, the function of the protein is not known. 
In a recent study, P. falciparum RNA seq sequences from seven stages including asex-
ual and sexual stages (ring, early and late troph, schizont, gametocyte II and V, and 
ookinete) also revealed high expression of PF3D7_1239400, PF3D7_0704100, 
PF3D7_0417400, PF3D7_1321000 and PF3D7_1316700 in matured  stage V gameto-
cytes as compared to the asexual stages (López-Barragán et al., 2011). 
The fact that the transcript expression of the two control genes, PF3D7_1031000 
(pfs25) and PF3D7_1412500 (actinII) was strong in gametocytes compared to asexual 
blood stage parasites and increased during gametocyte activation validates the qRT-
PCR results. Pfs25 is expressed in the vesicular structures during gametocyte matura-
tion then it relocate to the surface of macrogametes where it is highly expressed 
following activation and then subsequently present on the parasite surface until the 
ookinete stage (Rener et al., 1983; Quakyi et al., 1987; Scholz et al., 2008). ActinII is a 
sexual stage-specific actin isomer and has been shown to be highly expressed in the 
sexual stages (Wesseling et al., 1989) and in P. berghei actinII protein has been re-
ported to play a role during microgametogenesis (Deligianni et al., 2011). 
4.2.2.2 Genes with high transcript levels in gametocytes compared to asexual 
stages 
Twelve genes were identified with increased transcript expression in gametocytes 
compared to asexual blood stage parasites, and transcript levels either remained con-
stant, decreased or increased following activation. These include PF3D7_0302100 
(clk4), PF3D7_0818200 (14-3-3), PF3D7_1115200 (set7), PF3D7_0422300 (α-tubulin 
II), PF3D7_0708000, PF3D7_1103500 (encoding for a CPW-WPC protein), 
PF3D7_406200 (pfs16), PF3D7_1457000 (spp), PF3D7_0817600 (encoding an for 
unknown protein termed PPLP6), PF3D7_1225600, PF3D7_1438800 and 
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PF3D7_1023000. The P. falciparum mRNA splicing kinase CLK-4 (also termed 
SRPK1) is expressed in the asexual blood stages and gametocytes (Dixit et al., 2010; 
Agarwal et al., 2011) with expression levels shown to be higher in matured gameto-
cytes (López-Barragán et al., 2011). Also, a gene knock-out of the orthologous protein 
in P. berghei failed to exflagellate upon gametocyte activation suggesting a role in mi-
crogamete formation (Tewari et al., 2010). The proteins 14-3-3 belong to a family of 
highly conserved molecules present virtually in all eukaryotes and are known to regu-
late a large variety of cellular processes such as core metabolism, cell cycle, protein 
localization and trafficking and signal transduction (reviewed in van Heusden, 2005).  
They mediate these events through interaction with a large number of target proteins. 
In Plasmodium, it has been shown that dematin; a component of the erythrocyte mem-
brane skeleton is recuited by the malaria parasite following infection (Lalle et al., 
2011). The internalised dermatin interacts with Plasmodium 14-3-3 and the dematin-
14-3-3 interaction is strictly dependent on phosphorylation of dematin at specific ser-
ine residues (Lalle et al., 2011). Also, in a recent study, Dastidar and colleagues 
(Dastidar et al., 2013) identified Plasmodium 14-3-3 as a protein that binds selectively 
to P. falciparum histone H3 phosphorylated on Ser28. Noteworthy P. falciparum14-3-3 
has been shown to be expressed in gametocytes (López-Barragán et al., 2011).  
Transcript of set7 is destabilized in the absence of DOZI and CITH pointing at a trans-
lational repression of set7 in gametocytes and suggesting a role in epigenetic control 
mechanisms of the ookinete. Pfs16 is a transmembrane protein of the gametocyte 
PVM (Eksi and Williamson, 2011; Silvestrini et al., 2005; Baker et al., 1994; Bruce et 
al., 1994). After the PVM has ruptured during the egress of the activated gametocyte 
from the host cell, Pfs16 is not detectable any longer in the sexual stage parasite (So-
logub et al., 2011) which explains why there is a decrease of transcript following 
activation. Alpha-tubulin II is an isoform of tubulin which has been shown to be ex-
pressed in asexual blood stage parasites, in gametocytes and in microgametes 
(Schwank et al., 2010; Fennell et al., 2008; Rawlings et al., 1992). Targeted gene 
modification studies in P. berghei indicated that α-tubulin II plays an important role 
for microgametogenesis (Kooij et al., 2005). The fact that α-tubulin II transcript levels 
decrease during gametogenesis lets us conclude that the α-tubulin II filaments needed 
for the formation of the microgametes are already present in the mature gametocytes 
prior to activation. The presenilin-like signal peptide peptidase (SPP) was previously 
reported to be involved in merozoite invasion and cleavage of the erythrocyte cy-
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toskeletal protein band 3 (Li et al., 2008). A recent study, however, disagrees with 
these findings, and reported that SPP is an ER-resident protease required for growth of 
the erythrocytic stages (Marapana et al., 2012). SPP is considered as a potential drug 
target of liver and blood stage parasites (Marapana et al., 2012; Li et al., 2009; Par-
vanova et al., 2009). SPP has also been shown to be highly expressed in matured 
gametocyte (López-Barragán et al., 2011) which is in confirmity with our results. The 
combined data therefore indicate that SPP is present in the liver, blood and gametocyte 
stages, pointing to a multi-stage function of SPP.  
The gene product of PF3D7_0817600 is an unknown protein which was initially pre-
dicted to posses a MAC/PF domain, similar to the MAC/PF domains of the previously 
described plasmodial perforin-like proteins PPLP1-5 ((reviewed in Wirth and Pradel, 
2012), Sologub et al., 2011; Kaiser et al, 2004). However, recent annotation shows a 
lacked of the domain. We termed the protein PPLP6 in this study. The gene product of 
PF3D7_1103500 is a member of a family of nine secreted proteins with cysteine-rich 
CPW-WPC domains ((reviewed in Sutherland et al., 2009); Saeed et al., 2008). This 
domain is a conserved domain of about 61 residues in length that exhibits six well-
conserved cysteine residues and six well-conserved aromatic sites. The 
PF3D7_1103500 gene ortholog in P. berghei is under translational control. Also, the 
expression of PF3D7_1103500 has been shown to be upregulated in ookinetes point-
ing to a role of the protein in zygote to ookinete development. In a recent study, 
Kangwanrangsan and coworkers (Kangwanrangsan et al., 2013) showed that Plasmo-
dium yoeli cpw-wpc1 mRNA is transcribed in gametocyte while the protein is 
expressed  mainly on zygote/ookinete surfaces which further suggests that members of 
the CPW-WPC family are under translational control in Plasmodium. The expression 
of the protein on zygote or ookinete surfaces makes them potential targets for trans-
mission blocking vaccines. The genes PF3D7_1225600, PF3D7_1438800 and 
PF3D7_1023000 have been shown to be highly expressed in gametocytes (López-
Barragán et al., 2011) which corroborates with our results. Their functions are not 
known. 
4.2.2.3 Genes with high transcript levels in asexual blood stages 
The qRT-PCR also revealed five genes whose expression was predominant in the 
asexual blood stages and show a resurgence in transcript expression in gametocytes 
during maturation, i.e. PF3D7_1238900 (pk2), PF3D7_1136400 (encoding for a tetra-
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trico peptide repeat region; TPR), PF3D7_1021700, PF3D7_1026600 and 
PF3D7_1251200 (coronin). The calcium/calmodulin-dependent protein kinase PK2 
was mainly investigated in the asexual blood stages of P. falciparum (Kato et al., 
2008, Ward et al., 2004). A study of P. falciparum RNA seq sequences from seven 
stages (ring, early and late troph, schizont, gametocyte II and V, and ookenete) re-
vealed that the gene is expressed in gametocytes and highly upregulated in ookinetes 
(López-Barragán et al., 2011). This result is in confirmity with our findings and there-
fore suggesting that the protein may be important in the midgut stages of the malaria 
parasite. The gene product of PF3D7_1136400 comprises a TPR domain, which is 
known to mediate protein-protein interactions and the assembly of multiprotein com-
plexes (reviewed in Allan et al., 2011), but the function of the plasmodial TPR domain 
protein is not yet known.  Coronin is a WD repeat containing actin binding protein that 
was first characterized in Dictyostelium discoideum, where it is essential for phagocy-
tosis and motility (de Hostos, 1999). WD-repeat proteins are a large family found in 
all eukaryotes, implicated in a variety of functions ranging from signal transduction 
and transcription regulation to cell cycle control and apoptosis. The WD40 motifs act 
as a site for protein-protein interaction, and proteins containing WD40 repeats are 
known to serve as platforms for the assembly of protein complexes or mediators of 
transient interplay among other proteins (reviewed in Stirnimann et al., 2010). WD-
repeat proteins of P. falciparum have hitherto been described as receptors for protein 
kinase C, and as components of the myosin-driven motor complex (Madeira et al., 
2003; Foth et al., 2006, Tardieux et al., 1998). P. falciparum coronin has been shown 
to be associated with F-actin and therefore involved in actin dynamics (Tardieux et al., 
1998). Therefore the gene product of PF3D7_1251200 (coronin) could be important in 
this process in asexual parasites and gametocytes as depicted by its transcript level in 
these stages. 
 For four genes, PF3D7_0818900 (hsp70-1), PF3D7_080700 (su α6), PF3D7_0807500 
(gap50), and PF3D7_1444800 (encoding for fructose 1,6 bisphosphatealdolase, 
FBPA) expression was high in asexual blood stages and decreased during gametocyte 
development and following activation. SU α6 is a component of the plasmodial pro-
teasome, a proteolytic complex composed of more than 33 SUs that is responsible for 
the degradation and recycling of ubiquitinated proteins. As an external control we thus 
investigated the transcript levels of another α-ring component, su α5, and revealed 
similar changes in the transcript levels of su α5 in asexual blood stage parasites and 
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gametocytes before and after activation. The fact that the transcript level following 
gametocytes activation was low for su α5 and su α6 suggest that protein re-cycling is 
important for asexual and sexual development, but that it does not play an important 
role for the rapid morphological changes during gametogenesis. The genome of P. fal-
ciparum encodes for a variety of chaperones, including heat shock proteins (HSPs) of 
the HSP70, HSP90 and DnaJ/HSP40 families (reviewed in Pavithra et al., 2007). 
HSP70-1 was previously described to be located in the cytoplasm and nucleus of the 
parasite blood stages (Kappes et al., 1993) as well as in the PV, pointing to a role in 
protein transport to the erythrocyte (Nyalwidhe and Lingelbach, 2006). Another pro-
posed function of HSP70-1 includes the protein trafficking to the apicoplast (Ramya et 
al., 2007; Foth et al., 2003) , indicating that the chaperone has several essential func-
tions and is important for multiple life-cycle stages. 
The gene PF3D7_0807500 encodes for a transmembrane protein GAP50 which has 
been identified as part of the IMC of the parasite invasive stages, including the ooki-
nete (Baum et al., 2008, 2006). Recently, GAP50 was also described as a component 
of the gametocyte IMC (Dearnley et al., 2012; Kono et al., 2012; Simon et al., 2013). 
The transmembrane protein links myosin with the outer membrane of the IMC and 
thus contributes to gliding motility of the parasite. Gap 50 is also suspected to be un-
der translational control, thus the release of the translational repression and onset of 
protein synthesis during gametocyte activation might cause the detected decrease in 
the gap50 transcript level (Gunner Mair, unpublished observation). FBPA is an en-
zyme of glycolysis and in Plasmodium is also reported to be part of the motor 
complex, here linking TRAP to actinI (Baum et al., 2006; Buscaglia et al., 2006). 
Noteworthy in this context, during gametocytogenesis, malaria parasites shift from 
glycolysis towards mitochondrial respiration (van Dooren et al., 2006), which might 
explain the decrease in FBPA expression in gametocytes compared to asexual blood 
stage parasites. 
Transcript expression for five genes, PF3D7_0815800 (VSP9), PF3D7_0215400 (en-
coding for a WD40 motif), PF3D7_1351700 (alv6), PF3D7_1033200 (etramp10.2), 
and PF3D7_0207700 (sera4), were negligible in gametocytes. The gene 
PF3D7_0815800 encodes for a homolog to the yeast vacuolar sorting protein VSP9 
with a predicted function in protein-protein interactions, while PF3D7_0215400 en-
codes for a protein with a WD40 motif. The fact that their transcript levels were 
negligible in gametocytes and gametes suggest that they donot play important roles in 
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these stages. Furthermore, ALV6 is a member of the alveolin family, which comprises 
7 proteins in P. falciparum, associated with the membranous sacs of the IMC (Gould 
et al., 2008). The fact that alv6 expression decreases during gametocytogenesis is fair-
ly surprising, considering that gametocytes posses an IMC. It has to be elucidated, if 
the expression of any other ALV protein member is up-regulated in gametocytes. The 
early transcribed membrane proteins (ETRAMPs) are proteins of the plasmodial PVM 
(Spielmann et al., 2003; MacKella et al., 2011). In P. falciparum the proteins were 
shown to form complexes with the PVM protein exported protein 1 (EXP-1) (Spiel-
mann et al., 2006). To date, etramp10.2 transcripts were found in P. falciparum 
trophozoites and the mixed asexual stages and the liver stages of P. yoelii (Spielmann 
et al., 2003; MacKella et al., 2011). Because EXP-1 is also present in the gametocyte 
PVM (Sologub et al., 2011), the expression of some of the ETRAMPs in these stages 
can be expected. It thus remains to be elucidated, if the other two SSH-identified 
ETRAMPs, ETRAMP2 and ETRAMP4, might play a specific role for gametocytes. 
Expression of serine repeat antigen SERA4 in the asexual blood stages has previously 
been described (Miller et al., 2002). The SERA family comprises 9 proteins with func-
tions in asexual blood stage growth and host cell egress (reviewed in (Wirth and 
Pradel 2012; Rosenthal et al., 2011)). 
4.2.3 Changes in protein expression of SSH gene 
In order to determine if the changes in transcript level following qRT-PCR, are in con-
formity with that at the protein level, we selected some of the analyzed qRT-PCR 
genes and analyzed their protein expression levels using antibody against them via in-
direct immunofluorescence assay. We confirmed an up-regulation in the protein 
expression of PK2, actinII and Pfs25 following gametocyte activation indicating an 
important role of the protein following gametocytes activation in the mosquito midgut. 
Pfs 25 and ActinII have already been shown to be important in the development of the 
malaria parasite in the mosquito midgut (Vlachou et al., 2001; Deligianni et al., 2011) 
but the function of PK2 is not yet known. Also, CLK-4, proteasome SU α5, and 
PPLP6 were detected in asexual blood stage parasites and gametocytes during matura-
tion, but the proteins were down-regulated in gametocytes at 30 min p.a. which 
corroborates with our qRT-PCR results. The down regulation of CLK-4, SU α5 and 
PPLP6 suggest that the proteins are not important following gametocyte activation in 
the mosquito. Pfs16 was almost undetectable in gametes following gametocyte activa-
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tion. This is due to the fact that the protein is localized in the PVM and following ga-
metocytes activation for 30 min, the parasites has egressed from the enveloping 
erythrocyte and the PVM is destroyed. Noteworthy, the transcript level was also sig-
nificantly reduced following gametocyte activation as depicted by qRT-PCR. The 
slightly upregulation of GAP50 protein following gametocyte activation while the 
mRNA transcript level as depicted by qRT-PCR was low can be explained by the fact 
that translationally repressed gap50 transcript is present in the non-activated gameto-
cytes and that the release of repression during activation leads to rapid translation and 
in consequence to a loss in transcript abundance and an increase in protein abundance. 
Also, GAP50 has been recently shown to relocate from the gametocytes IMC to the 
surface of gametes following activation where it is able to bind factor H and prevent 
the parasite from complement lysis in the mosquito midgut (Simon et al., 2013). In 
agreement with the qRT-PCR results on ActinI transcript, the protein is present in both, 
asexual blood stages and gametocytes, and a minor up-regulation in the activated ga-
metocytes was detected. The 14-3-3 protein is also expressed in asexual blood stages, 
gametocyte and gametes as depicted by qRT-PCR and indirect immunofluorescent as-
say. The high expression of the protein in gametocytes and gametes suggest a role of 
the protein in these stages. 
The overall data on the changes in the P. falciparum transcriptome before and after 
activation of gametocytes provide first insights into the regulation of gene expression 
following initiation of gametogenesis in the mosquito vector and form a base for fur-
ther studies on genes important for the transmission of malaria parasites to the 
mosquito. Also, we identified novel genes involved in the sexual reproduction and fu-
ture development of the mosquito midgut stages, which might serve as important 
targets for transmission blocking strategies.  
 
4.3 Role of antimicrobial molecules as transmission blocking agents 
In this part of the study we determined the effect of antimicrobial molecules which 
could be exploited in transmission blocking strategies to prevent the spread of malaria 
by the mosquito.  
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4.3.1  Harmonine 
Since insects among all phyla in the animal kingdom seem to have succeeded best in 
life, accounting for more than one million different species (Vilmos et al., 1998), this 
is proof that they have developed a potent and efficient immune system to fight against 
pathogens. Therefore some of these substances produced by the innate immune re-
ponse of insects could be exploited to kill pathoges causing diseases in humans. The 
Asian harlequin ladybird beetles Harmonia axyridis has been known for its high inva-
sive nature in Europe which allows it to outpower and therefore dominate the most 
abundant native European ladybirds, Coccinella septempunctata and Adalia bipuncta-
ta (Roy et al., 2008). Its invasive success has been attributed to their enduring 
resistance against diverse pathogens due to its unprecedented expansion among genes 
encoding antimicrobial molecules (Vilcinskas et al., 2013).  The Asian harlequin lady-
bird beetle release droplets of hemolymph containing deterrent alkaloids through their 
leg joints when threatened or attacked as a means of defence. The active compound 
called harmonine (17R,9Z)-1,17-diaminooctadec-9-ene) was isolated from the hemo-
lymph and identified by mass spectrometry and shown to exhibit a broad-spectrum of  
antibacterial activities (Röhrich et al., 2012).We tested the compound against P. falci-
parum asexual stages as well as mosquito midgut stages. We showed that the 
compound exhibited significant effect on both asexual and sexual stages (gametocytes 
and zygotes) and in vivo transmission blocking assay showed a significant transmis-
sion blocking effect. The fact that the compound had an effect on both asexual and 
sexual stages implies it could serve as an important drug which is able to act against 
the erythrocytic stages, thereby preventing the clinical manisfestation of malaria and 
also against the sexual stages preventing the spread of the disease by the mosquito. 
Antimicrobial molecules isolated from the hemolymph of insects have also been 
shown to exhibit Plasmodium transmission blocking activities. Gomesin, an antim-
icrobial peptide isolated from the hemocytes of the spider Acanthoscurria gomesiana 
was also shown to inhibit the growth of intraerythrocytic forms of P. falciparum, P. 
berghei mature gametocytes, exflagellation of male gametes and the formation of 
ookinetes and exhibited transmission blocking effect in in vivo experiments ( Moreira 
et al., 2007). Shahabuddin and coworkers reported that injection of defensins from 
Phormia terranovae (flesh fly) and Aeschna cyanea (dragon fly) into the heamolymph 
of Aedes aegypti negatively affected the development of P. gallinaceum oocysts and 
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sporozoites (Shahabuddin et al., 1998). Gambicin an antimicrobial peptide isolated 
from An. gambiae has also been shown to exhihibit a moderate effect on P. berghei 
ookinetes (Vizioli et al., 2001). Harmonine at concentration of upto 100 µM did not 
affect the intergrity of uninfected RBCs indicating that the compound only acts on in-
fected parasitized RBCs. Harmonine also demonstrated moderate cytotoxicity to 
mammalian Hela cells. Since the compound is moderately toxic to human cells, we 
therefore suggest that the development and testing of derivaties may lead to the dis-
covery of less toxic anti-malarial drugs with both parasitocidal and transmission 
blocking activities. 
4.3.2 Recombinant produced peptides 
The transmission blocking effect of a range of recombinantly produced peptides in to-
bacco was tested against P. berghei. Several recombinant proteins produced in plants 
can serve for medical purposes like vaccines (reviewed in Glenz and Warzecha, 2006). 
All recombinant peptides tested in this study showed no transmission blocking activity 
in P. berhei. Several reasons could account for this lack of activity; one reason could 
be the fact that the recombinant peptides produced with expression targeted into the 
different compartments in tobacco lead to missfolding thereby making them unable to 
execute their functions. Also, another reason could be that the concentration of pep-
tides used in the study was not high enough to gain transmission blocking activities or 
the peptides do no actually act on the sexual stages of the malaria parasite.  
Among the peptides tested, only SM1 has been shown to inhibit the development of 
Plasmodium in the mosquito. It has been shown that SM1 bind to both the luminal side 
of the midgut epithelium and the distal lobes of the salivary gland in order to inhibit 
Plamodium development in the mosquito (Ghosh et al., 2001). However, the mechan-
ism of inhibition has only been shown in the mosquito salivary gland whereby the 
SM1 peptide competes with TRAP (Thrombospondin-related anonymous protein), a 
protein expressed in Plasmodium sporozoites for binding to saglin, a protein expressed 
on the suface of the mosquito salivary gland (Ghosh et al., 2009). The saglin/TRAP 
interaction is crucial for salivary gland invasion by Plasmodium sporozoites. When 
SM1 binds to saglin, TRAP is prevented from binding and therefore the sporozoites 
are unable to invade the mosquito salivary gland leading to inhibition of Plasmodium 
development. The receptor of SM1 in the mosquito midgut lumen is not yet known. 
The lack of activity of SM1 in our study is probably due to the improper folding of the 
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peptide. The experimental set up could also be a problem since in most studies where 
the transmission blocking activity of SM1 was tested, the peptide was either injected 
through the tail vein of an infected mouse and the inhibitory activity tested following 
feeding of mosquitoes on the treated mouse or the peptides were mixed together with 
Plasmodium infected blood which was not the case in our study. 
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5. Conclusions and future perspectives 
This doctoral thesis provides novel insights on strategies to reduce malaria transmis-
sion in the mosquito. In summary; 
1) We have identified the rod-shaped E. meningoseptica as a dominant midgut bacte-
rium of lab-reared An. stephensi. E. meningoseptica is well adapted to the mosquito 
midgut, transmitted between developmental stages and generations and not affected by 
the diet of the mosquito. Also, extracts from E. meningoseptica exhibited antibacterial, 
antifungal and antiplasmodial activities. Most importantly, isolates of E. meningosep-
tica were cultivable, making the bacterium a potential candidate vehicle for the 
generation of paratransgenic Anopheles mosquitoes. 
2) Following analysis of transcriptome changes during the initial phase of malaria 
transmission from the human to the mosquito, we have identified novel genes with 
high expression levels in activated gametocytes as compared to asexual blood stages, 
immature and mature gametocytes pointing to important roles downstream of gameto-
cyte transmission to the mosquito.  
3) We have shown the antiplasmodial and transmission blocking effect of the antimi-
crobial molecule harmonine, a defense compound isolated from the hemolymph of the 
Asian ladybug Harmonia axyridis. Harmonine thus represents a potential lead struc-
ture for the development of novel antimalarials. 
Future experiments will include a further characterization of E. meningoseptica as a 
paratransgenic weapon. First, E. meningoseptica will be tested for its survival in the 
mosquito midgut by treating mosquitoes with antibiotics to remove the midgut micro-
biota and then introducing E. meningoseptica via the sugar pads or the blood meal, 
allowing us to monitor the survival over a period of time. Then the bacterium will be 
tested for its transformation competence. As proof of concept, we intend to transform 
the bacterium with a plasmid which will enable it to express GFP. The survival of the 
bacterium after transformation, the stability of the plasmid in the transformed bacte-
rium and the expression of the GFP protein by E. meningoseptica will be determined. 
Also, the stability of the transformed GFP-E. meningoseptica in the mosquito midgut 
will also be evaluated following feeding to An. stephensi mosquitoes. If successful, the 
bacterium will then be genetically modified to express effector molecules such as in-
hibitory peptides or highly specific single chain antibodies and its transmission 
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blocking potential will be investigated using transmission blocking assays. Once the 
genetically modified E. meningoseptica is able to demonstrate transmission blocking 
effect in the mosquito, further experiments will be to determine the fitness of the para-
transgenic mosquito in the laboratory. Then we will assess the safety of the genetically 
modified bacterium to the environment and the most suitable way of delivery of the 
bacterium to mosquitoes in the field. 
Other future works will include the functional characterization of the genes with high 
transcript levels following gametocyte activation since their gene products may 
represent key targets for transmission blocking interventions. Firstly, specific antibo-
dies will be generated to determine the expression pattern and localization of the gene 
products in mosquito midgut stages by indirect immunofluorescent assays. Secondly, 
mutant malaria parasites in which the genes of interest are disrupted will be generated. 
The phenotype of the different mutants will be investigated for its survival through the 
transmission stages of the malaria parasite in the mosquito vector by membrane feed-
ing of mosquitoes with the mutant parasite lines. Disrupted gene products of mutant 
parasites with reduced malaria transmission in the mosquito may represent transmis-
sion blocking targets and will be investigated further for their potential as either 
transmission blocking drugs or transmission blocking vaccine targets. For determina-
tion if they represent transmission blocking drug targets, specific inhibitors targeting 
the gene products will be generated and testing on their ability to inhibit microgame-
togenesis through exflagellation inhibition assays. To determine if they represent 
transmission blocking vaccines targets, specific anti-sera against surface expressed 
gene products will be generated and tested for their transmission blocking effect 
through ex vivo membrane feeding assays. 
Lastly, due to the fact that harmonine exhibited moderate toxicity to human cells, the 
compound thus represents a potential lead structure for the development of novel an-
timalarials. Futher experiments will be to synthesize harmonine derivatives and test 
them for their antimalarial and transmission blocking effect as well as their toxic effect 
on human cells. If a highly selective derivative with antimalarial and transmission 
blocking activity is obtained, its pharmacokinetic properties can then be determined 
before proceeding to clinical trials. 
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7. Appendix 
7.1  Abbreviations 
% percentage 
°C degree celcius 
µ                             micro 
16s rRNA                16s ribosomal RNA 
aa               amino acid 
act                            activated 
ACTs                        artemisinin combination therapies 
AMA   apical membrane antigen 
APAD   3-acetylpyridine adenine dinucleotide 
APS    ammonium peroxyde sulfate 
ATP    adenosine 5’-triphosphate 
BLAST                   basic local alignment search tool 
bp                            base pairs 
BSA    bovine serum albumin 
cDNA    complementary DNA 
CO2    carbon dioxyde 
d                              days 
dATP    2’-deoxyadenosine-5’-triphosphate 
ddH2O                    doubled distilled water 
DEPC    diethyl pyrocarbonate 
DGGE                     denaturing gradient gel electrophoresis 
dH2O  distilled water 
DMEM                   Dulbecco's Modified Eagle Medium 
DMSO    dimethylsulfoxide 
DNA    deoxyribonucleic acid 
DNase   deoxyribonuclease 
dNTP    deoxynucleotide triphosphate 
DTT                         dithiothreitol 
EDTA                       Ethylenediaminetetraacetic acid 
EGF                          epidermal growth factor 
g     gram 
GC                            gametocyte 
GFP    green fluorescent protein 
GST    Glutathione-S-transferase 
h hour 
HEPES   N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid 
IC50    inhibitory concentration 50 
IFA    immunofluorescence assay 
IMC                         inner membrane complex 
IPTG   Isopropyl-β-D-1-thiogalactopyranoside 
kDa    kilodaltons 
l     liter 
M     molar 
mg                           milligram 
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min     minutes 
mRNA    messenger RNA 
MTT                                              (3-(4, 5-Dimethylthiazol-2-yl)-2,5 Diphenyl tetrazolium bro-
mide  
MW               molecular weight 
NBT                        nitroblue tetrazolium 
OD               optical density 
OTU                       operational taxonomic unit 
p.a                           post activation 
PABA                      paraaminobenzoic acid 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PVM                        parasitophorous vacuolar membrane 
RFLP                       restriction fragment length polymorphism 
RNA    ribonucleic acid 
RNase    ribonuclease 
RNase H    Ribonuclease H 
RT    room temperature 
SDS    sodium dodecyl sulfate 
sp.                           species 
SSH                         suppressive subtractive hybridization 
TBA                         transmission blocking antigen 
TBDs                       transmission blocking drugs 
TBVs                       transmission blocking vaccines 
TEMED   N, N, N’, N’-tetramethylethylendiamine 
TR                            translational repression 
Tris    tris-(hydroxymethyl)-aminomethane 
U     unit 
UV     ultraviolet 
v/v                          volume concentration 
w/v                            weight per volume 
WBA                       western blot analysis 
XA                           xathurenic acid 
 
 
 
7.2  16s rRNA gene and SSH sequences 
16s rRNA gene and SSH sequences obtained in this study can be found on the CD at-
tached to this thesis. 
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